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1.1 Herpes Simplex virus type I and Pseudorabies virus 
1.1.1 Introduction 
 The human herpes simplex virus type I (HSV-1) and the porcine pseudorabies virus 
(PRV), also known as Aujeszky’s disease virus or suid herpes virus type I (SHV-1) both 
belong to the family of the Herpesviridae. The members of the Herpesviridae all share 
biological characteristics, although there are important differences between the subfamilies. 
All herpesviruses have a double-stranded DNA genome, a virion size of 200 – 250 nm and a 
structure that consists of a capsid, tegument and envelope. They all encode their own 
enzymatic machinery for replication and DNA synthesis, and capsid formation and 
encapsidation of viral genomes take place in the nucleus. They also all undergo a latent 
phase in their lifecycle (Roizman and Pellet, 2001). 
 Based on their biological properties, genome content and organization, herpesviruses 
are mainly subdivided in three major subfamilies: Alphaherpesvirinae,  Betaherpesvirinae 
and Gammaherpesvirinae. The subfamilies differ in cell type where they establish latency 
and the duration of their replication cycle. The alphaherpesviruses, to which HSV-1 and PRV 
belong, have the broadest host range, replicate rapidly and establish latency mainly in 
sensory neurons. Betaherpesviruses have the most restricted host range, replicate very 
slowly and establish latency in a number of tissues including secretory glands, kidneys and 
lymphoreticular cells. Gammaherpesviruses have a restricted host range and establish 
latency in lymphoid tissue (Roizman and Pellet, 2001). 
 There are three important human alphaherpesviruses: herpes simplex virus type 1 
(HSV-1), herpes simplex virus type 2 (HSV-2) and varicella zoster virus (VZV). Other 
important animal alphaherpesviruses besides the porcine PRV are equine herpesvirus 1 and 
4 (EHV-1 and EHV-4), bovine herpesvirus 1 and 5 (BoHV-1 and BoHV-5), avian herpesvirus 
Marek’s disease virus (MDV), canine herpesvirus 1 (CHV-1) and feline herpesvirus 1 (FPV-1) 
(Roizman and Pellet, 2001).      
1.1.2 Pathogenesis 
 Herpes simplex has two virus variants: HSV-1 and HSV-2. The most common 
symptoms associated with HSV-1 are recurrent cold sores, but the virus may also cause 
recurrent ocular infections that represent the leading infectious cause of corneal blindness in 
the industrialized world. HSV-1 rarely causes encephalitis, which can be fatal. A large part of 
the human population is seropositive for HSV-1 (Jones, 2003). HSV-2 is the major cause of 
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recurrent genital lesions, although these may also be caused by HSV-1, but often causes 
asymptomatic infections. 
 PRV is the causative agent of Aujeszky’s disease in pigs and is highly pathogenic for 
mammals except higher primates and humans. Pigs are the only susceptible animals that 
survive a PRV infection and are therefore considered as the natural host (Gustafson, 1986; 
Pensaert and Kluge, 1989). The severity of the disease depends on the age of the pig and 
the immunological status. Neonatal piglets suffer from nervous system disorders (which may 
be fatal) while older pigs show respiratory and reproductive problems (Baskerville, 1973; 
Akkermans, 1976). 
 The primary site of infection is located at the upper respiratory tract from where the 
virus spreads via blood, lymph and nerves to the central nervous system and internal organs, 
which represent the secondary sites of infection (Sabo et al., 1969; Baskerville, 1973; Miry 
and Pensaert, 1989).      
1.1.3 Virion structure 
 All herpesviruses share the same virion structure and have a similar virion size of 200 
to 250nm. The virion consists of four structural elements (Fig. 1). The genome consists of a 
double-stranded lineair DNA molecule of approximately 144kbp for PRV and 152kbp for 
HSV-1 (Ben-Porat and Kaplan, 1985; Roizman et al., 1992). The PRV genome sequence 
consists of a unique long segment (UL) and a unique short segment (US) which is flanked by 
two inverted repeats, the terminal repeat sequence (TRS) and the internal repeat sequence 
(IRS) (Fig. 1C). The HSV genome has two repeat regions on both termini and a repeat 
region that is inserted in an inverted orientation separating the UL and US regions (Fig. 1D). 
The genes are designated as UL or US, dependent on the location of the gene within the 
genome, followed by a number that indicates the place of the gene in the genome (Ben-Porat 
and Kaplan, 1985). The HSV-1 genome contains 80 open reading frames (ORFs) while PRV 
only encodes 72 ORFs. The genome sequence of alphaherpesviruses is highly conserved, 
implying that most viruses have orthologous proteins. In fact, PRV does not encode a single 
unique gene that is not present in other herpesviruses (Klupp et al., 2004; Pomeranz et al., 
2005).   
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 The genome is surrounded by an icosahedral capsid that consists of 162 capsomers. 
The capsid together with the genome is called the nucleocapsid (Mettenleiter, 2000). The 
major capsid protein VP5 is encoded by UL19 which is conserved among herpesviruses 
(Newcomb et al., 1999). The nucleocapsid is surrounded by an amorphous electron dense 
protein layer, the tegument. The inner layer of the tegument is tightly associated with capsid 
proteins and the outer layer is more asymmetrical and heterogeneous and is located beneath 
the envelope (Grunewald et al., 2003). The envelope forms the outer layer of the virion and 
consists of a double phospholipid layer. This layer originates from budding of the capsids in 
vesicles derived from the trans-Golgi network (Mettenleiter, 2006; Mettenleiter and Minson, 
2006). 
 
 
 
 
 
Figure 1: A. Schematic representation of an alphaherpesvirus virion (adapted from Nauwynck et al., 2007). 
B. Transmission electron photomicrograph of a pseudorabies virion (Granzow et al., 1997). C. Schematic 
representation of the PRV genome structure. D. Schematic representation of the HSV genome structure. 
UL = unique long segment; US = unique short segment; IRS = internal repeat sequence; TRS = terminal 
repeat sequence. 
 
1.1.4 Replication cycle 
 The alphaherpesvirus replication cycle is composed of several steps: virus entry, 
transport of the capsid to the nucleus, transcription and DNA replication, virion assembly and 
finally egress. Figure 2 shows a schematic representation supported with electron 
micrographs of all the respective stages of the infection cycle of PRV. Details on the 
replication cycles are based on data obtained from both HSV-1 and PRV. 
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Entry (Fig. 2: step 1-2) 
 Virion attachment to the plasma membrane occurs in two stages. First, an unstable 
binding is established between the cellular heparan sulphate and the viral glycoprotein gC 
and, to a lesser exent, gB (Mettenleiter et al., 1990). This is followed by a stable interaction 
between gD and its cellular receptor. Although the labile binding significantly enhances viral 
infection, it is in fact not required for infection (Mettenleiter et al., 1990; Karger et al., 1995; 
Immergluck et al., 1998; Shukla and Spear, 2001; Spear and Longnecker, 2003). To date, 
the known binding partners for gD during entry are divided in three categories: members of 
the TNF receptor family, members of the immunoglobulin superfamily and specific sites in 
heparan sulphate moieties created by 3-O-sulfotransferases (Geraghty et al., 1998; Shukla 
et al., 1999; Spear et al., 2000; Heldwein and Krummenacher, 2008). For PRV, in the 
immunoglobulin superfamily, three cellular receptors have been identified: nectin-1, nectin-2, 
and poliovirus receptor CD155 (Spear et al., 2000). CD155 is not used by HSV for entry 
while nectin-1 and nectin-2 are. Other HSV gD receptors include the TNF receptor family 
member (HVEM) and heparan sulphate modified by 3-O-sulfotransferase (Nixdorf et al., 
1999; Campadelli-Fiume et al., 2000; Spear et al., 2000; Mettenleiter, 2002a; Spear and 
Longnecker, 2003).  
 More recently, it was described that besides gD also gB appears to interact with one 
or more receptors during entry of the virus. The paired immunoglobulin-like type 2 receptor 
PILRα acts as a coreceptor that associates with gB (Satoh et al., 2008). In addition, gB has 
also been reported to interact with lipid membranes (Hannah et al., 2009). Recently, it was 
described that gB can also interact with the non-muscle myosine heavy chain IIA (NMHC-IIA) 
to mediate entry in naturally permissive cells (Arii et al., 2010).  
 In order to mediate fusion between the envelope and the cellular membrane after 
attachment, several glycoproteins are required: gB, gD and gH-gL (Rauh and Mettenleiter, 
1991; Mettenleiter and Spear, 1994; Klupp et al., 1997). The gB and gH-gL glycoproteins are 
essential for fusion, as mutants lacking these proteins are not able to enter the cell (Rauh 
and Mettenleiter, 1991; Rauh et al., 1991; Peeters et al., 1992a; Klupp et al., 1997; Turner et 
al., 1998; Mata et al., 2001; Gianni et al., 2006; Reske et al., 2007; Subramanian and 
Geraghty, 2007). Although direct fusion between plasma membrane and viral envelope is still 
considered as the major route of entry, more recent research points towards endocytosis as 
a possible way of viral entrance in several cell types (Nicola et al., 2003; Gianni et al., 2004; 
Nicola and Straus, 2004; Milne et al., 2005; Nicola et al., 2005; Clement et al., 2006; 
Frampton et al., 2007; Hambleton et al., 2007). 
 
Chapter 1 - Introduction – Herpes Simplex virus type I and Pseudorabies virus 
 6 
Figure 2: Alphaherpesvirus replication cycle. Virions attach (1) and penetrate (2) the plasma membrane 
releasing the nucleocapsid surrounded by tegument into the cytoplasma. Capsids are then transported to 
the nucleus (N) (3) via interaction with microtubules (MT) (4), and dock at the nuclear pore (NP) (5) where 
the viral genome is released into the nucleus. Here, transcription of viral genes and genome replication 
occur (6) whereafter newly formed viral genomes are packaged during encapsidation (8) in newly formed 
capsids (7). These leave the nucleus by budding at the inner nuclear membrane (INM) (9), followed by 
fusion of the envelope of these primary virions that are located in the perinuclear space (10) with the 
outer nuclear membrane (ONM) (11). Secondary envelopment occurs through budding into vesicles of the 
trans-Golgi network (TGN) (12) containing viral glycoproteins, resulting in an enveloped virion. After 
transport to the plasma membrane (13), vesicle and plasma membrane fuse, releasing a mature, 
enveloped virion from the cell (14). (adapted from Mettenleiter et al., 2009).   
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Transport to the nucleus (Fig. 2: steps 3-5) 
 Upon entry in the cytoplasm, capsids are rapidly transported to the nuclear pore 
complexes, where they release the viral DNA genome into the nucleus. The transport 
through the cytosol is mediated via microtubule-based transport. Capsids engage dynein, a 
motor protein directed to the minus-end of the microtubules, to efficiently migrate from the 
periphery to the nucleus (Sodeik et al., 1997; Smith and Enquist, 2002). For HSV-1, the 
proteins VP11/12, VP26, UL9 and/or UL34 are proposed to recruit dynein to capsids as 
these proteins all have been shown to be able to interact with dynein (Purves et al., 1992; Ye 
et al., 2000; Martinez-Moreno et al., 2003; Douglas et al., 2004; Diefenbach et al., 2008). 
However, UL34 is absent in mature PRV virions and is not essential during PRV- and HSV-1 
infection (Klupp et al., 2000; Roller et al., 2000; Fuchs et al., 2002b). On the other hand, 
mutants lacking VP26 are still transported to the nucleus in a dynein-dependent manner, 
indicating that UL34 and/or VP26 are less likely candidates to mediate alphaherpesviruses 
transport along microtubules (Antinone et al., 2006; Dohner et al., 2006).     
 When the virions reach the nucleus, a docking complex is formed mediated by 
importin β and the VP1/2 tegument protein (Ojala et al., 2000). Thereafter, viral DNA is 
rapidly released into the nucleus (Batterson and Roizman, 1983; Sodeik et al., 1997; Ojala et 
al., 2000). 
Gene expression (Fig.2: step 6) 
 Upon arrival in the nucleus, the viral genome circularizes and is transcribed in a 
tightly regulated cascade manner (Ben-Porat and Kaplan, 1985). Viral replication proceeds 
through the rolling circle mechanism. Viral genes can be divided into three categories: 
immediate-early (IE), early (E) and late (L) genes. The latter can sometimes be subdivided 
into early-late and true-late. Expression of immediate-early and early genes occurs before 
onset of viral DNA replication and the expression of early-late genes starts before DNA 
replication but reaches its peak of transcription during replication. The expression of true-late 
genes only starts after replication has initiated. 
 First, IE genes are transcribed very rapidly upon delivery of the genome into the 
nucleus. These genes encode transcriptional regulatory proteins and therefore are necessary 
to activate the transcription cascade of E and L genes. The transcription of IE genes is 
initiated by the host cell machinary together with the viral protein VP16 (Pomeranz et al., 
2005). PRV only encodes one IE gene, IE180, while HSV-1 encodes 5 IE genes: ICP0, ICP4 
(the orthologue of IE180), ICP22, ICP27 and ICP47 (Cheung, 1989; Roizman and Knipe, 
2001). IE180 promotes expression of US4 (gG), UL12 (alkaline nuclease), UL22 (gH), UL23 
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(thymidine kinase) and UL41 (viral host shut off). The E gene products are mainly involved in 
nucleotide metabolism (UL23, UL39/40, UL50) and DNA synthesis (UL5, UL8, UL9, UL29, 
UL30, UL42, UL52) (Kit et al., 1987; Kaliman et al., 1994; Berthomme et al., 1995; Jons et 
al., 1997; Lehman and Boehmer, 1999). Finally, expression of late genes is triggered by DNA 
replication. These late genes mainly encode structural proteins involved in assembly and 
egress (Mettenleiter, 2000; Roizman and Knipe, 2001; Pomeranz et al., 2005).  
Assembly and egress (Fig. 2: steps 7-14) 
 Upon replication, capsid constituents are imported into the nucleus to build the new 
capsids around two scaffolding proteins (UL26 and UL26.5). During DNA encapsidation, the 
long linear concatemeric viral genome is cleaved into monomeric units and is simultaneously 
packaged into newly formed capsids by pulling them through a cylindrical entry pore encoded 
by UL6 (Ladin et al., 1980; Ben-Porat et al., 1984; Kwong and Frenkel, 1989; White et al., 
2003; Cardone et al., 2007). 
 Herpesviruses are too large to pass through the nuclear pore. In order to cross the 
nuclear envelope, herpesviruses utilize a unique envelopment/de-envelopment process at 
the inner and outer nuclear membrane, respectively (Hofemeister and O'hare, 2008). First, 
the nucleocapsids acquire their primary envelope and tegument by budding through the inner 
nuclear membrane (INM) leaving them in the perinuclear space. The viral proteins UL31 and 
UL34 are required for primary envelopment, and are found in all three herpesvirus 
subfamilies indicating that the process of primary envelopment is highly conserved (Ye and 
Roizman, 2000; Fuchs et al., 2002b; Mettenleiter, 2006). Expression of UL31/UL34 alters the 
nuclear lamina architecture allowing the viral capsids to enter the site of envelopment 
(Reynolds et al., 2004; Simpson-Holley et al., 2004), and expression of the UL31 and UL34 
proteins of PRV, without other viral proteins, is sufficient to generate an envelopment-like 
process at the inner nuclear membrane (Klupp et al., 2007). Primary enveloped virus 
particles that are located in the perinuclear space will then undergo a fusion event with the 
outer nuclear membrane (ONM), releasing the de-enveloped capsid in the cytosol. The viral 
protein US3 plays a poorly understood role during de-envelopment (Klupp et al., 2001; 
Reynolds et al., 2002). This de-envelopment process appears to be very rapid as very few 
enveloped capsids are observed in the perinuclear space (Skepper et al., 2001; Mettenleiter, 
2002b). In HSV-1, but not in PRV, a defect in nuclear egress was also observed in the 
absence of gB and gH (Farnsworth et al., 2007). Although nucleocapsids that reach the 
cytoplasm appear ‘naked’, they carry tegument proteins US3, UL36 and UL37 (Fuchs et al., 
2002a). Upon reaching the cytoplasm, tegumentation and final envelopment at vesicles of 
the trans-Golgi network (TGN) occur (Mettenleiter, 2004). UL36 is the major component of 
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the inner tegument and interacts with the minor capsid component UL25 (Coller et al., 2007). 
The UL11 tegument protein is thought to influence secondary envelopment by directing 
tegument proteins and capsids to the TGN budding site. The glycoprotein gM is involved in 
accumulation of the unusually diverse set of alphaherpesvirus envelope glycoproteins to the 
TGN budding site (Kopp et al., 2003; Kopp et al., 2004; Leege et al., 2009). Finally, mature 
enveloped virions are released from the host cell by exocytosis. In PRV, the viral proteins 
UL20 and gK seem to be involved in this process (Fuchs et al., 1997; Klupp et al., 1998). 
However, in HSV-1, data are contradictory as some groups report the same function for 
UL20 and gK as in PRV, while other groups argue that these proteins function during 
secondary envelopment (Baines et al., 1991; Avitabile et al., 1994; Foster et al., 2004a; 
Foster et al., 2004b; Fulmer et al., 2007).   
Intercellular spread      
 Alphaherpesvirus spread from an infected to an uninfected cell can occur through two 
main routes. Release of progeny virions from an infected cell into the extracellular space 
followed by attachment and entry in an uninfected neighbouring cell is the traditional way of 
viral spread. Additionally, alphaherpesviruses may also spread in a cell-associated way, 
which may be more efficient and rapid, and shields them from different antiviral components 
in the extracellular space, including virus-neutralizing antibodies. Several ways of cell-to-cell 
spread have been described. When an infected cell and an uninfected cell are in direct 
contact, spread can occur through fusion of plasma membranes of both cells, resulting in 
syncytia formation. This process is mediated by glycoproteins on the cell surface in a 
process that resembles the fusion between the viral envelope and the plasma membrane 
during viral entry. It is intriguing that in PRV, but not in HSV-1, gD is not required for cell-to-
cell spread while it is essential for viral entry (Rauh and Mettenleiter, 1991; Peeters et al., 
1992b; Ch'ng et al., 2007). In neurons, PRV gD induces varicosities (synaptic boutons) 
during viral infection. These varicosities have been described to serve as sites for viral cell-
to-cell spread (De Regge et al., 2006). The glycoprotein gE is involved in cell-to-cell spread 
in polarized epithelial cells by sorting virions to the cell junctions (Zsak et al., 1992; Johnson 
et al., 2001). The US3 protein of PRV and different other alphaherpesviruses induces 
protrusions that connect distant cells to infected cells, allowing efficient intercellular viral 
spread (Favoreel et al., 2005).  
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1.2 Alphaherpesvirus interaction with sensory neuronal cells 
1.2.1 Sensory neurons 
 The peripheral nervous system (PNS) consists of nerves and ganglia outside the 
brain and spinal cord. The main function of the PNS is to connect the central nervous system 
(CNS) to the limbs and organs. Sensory neurons that make part of the PNS are afferent 
neurons that transmit nerve impulses towards the CNS. Figure 3.A. shows the schematic 
representation of a sensory neuron. Sensory neurons are of special interest in the context of 
alphaherpesvirus biology as they represent the predominant site for the establishment of 
latency for most of these viruses. Several alphaherpesviruses have a tropism for trigeminal 
ganglion neurons (e.g. HSV-1, PRV and BoHV-1), dorsal root ganglion neurons (e.g. VZV) or 
sacral ganglion neurons (e.g. HSV-2) (Gutekunst et al., 1980; Ackermann et al., 1982; Croen 
et al., 1987). Localisation of the dorsal root ganglia, sacral ganglia, and trigeminal ganglia 
can be seen in Figure 3 and 4.  
   
 
 
 
 
 
 
 
 
 
 
 
Figure 3: A) Schematic representation of a sensory neuron and B) representation of the most important 
human nerves on the dorsal side of the body. Red underlined: dorsal root ganglia and sacral ganglia. 
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Trigeminal ganglion  
 The name trigeminal is derived from ‘tri’ and ‘geminus’ which means three  twins and 
originates from the fact that three major nerve branches originate from the trigeminal 
ganglion: the ophthalmic nerve, the maxillary nerve and the mandibular nerve. The 
ophthalmic and maxillary nerves are exclusively sensory, while the mandibular nerve 
contains both sensory and motor neurons. The three branches converge in the trigeminal 
ganglion which contains the cell bodies of incoming sensory nerve fibers. The trigeminal 
ganglion (TG) is analogous to the dorsal root ganglia of the spinal cord, which contains the 
cell bodies of incoming sensory fibers from the rest of the body. TG neurons are pseudo-
unipolar with one part of the neuronal axon directed to the CNS and the other part directed to 
the periphery (Firbas et al., 1995; Marieb et al., 2005). Figure 4 shows the localization of the 
three nerve branches that end up in the trigeminal ganglion and the region of the face 
innervated by the different nerve branches. The ophthalmic nerve conveys sensory impulses 
from the skin of the anterior scalp, upper eyelid, the conjunctiva and the cornea of the eye, 
the nose and the nasal mucosa and lacrimal gland. The maxillary nerve carries information 
from the lower eyelid, the palate, the nasal mucosa, the upper lip and the cheek. The 
mandibular nerve transports sensory information from the anterior tongue, skin of chin, lower 
lip and temporal region of the scalp. The motor functions regulated by the mandibular nerve 
comprise biting, chewing and swallowing (Marieb et al., 2005).   
  
 
 
 
 
 
    
Figure 4: A) schematic representation of the trigeminal nerves and B) the region they innervate.  
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Alphaherpesvirus infection of sensory neurons 
 HSV-1 and PRV share the ability to establish latency in neurons of the trigeminal 
ganglion. On average, cell bodies (containing the cell nucleus), are approximately 10cm 
away from the axon termini that innervate the face (Fig.4). HSV-1 and PRV make use of 
microtubule-based retrograde axonal transport to overcome this huge distance to deliver 
their genome in the nucleus (Sodeik et al., 1997; Diefenbach et al., 2008). After reaching the 
nucleus, the viruses can either start a lytic infection which results in the formation of newly 
formed virus particles or enter latency which consists of a dormant state of infection without 
the production of infectious virus (Roizman and Knipe, 2001). The general replication cycle of 
alphaherpesviruses has been discussed in 1.1.4, so only the major differences between 
typicial replication in e.g. epithelial cells and infection of neurons will be addressed here. 
 As the distance between the plasma membrane and the nucleus is much larger than 
in epithelial cells, the transport along the axons results in the inefficient ability of different viral 
tegument components, e.g. VP16, to reach the nucleus. Since VP16 is a viral transactivator, 
this neuron-specific feature is thought to be of special interest for the ability of the neurons to 
be prone to latent alphaherpesvirus infections, which will be discussed in the next part of the 
introduction (1.2.2).  
 The biggest difference between infection of epithelial cells and neurons lies in the 
mode of viral egress from an infected cell and spread to other cells. During a typical 
replication cycle, as in epithelial cells, progeny capsids that are produced in the nucleus and 
released in the cytoplasm, are thought to acquire their envelope by budding into vesicles 
derived from the trans-Golgi network, followed by release of the virions via exocytosis. In 
neurons, progeny virus particles need to travel back from the nucleus to the periphery along 
the axon, using anterograde microtubule-based transport. However, there is ongoing debate 
on the composition of virus particles travelling down the axon. Two models have been 
proposed regarding the transport in anterograde direction: the traditional model and the 
subvirion model. In the traditional (married) model, progeny viruses become fully assembled 
in the neuronal cell body by budding of the capsids in the trans-Golgi followed by 
anterograde transport of the enveloped virions carried in vesicles, towards the axon termini 
(Kristensson et al., 1974; Card et al., 1993; Tomishima and Enquist, 2001) (Figure 5). This 
model corresponds to the mode of egress in non-neuronal cells (1.1.4). Data to support this 
model come from the electron microscopic detection of fully enveloped PRV and HSV-1 
virions in vesicles in axons of different kinds of neurons: rat superior cervical ganglion 
neurons (SCG) and human and rat dorsal root ganglion neurons (DRG) (Marchand and 
Chapter 1 - Introduction – Alphaherpesvirus interaction with sensory neuronal cells 
 
 
 13 
Schwab, 1986; Lycke et al., 1988; Card et al., 1993; Ch'ng and Enquist, 2005; Del Rio et al., 
2005).  
 
 
 
 
 
 
 
 
 
Figure 5: Schematic representation of alphaherpesvirus entry and egress at axon termini.   The traditional 
model of egress shows anterograde transport of fully enveloped virions along the axon. The subvirion model 
comprises two proposals: A) capsids and tegument are transported separate from glycoprotein-containing 
vesicles that fuse with the plasma membrane prior to budding of the capsid to obtain its secondary envelope. B) 
capsids acquire their secondary envelope through budding in an glycoprotein-containing endosome present in the 
axon terminus and are subsequently released through exocytosis. (Adapted from Tomishima et al., 2001) 
 Another argument pro the traditional model is the fact that infectious PRV could be 
isolated from mid-axons of porcine TG neurons (Kritas et al., 1994b; Kritas et al., 1994a; 
Kritas et al., 1995). As it is irrefutable that incoming virions loose their envelope during entry, 
the former data cannot be explained by visualisation or detection of incoming virus during 
retrograde transport (Lycke et al., 1984; Lycke et al., 1988; Card et al., 1993; Tomishima and 
Enquist, 2002). More recent studies using dual-fluorescent PRV viruses (carrying a 
fluorescently tagged capsid and envelope) also support the traditional model (Del Rio et al., 
2005; Luxton et al., 2005; Antinone et al., 2006). The alternative model, the subvirion 
(separate) model, was proposed for the first time in 1994 by the Cunnigham lab (Penfold et 
al., 1994). This model proposes that the envelope proteins are transported to the axon 
termini in glycoprotein-containing vesicles separate from capsids which do not use vesicles 
for their transport. The initial data supporting this hypothesis came from an electron 
microscopy study that detected HSV-1 particles, at a time point when a majority of particles 
would be considered to be engaged in anterograde transport, as unenveloped capsids in 
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axons of human fetal DRG neurons (Penfold et al., 1994). Other studies using human or rat 
DRGs showed that unenveloped capsids surrounded by tegument proteins were located 
adjacent to microtubules, whereas glycoproteins and other tegument proteins were present 
in vesicles without capsids (Holland et al., 1999; Miranda-Saksena et al., 2000). More recent 
studies showed both for PRV and HSV-1 that capsids were separated from vesicles 
containing glycoproteins (Miranda-Saksena et al., 2000; Smith et al., 2001; Enquist et al., 
2002; Potel et al., 2003; Snyder et al., 2006; Snyder et al., 2007). Two models are proposed 
as part of the subvirion model (Fig. 5. A and B). The first hypothesis states that vesicles 
containing envelope proteins fuse with the axolemma, followed by budding of the capsid 
through this plasma membrane to release infectious virus. The second hypothesis states that 
vesicles containing glycoproteins fuse with endosomes present in the axon terminus, 
followed by budding of capsids in this endosome releasing infectious virus by exocytosis 
(Tomishima and Enquist, 2001).  
 It is still not clear which model of anterograde transport is correct, although it is 
possible that both models coexist. One possible explanation for the observed differences lies 
in the experimental setup. Different viruses, different neurons and different species make it 
extremely hard to evaluate the data in comparison to each other. Also, analyses on fixed 
samples (e.g. electron microscopy and confocal microscopy) should be interpreted with care 
as (i) they may contain fixation artefacts and (ii) they are more difficult to interpret since it is 
complicated to distinguish in fixed samples whether a particle is engaging in anterograde 
transport, retrograde transport or is not moving at all. A recently published study showed that 
anterograde transport of complete virions occurred for HSV-1, HSV-2 and PRV in rat SCGs. 
Fully assembled virus particles were detected intracellularly within vesicles in proximal and 
mid-axons adjacent to microtubules (Huang et al., 2011). Also, a recent report showed that 
the HSV-1 strain KOS, often used in studies addressing neuronal transport, carries a 
defective US9 gene (Negatsch et al., 2011). As US9 is essential for virus anterograde 
transport (Feierbach et al., 2007), this is likely to have affected results and conclusions 
concerning HSV-1 anterograde transport. 
 Alphaherpesviruses are transported via the axons back to the periphery where the 
virus can spread to epithelial cells and hence cause recurrent symptoms. Different studies 
have shown that the virus not only leaves the axon at the axon terminus, but also may exit 
the axon at pre-synaptic boutons (varicosities) along the axon shaft (Ch'ng and Enquist, 
2005; De Regge et al., 2006; Saksena et al., 2006). For PRV, it has been shown that the 
viral glycoprotein gD induces the formation of these varicosities through Cdc42 and p38 
MAPK signalling pathways (De Regge et al., 2006). 
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1.2.2 Latency/ reactivation 
 Latency is a central aspect of the life cycle of herpesviruses. Neurons are the most 
predominant site of latency for most alphaherpesviruses (see 1.2.1). Latency in this particular 
cell type is a strategy used by the virus to survive in the host for its entire lifetime and 
enables the virus to escape the host immune system. Latency is characterized by the 
absence of the production of infectious virus particles while the viral genome is present in the 
cell and can be reactivated upon specific stimuli which may give rise to recurrent viral spread 
and symptoms (e.g. cold sores and genital lesions by HSV). For some alphaherpesviruses 
(e.g. HSV and PRV but not VZV), another feature of latency is the presence of specific 
latency-associated transcripts (LATs) but the absence of any detectable viral protein. The 
exact importance of LATs for latency is not yet resolved. LATs have been attributed an anti-
apoptotic function through a microRNA (miRNA) encoded by the first exon of the LAT region 
(Gupta et al., 2006). Furthermore miRNAs were found directed against the immediate-early 
genes ICP0 and ICP4, indicative for the involvement of LATs in suppressing lytic gene 
expression, and thereby promoting latency. Other miRNAs in the LAT region are directed 
against ICP34.5, an important neurovirulence factor (Umbach et al., 2008). The 
latency/reactivation cycle can be subdivided in three phases: (i) the establishment of latency 
during which a dormant state is evoked followed by (ii) the maintenance of latency during 
which the virus is kept dormant and, upon specific stimuli, (iii) reactivation which may lead to 
the production of new virus particles. It has become increasingly clear that latency of 
alphaherpesviruses is dependent on the interplay between neuron, virus and immune 
system. The following sections will discuss this intriguing triple entente.       
Interaction between neuron, immune system and alphaherpesviruses  
 Several data indicate that alphaherpesvirus latency in neurons is the result of a 
delicate balance between the neurons, the immune system and the virus itself. It has been 
put forward that neurons represent a repressive environment for alphaherpesvirus 
replication, thereby contributing substantially to latency establishment in this particular cell 
type. Some neuron-specific properties and immune components that have been proposed to 
contribute to latency will be discussed below. 
 Since in latently infected neurons the expression of IE genes is hampered, the 
hypothesis was put forward that a transcriptional block occurred in neuronal cells, preventing 
initiation of lytic infection (Hagmann et al., 1995). A central factor in the activation of lytic 
infection is the formation of a complex between the viral tegument protein VP16 and the 
cellular proteins Oct-1 and HCF-1, which will bind to the IE promoter sequence (Hagmann et 
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al., 1995). In neurons however, the formation of this essential complex is hampered. It was 
hypothesized that VP16 is largely lost during transport along the axons leading to a less 
efficient onset of productive infection (Roizman and Sears, 1987; Kristie and Roizman, 
1988). However, a later study showed that latency was efficiently induced in the presence of 
a functional VP16 (Sears et al., 1991). It was also shown that HCF-1 is located 
predominantly in the cytoplasm in neurons whereas in non-neuronal cells it is present in the 
nucleus, where it can activate transcription (Kristie et al., 1999). In addition, the other critical 
cellular transcription factor, Oct-1, is only expressed in low abundance in neurons (Hagmann 
et al., 1995). Also very important in the context of latency is the fact that neurons are 
terminally differentiated and therefore express very few proteins required for DNA replication, 
which is necessary for viral replication (Nichol et al., 1996).  
 Besides the repressive environment of the neuron, the immune system also plays a 
central role in alphaherpesvirus latency in neurons. Indeed, for PRV, it has been shown that, 
in vitro, virtually all trigeminal ganglion neurons support initiation of productive infection 
(Geenen et al., 2005; Geenen et al., 2007). This indicates that the repressive properties of 
neurons are not the only factors in the equation to establish a latent infection. The interferon-
inducible transcription repressing nuclear domains (ND10s) have been shown to restrict viral 
replication. However, several studies reported abnormal ND10 structures or the absence of 
ND10s in neurons (Hsu and Everett, 2001; Negorev et al., 2001).  
 Studies using mice have shown that HSV-1 antigens were detectable in TGs at 2dpi 
and that titers reached their peak around 3 to 5dpi, declining between day 7 and 10 where 
after antigens were no longer detectable (Shimeld et al., 1995; Liu et al., 1996; Kodukula et 
al., 1999). This pattern corroborates with the induction of the immune system. At 3dpi 
macrophages start infiltrating the TGs and at 5dpi γδ-T cells were very closely associated 
with neurons (Liu et al., 1996). A modest increase in CD4+ cells and a large raise in CD8+ 
cells were seen at 7dpi (Liu et al., 1996). From 3dpi onwards IFNγ and IL4 production 
appeared and from 7dpi IL10 and TNF production became evident (Liu et al., 1996), although 
different studies gave different results concerning the time course of cytokine production 
(Halford et al., 1997; Kodukula et al., 1999). It was also shown that high levels of IFNα in the 
TGs resulted in a strong reduction of viral titers at 3 and 6dpi (Carr et al., 1998). These 
combined studies indirectly suggest that infiltrating immune cells and cytokines of the innate 
immune system in the TG may be involved in establishment of latency. Since latency 
establishment is believed to occur within days post infection, it is less clear whether the 
adaptive immune system is also involved in the establishment phase of latency. However, 
the exact mechanism of establishment of latency still remains to be elucidated.  
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 Several studies have reported that the presence of immune cells and cytokines in the 
TGs lasts longer than needed for the establishment of latency, and in fact appears to result in 
a sustained, low-level activation of the immune system in the ganglion. CD4+ T cells, CD8+ T 
cells and macrophages were found up to 92dpi in TGs of latently infected mice (Shimeld et 
al., 1995; Liu et al., 1996; Khanna et al., 2003). TNFα, amongst others, could also be 
detected until 92dpi (Liu et al., 1996). CD8+ T cells are present in particularly high numbers 
and for a long time in the TGs, and are localized in close opposition to the infected neurons 
(Khanna et al., 2003). The importance of CD8+ T cells most likely lies in their ability to 
repress reactivation, without killing the neurons. Indeed, CD8+ T cells have been shown to 
inhibit reactivation of latent HSV-1 during explant of latently infected mouse TG (Liu et al., 
2000). Also, mice deficient for CD8+ T cells failed to control HSV-1 infection resulting in fatal 
encephalitis between 7 and 12dpi (Lang and Nikolich-Zugich, 2005). CD8+ T cells release 
IFNγ as a potential non-cytolytic mode of suppressing virus replication (Guidotti and Chisari, 
2001). Indeed, it was reported that administration of IFNγ to explanted latenly infected mouse 
TG was sufficient to prevent reactivation (Liu et al., 2001; Decman et al., 2005). The role of 
IFNγ in the maintenance of latency was confirmed in IFNγ knock-out mice, which showed a 
significantly higher rate of HSV reactivation (Minami et al., 2002). The constant presence of 
cytokines and immune cells point to the direction of a continuous attempt of the virus to 
reactivate and a subsequent rapid response of the immune system to prevent these initial 
reactivation events leading to production of infectious virus.        
Chromatin modifications 
 (adapted from Van Opdenbosch N., Favoreel F.W. and Van de Walle G, 2011, Biology of the 
Cell, in press) 
 In herpesvirus biology, histone modifications are being studied with increasing 
interest, mainly because chromatin modifications appear to offer an epigenetic switch 
between lytic and latent infections (Minarovits, 2006; Knipe and Cliffe, 2008; Reeves, 2011). 
The most important histone modifications with regard to regulation of herpesvirus 
transcription are histone acetylations and methylations. Acetylation of histones results in 
open chromatin, which allows transcription, while deacetylation causes the chromatin to 
close and therefore block transcription. Tri-methylation can cause both activation and 
repression of transcription based on the position where this post-translational modification 
occurs. For example, tri-methylation of H3K9 and H3K27 is linked to transcriptional 
repression while tri-methylation of H3K4 and H3K36 causes transcriptional activation. Di-
methylation of H3K4 and mono-methylation of H3K9 are also markers for transcriptional 
activation, while di-methylation of H3K9 again are linked to transcriptional repression 
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(Bedford and Clarke, 2009; Peserico and Simone, 2011).  Clear differences have been 
observed in histone modifications on latent and lytic alphaherpesvirus genomes. 
 During latent HSV-1 infection, only a small, intron-containing part of the genome is 
available for transcription, leading to the expression of the latency-associated transcript 
(LAT). It was shown that the latent HSV-1 genome is highly associated with nucleosomes, 
including the LAT region, and it has been proposed that the histone composition may be a 
major regulator of HSV-1 latency (Deshmane and Fraser, 1989; Kubat et al., 2004). Indeed, 
ChIP assays of latent HSV-1 genomes revealed that the LAT region is associated with 
acetylated H3K9/K14, implying a transcriptionally active euchromatin structure, while the 
DNA polymerase region was not enriched with acetylated H3K9/K14, indicating a 
transcriptionally inactive chromatin structure. LAT by itself also affects the chromatine 
structure and therefore, affects latency. Early reports already indicated that LATs are able to 
repress lytic gene expression in sensory neurons (Garber et al., 1997). More recently, it was 
demonstrated that the LAT gene increases the levels of H3K9me2 and reduces the levels of 
H3K4me2 on lytic gene promoters, indicating that the LAT gene promotes a transcriptionally 
suppressed heterochromatin structure on lytic gene promoters (Wang et al., 2005). As 
mentioned higher, explanting mouse trigeminal ganglia containing latent HSV-1 results in 
virus reactivation (Stevens and Cook, 1971). Using this model, it was shown that the level of 
acetylated H3K9/K14 is reduced in the LAT enhancer at early times post explant, suggestive 
for silencing of the LAT region. Subsequently, the amount of LAT RNA diminishes and this is 
accompanied by an increased acetylation in the ICP0 promoter, which indicates the onset of 
reactivation (Amelio et al., 2006). Likewise, addition of the HDAC inhibitor sodium butyrate 
results in reduced acetylation of H3K9/K14 on both the LAT promoter and enhancer on the 
one hand and an increase in acetylation on the ICP0 and ICP4 promoters on the other hand, 
again pointing towards reactivation (Neumann et al., 2007). These findings are in line with 
previous data showing that addition of HDAC inhibitors led to the production of increased 
virus progeny in quiescently infected cells (Danaher et al., 2005). On latent HSV-1 genomes, 
both constitutive as well as facultative types of heterochromatin are present, as 
demonstrated by the presence of the facultative heterochromatin marker H3K27me3 and the 
constitutive marker H3K9me3. Interestingly, it was shown that in the absence of LAT, the 
latent genome undergoes a dramatic increase in H3K27me3, indicating that the viral genome 
contains more facultative heterochromatin, which likely renders lytic genes more prone to 
activation (Cliffe et al., 2009; Kwiatkowski et al., 2009). 
 Different immediate early and early viral proteins have been shown to interact with 
chromatin-remodeling complexes, thereby affecting gene transcription. The net result of 
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these interactions appears to be to promote lytic replication, and therefore perhaps 
reactivation from latency. The most notable alphaherpesvirus proteins involved in activating 
lytic gene expression through histone modifications are VP16, ICP0 and US3, which are 
discussed in more detail below. 
 VP16 is able to recruit the chromatin-remodeling and transcription activating complex 
SWI/SNF to the IE promoters (Memedula and Belmont, 2003; Herrera and Triezenberg, 
2004). Importantly, VP16 has recently been suggested to be critically involved in reactivation 
of HSV-1 from latency in mice (Thompson et al., 2009). Due to the role of VP16 in recruiting 
chromatin-modifying proteins, the hypothesis arose that these coactivators are essential for 
IE gene expression during lytic infection and perhaps reactivation from latency. However, 
disrupting the expression of the SWI/SNF complex did not impair IE gene expression in HSV-
1 infected cells, suggesting that these transcriptional coactivators are not required for the IE 
gene expression of nucleosome-associated HSV-1 genomes (Kutluay et al., 2009). As 
mentioned before, VP16 interacts with HCF-1 to assemble a transcription initiation complex. 
HCF-1 is also part of several chromatin modifying complexes including the Set1-MLL HMT 
complex, the LSD1 and mSin3-HDAC1/2HD complexes, and the PCAF HAT complex (Kolb 
and Kristie, 2008; Peng et al., 2010) and HCF-1 was shown to be essential for IE gene 
expression, both in HSV-1 and VZV (Narayanan et al., 2005). More specifically, VP16 
recruits the HCF-1 cellular complex which includes hSet1 and MLL1 and this direct 
recruitment of hSet1-MLL to the IE promoters results in the loss of repressive (H3K9me3) 
and gain of activating (H3K4me3) chromatin methylation marks leading to activation of 
transcription (Huang et al., 2006; Narayanan et al., 2007). In addition, the histone 
demethylase (HD) LSD1 is also enrolled in the activating complex in an HCF-1 dependent 
manner (Liang et al., 2009).  Recently, it was discovered that HCF-1 not only drives 
productive infection upon viral entry, but is also involved in HSV-1 reactivation from latency. 
Indeed, triggering of reactivation through the explant of latently infected mouse TG or 
scarification of the eyes of latently infected mice, resulted in rapid relocation of HCF-1 to the 
nucleus of sensory neurons where it participates in the onset of transcription (Kolb and 
Kristie, 2008; Whitlow and Kristie, 2009).  
 The immediate-early ICP0 protein is involved in the inhibition of histone deacetylases 
(HDACs) to prevent silencing of the viral genome and thus support lytic replication as the 
absence of ICP0 can partly be compensated for by the HDAC inhibitors trichostatin A and 
sodium butyrate (Hobbs and Deluca, 1999; Poon et al., 2002; Poon et al., 2003). In this way, 
ICP0 may promote lytic infection and reactivation from latency. During lytic replication, the 
VP16/HCF-1 complex will bind to the ICP0 promoter to initiate transcription of this gene and 
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other IE genes, while the early (E)- and late (L)- gene promoters are bound by the CoREST 
repressive complex which also includes HDAC1/2 and LSD1(Fig.6). Expression of ICP0 will 
then allow for transcription of the E- and L- genes via two ICP0 functions: (i) the destruction 
of ND10s by disruption of PML and (ii) dislocation of HDAC1/2 from the repressive 
CoREST/REST complex (Roizman, 2011) (Fig. 6). The current hypotheses on how these two 
functions of ICP0 are important for the regulation of gene activation/silencing will be 
discussed in more detail in the next paragraphs. In general it is stated that both functions of 
ICP0 are interdependent and largely depend on events in the ND10 (Gu and Roizman, 
2009b).   
 First, ICP0 is involved in disruption of the ND10 (Everett and Maul, 1994). ND10s are 
considered as antiviral structures containing cellular proteins which suppress viral replication 
and which are upregulated by interferon (Tavalai and Stamminger, 2008). ICP0 is specifically 
involved in the proteasome-dependent degradation of proteins present in ND10s, namely 
ND10-associated proteins promyelocytic leukemia (PML), Sp100, ATRX and hDaxx (Chelbi-
Alix and De Thé, 1999). Through its RING finger domain, ICP0 is able to bind to the ND10-
associated cellular ubiquitin specific protease (USP) 7, which was originally named 
herpesvirus-associated ubiquitin specific protease (HAUSP) (Everett et al., 1997). ICP0 was 
shown to also directly interact with Bmal1, another protein that is localized in ND10s. Since 
Bmal1 associates with the transcriptional coactivator and histone acetyl transferase (HAT) 
CLOCK, the ICP0-Bmal1 interaction may affect viral gene expression. Indeed, it was shown 
that overexpression of CLOCK partially compensated for the absence of ICP0 in HSV-1 
deletion mutants by allowing a higher viral yield and moreover, depletion of CLOCK resulted 
in a significant decrease in expression of viral proteins. In addition, it was shown that CLOCK 
is part of a transcriptional complex including the viral proteins ICP4, ICP22 and ICP27 
(Kalamvoki and Roizman, 2011). Recently, it was suggested that ICP0 also regulates viral 
transcription through a specific interaction with the HAT PCAF. Since ICP0 and PCAF were 
found to co-localize in the ND10s, it was suggested that PCAF improves the ability of ICP0 to 
activate transcription (Li et al., 2009) (Fig. 6).  
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Figure 6: Some of the major interactions of HSV-1 with histone-modifying enzymes to regulate gene 
expression during lytic infection. After initial infection of epithelial cells of the upper respiratory tract, lytic 
replication starts by recruiting cellular factors to the immediate-early gene promoters. The produced ICP0 will then 
allow for transcription of the E- and L- genes via two functions: (i) the destruction of ND10s by disrupting PML and 
(ii) dislocation of HDAC1/2 from the CoREST/REST complex. Here, the major viral proteins and cellular histone-
modifying enzymes that are involved are depicted. HDAC: histone deacetylase, HAT: Histone acetyl transferase, 
HMT: histone methyl transferase, HD: histone demethylase, TF: transcription factor. 
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 Secondly, ICP0 is able to interfere with silencing of viral DNA following immediate-
early gene expression by disrupting the function of HDACs (Cliffe and Knipe, 2008). ICP0 
directly associates with class II HDACs, but not with class I HDACs when they are present in 
different histone-modifying complexes (Lomonte et al., 2004). Furthermore, the C-terminal 
end of ICP0 appears to share a sequence homologous to the N-terminal domain of CoREST. 
This results in a competition of ICP0 for the binding of HDAC1/2 to the repressive 
CoREST/REST/HDAC/LSD1 complex and hence, HDAC1/2 become dislodged from this 
complex in the presence of ICP0 (Gu et al., 2005; Gu and Roizman, 2007) (Fig. 6). The latter 
was shown to be followed by a phosphorylation of HDAC1 and CoREST and subsequent 
translocation of these proteins to the cytoplasm. These two activities were found to be 
independent of ICP0, but to mediated by the viral kinase US3 (Gu et al., 2005; Gu and 
Roizman, 2007). Another histone modifying enzyme, LSD1, which is also part of the 
CoREST complex and which has a role in viral gene repression, is partially degraded in a 
proteasome-dependent manner during a productive HSV-1 infection, although the 
responsible mechanism for this degradation has not yet been identified (Gu and Roizman, 
2009a) (Fig. 6). The effect of ICP0 on promoting viral replication may extend beyond the 
initial stages of productive infection, and ICP0 might also be involved in reactivation from 
latency. In a study from Coleman et al. (2008), a fibroblast model of latency was used to 
illustrate that delivery of ICP0 to quiescent virus genomes resulted in a de-repression, which 
was characterized by enrichment of acetylated histones on HSV-1 promoters (Coleman et 
al., 2008). A recent study from Ferenczy & Deluca (2011) showed that ICP0 expression 
resulted in a decrease in heterochromatin on the whole quiescent genome. High expression 
of ICP0 was clearly able to facilitate the removal of histones from quiescent viruses, but a 
low ICP0 expression was not (Ferenczy and Deluca, 2011).   
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1.3 Interferon-mediated antiviral effects and alphaherpesvirus- 
 encoded countermeasures 
1.3.1 Introduction 
 Interferons (IFNs) are a group of secreted cytokines that elicit distinct antiviral effects. 
In this way, IFNs are amongst the key factors of the innate and adaptive immune response 
against viral infections. They also possess a wide range of other biological activities including 
regulation of cell growth, differentiation and apoptosis and modulation of immune responses 
(Samuel, 2001; Meyer, 2009). Interferons are generally grouped into three classes according 
to their amino acid sequence, designated type I, II and III. Type I IFN is also known as viral 
IFN and includes IFNα, IFNβ and IFNω. These IFNs are mainly induced by viral infection and 
can be produced by most infected cell types. However, plasmacytoid dendritic cells (pDCs) 
are responsible for a large part of the type I IFN production. In mammals, IFNα is encoded by 
numerous genes (13 in man), while one to three genes encode IFNβ (1 in man). IFNβ 
appears to be essential for a fully effective antiviral response since IFNα subspecies do not 
compensate for the loss of IFNβ (Deonarain et al., 2000; Samuel, 2001; Liu, 2005). Type II 
IFN is referred to as immune IFN or IFNγ, which can only be produced by a certain number 
of immune cells, especially T-lymphocytes, NK cells, macrophages and conventional 
dendritic cells (cDCs) (Bach et al., 1997). The most important role for IFNγ is to control long 
term viral infections as it is a key mediator of the virus-specific cellular immunity (Muller et al., 
1994; Cantin et al., 1999). IFNγ is encoded by a single gene (Samuel, 2001). Type III IFNs 
consist of three IFNλ molecules and represent a class of relatively novel cytokines with 
biological activities similar to type I IFN. These IFNs seem to have a more specialized role in 
antiviral defense by exerting host-protection primarily at epithelial surfaces (Ank et al., 2008; 
Sommereyns et al., 2008; Ank and Paludan, 2009). The type III IFN are coproduced with 
IFNβ, but act through binding to a different receptor (Meyer, 2009).  
 The IFN-mediated innate immune system represents the front line of host defence 
against viral infections. Upon recognition of viral components, both virus-infected cells and 
immune cells rapidly initiate secretion of IFNs. IFNs do not possess intrinsic antiviral 
properties, but induce an antiviral state in neighbouring cells that are not yet infected. Binding 
of the IFNs to their specific receptor leads to the expression of an array of cellular proteins, 
several of which display antiviral capacities (Samuel, 1991; Samuel, 2001).  In the next 
paragraphs, some of these cellular proteins will be described in detail, followed by a section 
on alphaherpesviral proteins that counteract the IFN system. 
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1.3.2 Induction of IFN production 
 During evolution, mammalian cells have evolved a large variety of cellular sensors for 
viral infection. It is the engagement of these receptors that will eventually lead to the 
production of type I IFNs. These receptors can be divided into two classes based on their 
localization. They either associate with cell membranes or are present in the cytoplasm. The 
difference in localization has an important relevance for the flexibility in triggering type I IFN 
production, either in infected cells or before cells actually get infected (Garcia-Sastre and 
Biron, 2006) (Figure 7). 
 
 
 
 
 
 
 
 
 
Extracytoplasmic pathways for pathogen sensing     
 The Toll-like receptor (TLR) family is composed of membrane proteins containing 
sequences that recognize microbe-associated molecular patterns (MAMPs) in the 
extracellular environment (Medzhitov and Janeway, 1998; Ausubel, 2005). Upon activation, 
TLRs transmit signals through their cytoplasmic Toll-interleukin-1 receptor (TIR) domains 
resulting in the stimulation of gene expression of multiple genes important in both innate and 
adaptive immunity, including type I IFN (Garcia-Sastre and Biron, 2006). TLR3, TLR7, TLR8 
and TLR9 appear to be particularly important in recognizing viral components. TLR3 interacts 
with dsRNA (most viruses), TLR7 and TLR8 interact with ssRNA (RNA viruses) and TLR9 is 
important for the recognition of DNA and is as such involved in the antiviral defense against 
herpesviruses (Hemmi et al., 2000; Alexopoulou et al., 2001; Diebold et al., 2004; Heil et al., 
Figure 7: IFN production pathway (adapted from Deruelle, 2010). 
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2004; Lund et al., 2004; Akira et al., 2006). These TLRs are localized in endosomal 
compartments and contact with viral components occurs through endosomal-mediated 
internalization of virus or viral material. To allow this contact, viral degradation in the 
endosome is required (Garcia-Sastre and Biron, 2006).  
 Signalling is different for TLR3 versus TLR7/8/9. In response to dsRNA, TLR3 recruits 
a TIR-domain containing adapter protein called TRIF which is able to indirectly activate 
numerous transcription factors, including IFN regulatory factor 3 (IRF3) which, when 
phosphorylated, induces the expression of type I IFN. NF-κB and activating protein 1 (AP1) 
are also stimulated by TRIF resulting in regulation of IFNβ production (Kawai and Akira, 
2006; Randall and Goodbourn, 2008) (Fig.7). Upon nucleic acid recognition, TLR7, TLR8 
and TLR9 recruit a TIR-domain containing adapter protein called MyD88, which is used by all 
TLRs except TLR3, leading to the activation of NF-κB. The type I IFN production upon 
TLR7/8/9 is independent of IRF3 but occurs through another member of the family, IRF7 
(Fig.7). IRF7 is structurally very similar to IRF3 but is able to activate both IFNα and IFNβ 
promoters (Marie et al., 1998; Kawai and Akira, 2006; Randall and Goodbourn, 2008). 
TLR7/8/9 and IRF7 are constitutively expressed in pDCs correlating with the ability of this 
particular cell type to rapidly synthesize massive amounts of type I IFNs (Kato et al., 2005; 
Garcia-Sastre and Biron, 2006). Type III IFNs can also be induced by activation of TLRs as 
the promoters of type III IFN genes share similarities with type I IFN genes and both are 
regulated by IRF3 and IRF7 (Ank et al., 2008; Ank and Paludan, 2009).  
Cytoplasmic pathways for pathogen sensing     
 TLRs recognize pathogens either at the cell surface or in endosomal compartments, 
indicating that the TLR system is not used for the detection of pathogens that already have 
invaded the cytosol (Akira et al., 2006). Fibroblasts and cDCs lacking MyD88 and TRIF are 
still capable of inducing type I IFN upon viral infection. This indicates that the TLR system is 
not required for viral detection in several cell types (Akira et al., 2006). The TLR-independent 
cytosolic pathways of viral recognition can be subdivided in two categories: RNA recognition 
receptors and DNA recognition receptors (Takaoka and Taniguchi, 2008). The first category, 
the RNA recognition receptors, consists of members of a family of DExD/H box RNA 
helicases which contain a caspase-recruiting domain (CARD) (Yoneyama et al., 2004). So 
far, two such sensors have been described: the retinoic acid-inducible gene I (RIG-I) and the 
melanoma differentiation-associated gene 5 (mda5) (Kang et al., 2002; Andrejeva et al., 
2004; Yoneyama et al., 2004) (Fig.7). Both helicases interact through their CARD domain 
with the CARD-like domain of the mitochondrial antiviral signalling protein (MAVS), which is 
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also called IFNβ promoter stimulator 1 (IPS1), virus-induced signalling adaptor (VISA) or 
CARD adaptor-inducing IFNβ (CARDIF) (Kawai et al., 2005; Meylan et al., 2005; Seth et al., 
2005; Xu et al., 2005). The binding between RIG-I and one of these RIG-I-like receptors 
(RLRs) results in the activation of IRF3, NF-κB and AP1, subsequently leading to type I IFN 
production (Akira et al., 2006; Garcia-Sastre and Biron, 2006; Takeuchi and Akira, 2009). 
RLRs also seem to stimulate expression of type III IFN since ectopic expression of a 
constitutively active form of RIG-I enhances expression of both IFNβ and IFNλ (Matikainen et 
al., 2006). 
 The second category of cytosolic recognition factors are the DNA recognition 
receptors. These are involved in the initiation of an innate immune response against viral 
dsDNA, like herpesviruses. The first real DNA-sensing molecule that was identified is the 
ZBP1/DLM-1 or DNA-dependent activator of IRFs (DAI) (Fig.7). This protein is able to 
interact with DNA, leading to activation of IRF transcription factors for type I IFN gene 
induction (Takaoka et al., 2007). It was shown that IRF3 is the major transcription factor to 
induce type I IFN in response to cytoplasmic DNA (Takaoka et al., 2007). Most of these 
studies were performed with synthetic DNA. However, more recently, ZBP1 was implicated in 
the activation of type I IFN upon HCMV infection (Defilippis et al., 2010). STING (stimulator 
of interferon genes) is an endoplasmic reticulum resident transmembrane protein that has 
been shown to facilitate production of type I IFNs (Ishikawa and Barber, 2008). The same 
group demonstrated that STING may be essential for the recognition of intracellular 
herpesvirus DNA, leading to the production of IFN, as the loss of STING rendered mice 
susceptible to lethal HSV infection (Ishikawa et al., 2009). More recently, yet another 
cytoplasmic DNA sensor was discovered. The IFI16 protein is a member of the PYHIN 
protein family that contains a pyrin domain and two DNA-binding HIN domains and was 
found to interact with transfected DNA to induce IFNβ through recruitment of STING. 
Therefore PHYIN proteins are proposed to be a new family of innate DNA sensors called 
‘AIM2-like receptors’ (ALRs) (Unterholzner et al., 2010).  
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1.3.3 Signal transduction in response to IFNs 
 The biological activities of IFNs are initiated by the binding of IFNs to their cognate 
receptors on the surface of the cell, resulting in the activation of the Jak/STAT pathways 
(reviewed in Goodbourn et al., 2000; Samuel, 2001; Randall and Goodbourn, 2008) (Figure 
8). 
 
 
 
 
 
 
 
 
 
 
 
 All type I IFNs share a common heterodimeric receptor composed of IFNAR1 and 
IFNAR2 (reviewed in (Mogensen et al., 1999). Prior to stimulation of the receptor, the 
cytoplasmic domains of IFNAR1 and IFNAR2 are associated with the ‘Janus’ tyrosine kinase 
Tyk2 and Jak1, respectively (Colamonici et al., 1994; Novick et al., 1994). IFNAR2 is also 
bound to STAT2 that weakly interacts with STAT1 (Li et al., 1997). Ligand-induced 
dimerization of both parts of the receptor causes a conformational change, resulting in the 
phosphorylation of tyrosine 466 (Tyr466) of IFNAR1 by Tyk2 thereby creating a docking site 
for STAT2 (Colamonici et al., 1994; Novick et al., 1994; Yan et al., 1996). Subsequently, 
STAT2 is phosphorylated by Tyk2 on Tyr690 while STAT1 is phosphorylated by Jak1 on Tyr701 
allowing the formation of a stable heterodimer (Shuai et al., 1993; Leung et al., 1995; 
Qureshi et al., 1996). The latter creates a novel NLS and phosphorylation of STAT2 
inactivates the dominant constitutive nuclear export signal of STAT2, resulting in the nuclear 
transport of the dimer where it remains until dephosphorylation occurs (Banninger and Reich, 
2004; Frahm et al., 2006; Reich and Liu, 2006). The STAT1-STAT2 complex associates with 
IRF9 to form a heterotrimer ISGF3 complex. This ISGF3 complex is able to bind to the IFN-
stimulated response element (ISRE) present in the promoters of most IFN-inducible genes 
(Goodbourn et al., 2000; Randall and Goodbourn, 2008). Before, it was generally accepted 
Figure 8: Signal transduction in response to IFNs (adapted from Deruelle, 2010). 
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that the assembly of ISGF3 took place in the nucleus, but more recently it was shown that 
assembly is co-ordinated at the receptor (Tang et al., 2007). Upon stimulation of IFNAR2, the 
transcriptional co-factor CBP is recruited causing the acetylation of IFNAR2, which creates a 
docking site for IRF9. The latter as well as STAT1 and STAT2 will subsequently also 
undergo acetylation, which may aid the formation of the ISGF3 complex (Tang et al., 2007). 
 Type III IFN signalling follows a highly similar pattern as type I IFN although a 
different receptor is engaged (Zhou et al., 2007). The type III IFN receptor consists of the 
IL10R2 chain and the IFNλ-specific IL28Rα chain (also called IFNLR1). The latter receptors 
are only expressed in epithelial cells and pDCs (Ank and Paludan, 2009). 
 Type II IFN differs somewhat from this signalling pathway. Like the other IFN 
receptors, the constitutive type II IFN receptor also consists of a heterodimeric glycoprotein, 
composed of IFNGR1 and IFNGR2. These latter are weakly pre-associated in unstimulated 
cells (Bach et al., 1996). The cytoplamsic domains of the receptors are linked to Jak1 and 
Jak2, respectively (Kotenko et al., 1995; Sakatsume et al., 1995; Bach et al., 1996; Kaplan et 
al., 1996). Upon IFNγ binding, the receptors undergo dimerization, triggering the signalling 
pathway (Greenlund et al., 1994; Igarashi et al., 1994; Greenlund et al., 1995; Bach et al., 
1996). As a consequence of dimerization, Jak2 is activated, which trans-phosphorylates and 
activates Jak1 (Briscoe et al., 1996). The activated Jaks then phosphorylate a tyrosine-
containing sequence near the C-terminus of IFNGR1, thereby forming paired binding sites for 
STAT1 (Greenlund et al., 1994; Greenlund et al., 1995). Two STAT1 molecules are then able 
to interact with IFNGR1 and are phosphorylated at Tyr701, resulting in their activation and 
dissociation from the receptors (Shuai et al., 1993; Shuai et al., 1994). The active STAT1 
molecules form a homodimer, which translocates to the nucleus and binds the gamma-
activation sequence (GAS), thereby stimulating transcription of specific interferon-stimulated 
genes (ISGs) (Sekimoto et al., 1996; Stark et al., 1998). It is important to notice that the GAS 
is different from the ISRE and that the binding of the STAT1 complex does not require IRF9 
(Goodbourn et al., 2000; Randall and Goodbourn, 2008).     
 It has also been reported that STAT1 homodimers may activate type I IFN signalling 
and trigger transcription of some type I IFN-regulated genes, but the overall significance in 
antiviral response is unknown (Decker et al., 1991; Randall and Goodbourn, 2008). 
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1.3.4 Interferon-mediated antiviral effects 
 Treatment of cells with type I IFN results in the stimulation of expression of hundreds 
of genes, several of which are involved in the establishment of the so-called antiviral state of 
the cell. Several of these genes encode enzymes, e.g. dsRNA-dependent protein kinase R 
(PKR), 2’5’-oligoadenylate synthetase (OAS) and Mx (reviewed in Goodbourn et al., 2000; 
Samuel, 2001; Randall and Goodbourn, 2008). Figure 9 shows a schematic overview of the 
IFN-inducible products as described below. 
  Figure 9: overview of IFN-inducible antiviral proteins (adapted from Deruelle, 2010). 
 
dsRNA-dependent protein kinase R (PKR) 
 The IFN-inducible PKR is a serine/threonine kinase with multiple functions in control 
of transcription and translation (reviewed in Clemens and Elia, 1997). PKR is synthesized in 
an inactive form and, in response to the cofactor dsRNA produced during viral infection, 
undergoes a conformational change resulting in dimerization and activation (Meurs et al., 
1990; Katze et al., 1991; George et al., 1996). Alternatively, PKR may be activated by a 
stress-activated protein called protein kinase R (PKR)-activating protein (PACT) (Ito et al., 
1999; Patel et al., 2000). One of the best characterized PKR substrates is the α subunit of 
the eukaryotic translation initiation factor 2 (eIF2α). Phosphorylated eIF2α prevents the 
recycling of eIF2α such that translation initiation is halted (Meurs et al., 1992; Meurs et al., 
1993). A variety of physiologic conditions, including the combination of IFN and virus 
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infection, cause the phosphorylation state of eIF2α to increase and a subsequent 
suppression of mRNA translation. In the initial step of translation, the initiator Met-tRNA is 
recruited to the 40S ribosomal subunit via an interaction with GTP-bound eIF2α. This 
complex then interacts with mRNA, other initiator factors and the large ribosomal subunit to 
form a pre-initiator complex, with subsequent hydrolysis of the GTP molecule bound to eIF2α 
and release of GDP-bound eIF2α. To allow to participate in another round of translation 
initiation, the GDP molecule bound to eIF2α must be exchanged for GTP. This is catalysed 
by the guanine exchange factor eIF2β. Phosphorylated eIF2α strongly interacts with eIF2β 
and traps it such that it cannot mediate recycling of eIF2α. Since eIF2β is present in limiting 
amounts, translation is inhibited (Ramaiah et al., 1994; Clemens and Elia, 1997; Goodbourn 
et al., 2000; Randall and Goodbourn, 2008). 
 PKR, in response to dsRNA, is also involved in the activation of NF-κB, which is 
essential for induction of IFNβ production. It has also been suggested that PKR influences 
the activity of the transcription factors STAT1, IRF1 and p53 (Kumar et al., 1997; Wong et al., 
1997; Cuddihy et al., 1999a; Cuddihy et al., 1999b; Ramana et al., 2000). PKR can also aid 
the clearance of viruses by mediating apoptosis (Der et al., 1997; King and Goodbourn, 
1998; Tanaka et al., 1998; Goodbourn et al., 2000).  
 Although there is abundant evidence that PKR plays a major role in regulating virus 
infection, PKR is not sufficient to mediate the full antiviral response. Evidence for this came 
from PKR knockout mice that still show IFN-mediated resistance against viral infection (Yang 
et al., 1995; Abraham et al., 1999; Goodbourn et al., 2000). 
2’5’-oligoadenylate synthetase (OAS) and RNaseL 
 The 2’5’-oligoadenylate synthetases are a group of enzymes that are induced by IFNs 
in mammalian cells. They catalyze the synthesis of adenosine oligomers linked by 
phosphodiester bonds in the unusual conformation of 2’ to 5’ (Kerr and Brown, 1978). Like 
PKR, OAS is synthesized in an inactive form and utilizes dsRNA as cofactor. The 2’5’ 
adenosine molecules bind with high affinity to endoribonuclease L (RNaseL) and induce its 
activation by dimerization. Active RNaseL catalyses the cleavage of ssRNA, including 
mRNA. This may lead to inhibition of protein synthesis (Imai et al., 1982; Silverman, 1997). It 
has also been shown that RNaseL is able to cleave 28S ribosomal RNA in a site-specific 
manner resulting in ribosomal inactivation and thus translational inhibition (Goodbourn et al., 
2000; Iordanov et al., 2000). Since OAS is very labile, the activation of RNaseL relies on 
locally activated OAS within the cell, thus ensuring that viral transcripts are destroyed 
preferentially over cellular mRNAs (Nilsen and Baglioni, 1979; Goodbourn et al., 2000). 
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Mx 
 Mx and the Mx family of genes encode large GTPases related to dynamin. The 
GTPase activity appears to be essential for their antiviral functions (Pitossi et al., 1993). They 
exert an antiviral effect against a wide range of RNA viruses. The Mx GTPases probably 
interfere with virus replication by inhibiting viral polymerases (Stranden et al., 1993). The Mx 
GTPases are also able to recognize nucleocapsid-like structures and disturb their localization 
within the cell, resulting in a restricted virus replication (Kochs et al., 1998; Goodbourn et al., 
2000; Weber et al., 2000; Randall and Goodbourn, 2008). 
ISG15, ISG54 and ISG56 
 Several genes are upregulated in response to IFN and were named according to their 
molecular weight. For example, ISG15 is a 15kDa protein induced by IFN. Of all the IFN-
stimulated genes, ISG15 is the most abundant but little is known about its function (reviewed 
by Kerscher et al., 2006). ISG15 modification, called ISGylation, occurs on over 100 cellular 
proteins and is catalyzed by the action of IFN-inducible E1, E2 and E3 ubiquitin ligases. 
Unlike ubiquitination, ISGylation is an IFN-stimulated and regulated process that appears to 
mimic mono-ubiquitination functions, such as modulation of enzymatic activity, rather than 
the poly-ubiquitination function of protein degradation (Harty et al., 2009). It has been shown 
that ISGylation inhibits degradation of proteins rather than stimulating it like ubiquitination 
(Sadler and Williams, 2008; Durfee et al., 2010; Liu et al., 2010; Shi et al., 2010). Many of the 
substrates for ISG15 play important roles in the innate immunity including Jak1, Erk1, 
STAT1, PKR, MxA, RIG-I and IRF3 (Malakhov et al., 2003; Zhao et al., 2005; Lu et al., 2006; 
Okumura et al., 2007; Randall and Goodbourn, 2008). Interestingly, ISG15 is also released 
from IFN-treated cells. Several activities have been attributed to recombinant or extracellular 
ISG15 including an induction of NK cell proliferation, augmented lymphokine-activated-killer 
(LAK) activity, increased production of IFN-γ, maturation of DC, chemotactic activity towards 
neutrophils. To date, no cell surface receptor has been identified that binds to ISG15; 
therefore the role that its potential cytokine activity plays in vivo is yet to be ascertained 
(D'cunha et al., 1996; Padovan et al., 2002; Owhashi et al., 2003; Lenschow, 2010).   
 ISG54 and ISG56 are related proteins that inhibit translation by interacting with the 
multiprotein translation initiation factor eIF3 complex thereby inhibiting its ability to stabilize 
the eIF2α-GTP-tRNA complex (Hui et al., 2003; Randall and Goodbourn, 2008). 
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Promyelocytic leukaemia (PML) nuclear bodies        
 The role of PML nuclear bodies in the antiviral response has been extensively studied 
(Everett and Chelbi-Alix, 2007). These PML bodies or ND10 bodies contain, amongst others, 
IFN-inducible PML and Sp100. They play an important role in transcriptional responses to 
stress and regulate chromatin structure and thus gene promoter accessibility. The depletion 
of PML enhances growth of herpesviruses, indicating that ND10s do play a role in restricting 
viral replication (Randall and Goodbourn, 2008).  
RNA editing proteins 
 Several ‘restriction factors’ that are able to restrict replication of retroviruses have 
been identified. These are proteins that control normal cell functions and are under positive 
selection pressure as they are evolving rapidly. The best characterized example is 
apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like (APOBEC) 3F and 3G 
genes (APOBEC3F and APOBEC3G) and the unrelated tripartite motif-α (TRIM5α) gene. 
Although they are expressed constitutively, they are strongly upregulated by type I IFNs in all 
cell types (Asaoka et al., 2005; Bonvin et al., 2006; Chen et al., 2006; Peng et al., 2006; 
Sarkis et al., 2006; Argyris et al., 2007; Sakuma et al., 2007; Ying et al., 2007). The universal 
mechanism used by these proteins involves RNA editing through cytidine deamination and 
subsequent mutation of the viral RNA template (Baumert et al., 2007; Randall and 
Goodbourn, 2008). It was recently shown that APOBEC3C is able to reduce both virus titers 
and particle/PFU ratio in tissue cultures infected with HSV-1 (Suspene et al., 2011).  
 Another important RNA-editing enzyme, called ADAR1, is induced by IFN and acts as 
an RNA-specific adenosine deaminase (George and Samuel, 1999). It was described that 
ADAR1 is involved in the editing of viral RNA transcripts and cellular pre-mRNAs (Bass, 
1997; Samuel, 2001).  
IFITM 
 The interferon induced transmembrane (IFITM) proteins 1, 2 and 3 were recently 
identified as host factors that are able to restrict viral entry (Brass et al., 2009; Liu et al., 
2010). Knockdown of IFITM3 or deletion of the Ifitm locus increased susceptibility of the cells 
to viral infections, although the exact mechanism remains unknown (Yount et al., 2010).   
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1.3.5 Alphaherpesvirus-encoded countermeasures to the IFN response 
 There are five main ways by which viruses circumvent the IFN response: i) interfering 
globally with host-cell gene expression and/or protein synthesis; ii) minimizing IFN induction 
by limiting production of MAMPs and/or by specifically blocking IFN-induction cascades; iii) 
inhibiting IFN signalling; iv) blocking the action of IFN-induced enzymes with antiviral effects 
and v) having a replication strategy that is largely insensitive to IFN (Randall and Goodbourn, 
2008). Different viruses have evolved a great diversity of mechanisms to achieve similar 
ends to counteract the IFN response. A combination of the above mentioned strategies might 
be necessary to sufficiently circumvent IFN-mediated antiviral effects to allow replication and 
spread. Figure 10 shows schematically where the HSV-1-encoded viral proteins interact with 
the IFN production or signalling pathway. An overview of all alphaherpesvirus-encoded IFN-
antagonists is given below (Table 1). 
 Several viral proteins of HSV-1 have been described to have antagonistic effects on 
IFN production, mainly by targeting IRF3 (belonging to strategy ii) mentioned higher). The 
activated IRF3 is sequestered by ICP0 together with its co-activator CBP/p300, followed by 
inactivation and degradation of IRF3 hence blocking IFNβ production (Melroe et al., 2007). It 
has also been shown that ICP0 inhibits IRF7 through its RING finger domain (Lin et al., 
2004). In addition to ICP0, the endoribonuclease vhs protein of HSV-1 was found to non-
specifically degrade ISG transcripts that accumulate in the absence of ICP0 (Lin et al., 2004). 
Recently, it was described that infection with a vhs deficient virus induces more IFN than WT 
virus again indicating that vhs functions to reduce innate immune responses by reducing 
levels of dsRNA (Pasieka et al., 2008).  ICP27 is also able to inhibit IRF3 activation and NF-
κB in human macrophages and DCs (Melchjorsen et al., 2006). In contrast, in a primary 
human fibroblast cell line, infection with a ICP27-null mutant did not result in an observable 
ISG induction and no increase in IRF3 activity was found, indicating that the involvement of 
ICP27 in IRF3 inhibition may be cell type dependent (Lin et al., 2004; Melroe et al., 2004; 
Paladino and Mossman, 2009). Another protein of HSV-1, US3, has been suggested to 
downregulate the TLR3-mediated response, preventing IRF3 activation (Peri et al., 2008).  
Recently, it was shown that ICP34.5 can inhibit IRF3 activation through binding of TBK1 
(Verpooten et al., 2009).  
 Next to HSV-1, the BoHV-1 protein bICP0, was shown to inhibit the kinases TBK1 
and IKKi, leading to inhibition of IRF3 and thus IFN production (Henderson et al., 2005).  
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 Also for VZV, it has been described that production of type I IFN can be reduced 
through inhibition of the NF-κB pathway, but through a still unknown mechanism (Jones and 
Arvin, 2006). Recently, it was shown that the VZV protein ORF47 is able to bind IRF3, which 
prevents its homodimerization and subsequent induction of ISG (Vandevenne et al., 2011). 
Another recent study showed that ORF61 causes degradation of activated IRF3 (Zhu et al., 
2011). 
 Alphaherpesviruses have also been reported to interfere with IFN signalling, typically 
by blocking the Jak/STAT signalling pathway, thereby inhibiting production of ISG (strategy 
iii). Inhibition of Jak1, Tyk2, STAT1 and STAT2 phosphorylation during the initial phases of 
infection with HSV-1 was reported in early studies (Yokota et al., 2001). This inhibition of 
Jak/STAT phosphorylation correlated with the induction of suppressor of cytokine signalling 3 
(SOCS3), which is a negative regulator of IFN signalling, and the viral proteins vhs and 
UL13 were found to be involved (Yokota et al., 2001; Yokota et al., 2004). Chee and 
Roizman subsequently showed that vhs was at least partly responsible for the decline in 
Jak/STAT protein members (Chee and Roizman, 2004). More recently, it was reported that 
HSV-1 is able to interfere with IFNγ induced STAT1 signalling in infected mature DCs due to 
downregulation of IFNGR1 and inhibition of STAT1 phosphorylation. It was suggested that 
vhs again plays an important role in this process (Eisemann et al., 2007). ICP27 can also 
downregulate STAT1 phosphorylation upstream of Jak1 activation (Johnson et al., 2008; 
Johnson and Knipe, 2010). In addition, Liang and Roizman reported that US3 
phosphorylates a subunit of the IFNγ receptor, thereby inhibiting downstream signalling 
(Liang and Roizman, 2008). An earlier report suggested that US3 is involved in overcoming 
the IFN-induced antiviral state since, based on plaque number and size, a US3null HSV-1 
virus was found to be more sensitive to IFNα compared to WT virus (Piroozmand et al., 
2004).  
 For VZV, it was described that expression of STAT1 and Jak2 are inhibited, while 
Jak1 expression levels remain unaltered (Samuel, 2001). Expression of IRF1 and MHCII 
transactivator (CIITA), which are regulated by IFNγ, are also inhibited by VZV (Abendroth et 
al., 2000). The VZV orthologue of US3, ORF66, decreases the level of STAT1 
phosphorylation following IFNγ exposure (Schaap et al., 2005).  
 For PRV, it has been shown that the IFN-mediated immune response can be 
counteracted by a decreased phosphorylation of STAT1. Brukman and Enquist showed that 
structural components of the virion are sufficient to mediate this, although the exact 
mechanism remains undetermined (Brukman and Enquist, 2006b).  
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 Alphaherpesviruses can also antagonize the IFN-inducible antiviral proteins (strategy 
iv). ICP0 of HSV-1 is able to interact with the proteasome-dependent degradation pathway 
leading to a destabilisation of certain ISG products, including PML (Maul et al., 1993; Maul 
and Everett, 1994; Chelbi-Alix and De The, 1999; Chelbi-Alix and De Thé, 1999; Parkinson 
and Everett, 2000; Eidson et al., 2002). The RING finger domain of ICP0 is required for this 
proteasomal degradation as it acts as a ubiquitin E3 ligase (Everett and Maul, 1994; Maul 
and Everett, 1994; Boutell et al., 2002). In addition, HSV-1 encodes two proteins that 
interfere with the PKR pathway: ICP34.5 and US11. ICP34.5 acts through the recruitment of 
the cellular protein phosphatase 1 (PP1), forming a high-molecular weight complex that 
efficiently dephosphorylates eIF2α (He et al., 1997; He et al., 1998). Recently, it was shown 
that ICP34.5 functions as a bridge between PP1 and eIF2α as both proteins are able to 
directly bind ICP34.5, thereby allowing the proteins to be in each other’s vicinity (Li et al., 
2011).  The US11 protein alters the PKR pathway in a different way. US11 interacts with 
dsRNA directly to inhibit PKR phosphorylation and activation, thereby preventing eIF2α 
phosphorylation (Poppers et al., 2000; Sanchez and Mohr, 2007). Both proteins are required 
for virus replication in IFN-treated cells as their combined action prevents the accumulation 
of phosphorylated eIF2α (Mulvey et al., 2003; Mulvey et al., 2004). 
 For VZV, it was described that IE63, orthologue of ICP22 of HSV-1, is required and 
sufficient to inhibit phosphorylation of eIF2α but the underlying mechanism still remains 
unknown (Ambagala and Cohen, 2007).  
 PRV encodes EP0, an orthologue of ICP0 of HSV-1, which has been described to 
counteract the IFN-induced antiviral state in primary pig cells, but not in non-host cells 
(Brukman and Enquist, 2006a).   
 
 
Figure 10: Overview of the viral proteins encoded by Herpes Simplex Virus that counteract the interferon 
system.  
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Table 1: Overview of viral proteins that counteract IFN-mediated antiviral effects 
Virus Protein Function Reference 
HSV-1 ICP0 Inhibition of IRF3 
Inhibition of IRF7 
Degradation of IFN-inducible gene products e.g. PML 
Melroe et al. 2007 
Lin et al., 2004 
Maul and Everett, 1994 
 
 
 
 
 
 
 
 
 
 
 
 
BHV-1 
VZV 
 
 
 
PRV 
 
Vhs 
 
 
UL13 
ICP27 
 
US3 
 
 
ICP34.5 
 
US11 
bICP0 
ORF47 
ORF66 
IE63 
ORF61 
EP0 
? 
Degradation of ISG transcripts 
Decline in Jak/STAT protein levels 
Inhibition of STAT1 phosphorylation 
Inhibition of Jak/STAT phosphorylation 
Inhibition of IRF3 and NF-κB 
Downregulate STAT1 phosphorylation 
Phosphorylation of IFNγ receptor subunit 
Preventing IRF3 activation 
Overcomes an IFN-induced antiviral state 
Inhibition of IRF3 through binding TBK1 
Recruitment of PP1 to dephosphorylate eIF2α 
Inhibits PKR activation, preventing phosphorylation of eIF2α 
Inhibition of TBK1 and IKKi, leading to inhibition of IRF3 
Binding to IRF3 and prevent homodimerization 
Decrease phosphorylation of STAT1 
Induces dephosphorylation of eIF2α 
Degradation of activated IRF3 
Overcomes an IFN-induced antiviral state 
Decrease phosphorylation of STAT1 
Lin et al., 2004 
Chee and Roizman, 2004 
Eisemann et al., 2007 
Yokota et al., 2004 
Melchjorsen et al., 2006 
Johnson et al., 2008 
Liang and Roizman, 2008 
Peri et al., 2008 
Piroozmand et al., 2004 
Verpooten et al., 2009 
He et al., 1997 
Poppers et al., 2000 
Henderson et al., 2005 
Vandevenne et al., 2011 
Schaap et al., 2005 
Ambagala and Cohen, 2007 
Zhu et al., 2011 
Brukman and Enquist, 2006 
Brukman and Enquist, 2006 
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 Herpesviruses are among the most successful pathogens, establishing lifelong latent 
infections from which they may reactivate to spread to new hosts. Key to this success is their 
delicate and complex balance with the host immune system. Interferon is one of the major 
components of the host defense against viruses in general and herpesviruses in particular. 
Indeed, defects in the interferon system, particularly the type I interferon system, may lead to 
aggravated and sometimes fatal herpesvirus disease (Al-Khatib et al., 2002; Al-Khatib et al., 
2003; Vollstedt et al., 2004; Casrouge et al., 2006; Zhang et al., 2007; Zhang et al., 2008; 
Perez De Diego et al., 2010). 
 The general aim of the current thesis was to gain a better insight in the interaction of 
herpesviruses with the interferon system. Our studies focussed on the porcine 
alphaherpesvirus pseudorabies virus and the closely related subfamily human member of 
this subfamily, the herpes simplex virus.  
 A first aim of this study was to investigate, using an in vitro system, whether type I 
interferon may play a role in the establishment of PRV and HSV-1 latency in sensory 
neurons (Chapter 3). 
 To further dissect the role for IFN in latency establishment, we next investigated the 
effect of IFN on immediate-early gene transcription and translation, both for PRV (IE180 
gene) and HSV-1 (ICP4 gene) (Chapter 4). 
 Further, we investigated whether part of the suppressive effect of IFN on expression 
of the IE gene ICP4 of HSV may be through a previously uncharacterized effect of IFN on 
histone modifications (Chapter 5). 
 As a countermeasure towards the suppressive effects of IFN on viral replication, 
herpesviruses have developed systems to interfere with the antiviral effects of IFN. In a 
fourth experimental chapter, we investigated how PRV blocks phosphorylation of eIF2α, one 
of the most potent antiviral effects of IFN (Chapter 6). 
  
 
 
 
 
Chapter 2 - Aims 
 57 
References 
Al-Khatib, K., Williams, B.R., Silverman, R.H., Halford, W. and Carr, D.J. (2003) The murine double-
stranded RNA-dependent protein kinase PKR and the murine 2',5'-oligoadenylate synthetase-
dependent RNase L are required for IFN-beta-mediated resistance against herpes simplex 
virus type 1 in primary trigeminal ganglion culture. Virology 313,126-35 
Al-Khatib, K., Williams, B.R., Silverman, R.H., Halford, W.P. and Carr, D.J. (2002) Absence of PKR 
attenuates the anti-HSV-1 activity of an adenoviral vector expressing murine IFN-beta. J 
Interferon Cytokine Res 22,861-71 
Casrouge, A., Zhang, S.Y., Eidenschenk, C., Jouanguy, E., Puel, A., Yang, K., Alcais, A., Picard, C., 
Mahfoufi, N., Nicolas, N., Lorenzo, L., Plancoulaine, S., Senechal, B., Geissmann, F., Tabeta, 
K., Hoebe, K., Du, X., Miller, R.L., Heron, B., Mignot, C., De Villemeur, T.B., Lebon, P., Dulac, 
O., Rozenberg, F., Beutler, B., Tardieu, M., Abel, L. and Casanova, J.L. (2006) Herpes 
simplex virus encephalitis in human UNC-93B deficiency. Science 314,308-12 
Perez De Diego, R., Sancho-Shimizu, V., Lorenzo, L., Puel, A., Plancoulaine, S., Picard, C., Herman, 
M., Cardon, A., Durandy, A., Bustamante, J., Vallabhapurapu, S., Bravo, J., Warnatz, K., 
Chaix, Y., Cascarrigny, F., Lebon, P., Rozenberg, F., Karin, M., Tardieu, M., Al-Muhsen, S., 
Jouanguy, E., Zhang, S.Y., Abel, L. and Casanova, J.L. (2010) Human TRAF3 adaptor 
molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to 
herpes simplex encephalitis. Immunity 33,400-11 
Vollstedt, S., Arnold, S., Schwerdel, C., Franchini, M., Alber, G., Di Santo, J.P., Ackermann, M. and 
Suter, M. (2004) Interplay between alpha/beta and gamma interferons with B, T, and natural 
killer cells in the defense against herpes simplex virus type 1. J Virol 78,3846-50 
Zhang, S.Y., Boisson-Dupuis, S., Chapgier, A., Yang, K., Bustamante, J., Puel, A., Picard, C., Abel, L., 
Jouanguy, E. and Casanova, J.L. (2008) Inborn errors of interferon (IFN)-mediated immunity 
in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda 
in host defense. Immunol Rev 226,29-40 
Zhang, S.Y., Jouanguy, E., Ugolini, S., Smahi, A., Elain, G., Romero, P., Segal, D., Sancho-Shimizu, 
V., Lorenzo, L., Puel, A., Picard, C., Chapgier, A., Plancoulaine, S., Titeux, M., Cognet, C., 
Von Bernuth, H., Ku, C.L., Casrouge, A., Zhang, X.X., Barreiro, L., Leonard, J., Hamilton, C., 
Lebon, P., Heron, B., Vallee, L., Quintana-Murci, L., Hovnanian, A., Rozenberg, F., Vivier, E., 
Geissmann, F., Tardieu, M., Abel, L. and Casanova, J.L. (2007) TLR3 deficiency in patients 
with herpes simplex encephalitis. Science 317,1522-7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
  
 
 
 
 
 
 
 
__________________________________________________________ 
 
Chapter 3: Interferon Alpha Induces Establishment of 
Alphaherpesvirus Latency in Sensory Neurons In Vitro 
__________________________________________________________ 
 
 
 
 
 
Adapted from: De Regge N*, Van Opdenbosch N*, Nauwynck H, Efstathiou S and 
Favoreel HW. PLoS One, 2010, e13076 
* These authors share the first authorship 
 
Chapter 3 – Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons  
                    in vitro 
 
 60 
Abstract 
BACKGROUND: Several alphaherpesviruses, including herpes simplex virus 1 (HSV-1) and 
pseudorabies virus (PRV), establish lifelong latency in neurons of the trigeminal ganglion 
(TG). Although it is thought that efficient establishment of alphaherpesvirus latency is based 
on a subtle interplay between virus, neurons and the immune system, it is not clear which 
immune components are of major importance for the establishment of latency. 
METHODOLOGY/PRINCIPAL FINDINGS: Here, using an in vitro model that enables a 
natural route of infection, we show that interferon alpha (IFNα) has the previously 
uncharacterized capacity to induce a quiescent HSV-1 and PRV infection in porcine TG 
neurons that shows strong similarity to in vivo latency.  IFNα induced a stably suppressed 
HSV-1 and PRV infection in TG neurons in vitro. Subsequent treatment of neurons 
containing stably suppressed virus with forskolin resulted in reactivation of both viruses. HSV 
and PRV latency in vivo is often accompanied by the expression of latency associated 
transcripts (LATs). Infection of TG neurons with an HSV-1 mutant expressing LacZ under 
control of the LAT promoter showed activation of the LAT promoter and RT-PCR analysis 
confirmed that both HSV-1 and PRV express LATs during latency in vitro. 
CONCLUSIONS/SIGNIFICANCE: These data represent a unique in vitro model of 
alphaherpesvirus latency and indicate that IFNα may be a driving force in promoting efficient 
latency establishment.  
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1. Introduction 
 Alphaherpesviruses are a subfamily of the herpesviruses containing closely related 
human and animal pathogens, including human HSV-1 (cold sores, corneal blindness, and 
encephalitis) and important animal viruses such as the porcine pseudorabies virus (PRV) 
and bovine herpesvirus 1 (BoHV-1; respiratory symptoms, abortions, and/or neurological 
symptoms).  
 Cycles of latency and reactivation arguably constitute the most important and 
fascinating hallmarks of alphaherpesvirus infections. Alphaherpesviruses generally establish 
latency in sensory neurons, and neurons of the trigeminal ganglion (TG) are the predominant 
site of latency for several important alphaherpesviruses, such as HSV-1, PRV, and BoHV-1 
(Croen et al., 1987; Gutekunst et al., 1980; Jones, 2003). Although there is direct and indirect 
evidence to support the general concept that alphaherpesvirus latency and reactivation is 
based on a subtle interplay between virus, neurons and the immune system, many questions 
remain about the immune components that are involved in the establishment of latency 
(Decman et al., 2005).  
 It is becoming increasingly clear that the innate immune system has an important role 
in controlling alphaherpesvirus infections. Type I interferons (IFNα and -β) are among the first 
immune effectors produced upon alphaherpesvirus infection (Jones et al., 2003; Mikloska et 
al., 1998) and it has been shown that they are important in limiting viral replication and 
spread in vitro, but also in vivo at the periphery during initial infection and during reactivation 
(Hendricks et al., 1991; Mikloska & Cunningham, 2001; Sainz & Halford, 2002). Furthermore, 
type I interferons have been shown to be present at the periphery (Hendricks et al., 1991) 
and within the ganglion (Carr et al., 1998) around the time point that latency is established.  
 In the current study, using an in vitro two-chamber model that enables a natural route 
of alphaherpesvirus infection of porcine TG neurons (De Regge et al., 2006a; De Regge et 
al., 2006b), we report that treatment of TG neurons with IFNα is sufficient to induce a 
quiescent HSV-1 and PRV infection in vitro that shows strong similarities to in vivo latency, 
thereby providing a novel and unique in vitro model to study HSV/PRV latency and 
reactivation and suggesting that IFNα may represent a key immune component involved in 
efficient establishment of alphaherpesvirus latency in sensory neurons. 
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2. Material and methods 
2.1. Ethics statement 
 Trigeminal ganglia were derived from animals that were euthanized at the Faculty of 
Veterinary Medicine, Ghent University, Belgium, according to FELASA guidelines 
(Federation of European Laboratory Animal Science Associations). 
2.2. Cells and viruses 
 Wild type PRV strain Becker (Card et al., 1990) was propagated on Swine Testicle 
cells. Wild type HSV-1 strain F (Ejercito et al., 1986) and HSV-1 mutants SΔUS5-LacZ (Balan 
et al., 1994) and LbetaA (Lachmann & Efstathiou, 1997) were propagated on Vero cells. 
2.3. Cultivation and inoculation of primary trigeminal ganglion neuronal cultures in 
a two-chamber model 
 Porcine trigeminal ganglia were excised from 2 to 4 week old piglets and dissociated 
by enzymatic digestion with 0.2% collagenase A (Roche)(17). The harvested cells were 
resuspended in culture medium (MEM supplemented with 10% fetal bovine serum, 100 U/ml 
penicillin, 0.1 mg/ml streptomycin, 0.1 mg/ml kanamycin and 30 ng/ml nerve growth factor 
(Sigma) and seeded in the inner chamber of an in vitro two-chamber model. The two-
chamber model consists of a polystyrene cloning cylinder (Sigma) that is fixed with silicon 
grease on a collagen coated cover glass inserted in a 6 well plate (De Regge et al., 2006a). 
The inside of the cylinder forms the inner chamber, the outside forms the outer chamber. 
One day after seeding, cultures are washed with RPMI (Gibco) to remove non-adherent cells 
and from then on, culture medium is changed three times a week. After two to three weeks of 
cultivation, when clear axon growth can be observed in the outer chamber, two-chamber 
models are ready for inoculation with virus. Inoculation with all viruses used was done by 
adding 2x107 PFU to the outer chamber. For PRV, two hours after inoculation of the outer 
chamber, medium containing PRV was removed and the outer chamber was washed twice 
with culture medium. Afterwards, new culture medium supplemented with polyclonal 
antibodies to PRV and guinea pig complement (Sigma) was added to prevent continuous 
infection pressure from the outer chamber to neurons in the inner chamber. For HSV-1, the 
virus was removed at 48h after inoculation by washing and new culture medium 
supplemented with monoclonal antibodies to HSV-1 gD and guinea pig complement was 
added. 
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2.4. Antibodies, cytokines and chemicals 
 Polyclonal porcine FITC-labeled anti-PRV antibodies (Nauwynck & Pensaert, 1995) 
were used to detect late PRV proteins gB, gD and gE (Geenen et al., 2005). Monoclonal 
mouse-anti-PRV gD antibody 13D12 was described earlier (Nauwynck & Pensaert, 1995). 
Polyclonal rabbit-anti-PRV IE180 antibody was a kind gift from E. Tabarés (Universidad 
Autonoma de Madrid, Spain). Monoclonal mouse-anti-HSV-1 gD (124/468) and –anti-HSV-1 
ICP4 (sc56986) were purchased from Santa Cruz Biotechnology and the neuronal marker 
rabbit-anti-neurofilament 200 from Sigma. Texas red-labeled goat-anti-rabbit antibodies and 
FITC-labeled goat-anti-mouse antibodies were from Invitrogen. Recombinant porcine IFNα 
and IFNγ were purchased from R&D and X-gal and forskolin were obtained from Sigma. 
2.5. Quantification of the percentage viral antigen or β-galactosidase positive 
infected neurons 
 The ratio between viral antigen positive or β-galactosidase positive neurons in the 
inner chamber to the number of axons in the outer chamber after different treatments was 
determined by calculating viral antigen positive neuronal cell bodies (immunofluorescence) or 
beta-galactosidase positive neurons (X-gal) in the inner chamber and immunofluorescently 
labeled axons in the outer chamber. For each experiment, at least 25 neurons with outgrowth 
to the outer chamber were examined. Data shown represent means ± s.e.m. of independent 
triplicate assays. 
2.6. Immunofluorescence staining procedures 
 Two-chamber systems to be used for immunofluorescent detection of viral antigen 
positive neurons were washed in PBS and fixed in 100% methanol for 20 min at -20°C. In 
two-chamber systems to be used for analysis of β-galactosidase positive neurons in the inner 
chamber, the outer chamber was fixed in 4% paraformaldehyde in PBS for 10 min and 
subsequently permeabilized in 0.2% TritonX-100 in PBS for 2 min. All antibodies were diluted 
in PBS, all to a dilution of 1:100. Cells were incubated with each antibody for 1h at 37°C and 
were washed two times between all incubation steps and after the last incubation step. 
2.7. Detection of β-galactosidase activity 
 Cells in the inner chamber of two-chamber systems were fixed in 2% 
paraformaldehyde-0.2% glutaraldehyde in PBS for 15 min at RT and subsequently incubated 
with staining buffer (0.01% Na-deoxycholate, 0.02% NP40, 2 mM MgCl2, 4.5 mM potassium 
ferricyanide, 4.5 mM potassium ferrocyanide in PBS) for 5min at RT, followed by incubation 
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with X-gal buffer (staining buffer supplemented with 1 mg/ml X-gal) for 4h at 37°C. 
Afterwards, the inner chamber was washed twice with PBS and immediately analyzed by 
light microscopy. 
2.8. RT-PCR 
 RNA from cells grown in the inner chamber of two-chamber systems was isolated and 
purified using the Trizol Plus RNA purification kit (Invitrogen) according to manufacturer’s 
instructions, followed by a DNaseI digestion to degrade any contaminating DNA. RNA was 
reverse transcribed using SuperScript III RT enzyme (Invitrogen) according to manufacturer’s 
instructions. OligodT primers were used for reverse transcription of actin, PRV IE180, PRV 
gB, PRV LAT, HSV-1 ICP0, HSV-1 gB and HSV-1 gD RNA and a gene specific primer (GSP-
LAT) that allows amplification of the 2kb LAT intron (Table 1) was used for reverse 
transcription of HSV-1 LAT RNA. The cDNA was then amplified by PCR using the AccuPrime 
Taq DNA polymerase system (Invitrogen). The sequences of primers, annealing 
temperatures and predicted lengths of amplified fragments can be found in Table 1.  
Amplified PCR fragments were analyzed by agarose gel electrophoresis and staining with 
Ethidium Bromide. The specificity of amplified fragments was verified by predicted sizes and 
by sequencing fragments that were purified from the agarose gel. Purified fragments were 
subjected to cycle sequencing with a Big Dye Terminator Cycle Sequencing kit v1.1 (Applied 
Biosystems) and cycle sequencing reaction products were purified using ethanol precipitation 
and separated on an ABI Genetic Analyzer 310 (Applied Biosystems). Obtained fragment 
sequences were compared with the NCBI nucleotide collection (nr/nt) database using 
MegaBlast. 
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Table 1: RT-PCR specifications  
 primer sequence (5’-3’) 
annealing 
temp. 
predicted 
length 
porcine actin forward: ATGCAGAAGGAGATCACGGC 
50 199 
  reverse: AGTCCGCCTAGAAGCATTTG 
      
PRV IE180 forward: ACGCGAGAGGAAGTAGGGAG 
57 393 
  reverse: GTACCTGCACCGCAGTGAAG 
 gB forward: CCTCCTCGACGATGCAGTTG 
59 
281 
   reverse: CACGAACCGCTTCACAGACC 
 LAT forward: CATAAAGCCAGTTGAAGACGGGG 
59 526 
  reverse: TAGAGGGTCTTGGGGATGTTGG 
      
HSV-1 ICP0 forward: GCCCACTATCAGGTACAC 
55 301 
  reverse: CACGGAACTGTTCGAGAC 
 gB forward: TGGCGTCGGAAGAGAATCGG 
59 213 
  reverse: AGCAGGTCGACGGCTTCTAC 
 gD forward: AGCCAAGGGCTCCTGTAAG 
58 352 
  reverse: GTCCTGGATCGACGGTATGTG 
 GSP-LAT  TGGTGGACCAGACGGGAAAC   
 LAT forward: CCGCGATACATCCAACAC 
53 383 
  reverse: GAACAGCCTCTGGATGAC 
Primer sequences and annealing temperatures (°C) used in RT-PCR and predicted length (bp) of amplified 
fragments. 
 
2.9. Confocal microscopy 
 Samples were analyzed on a Leica TCS SP2 laser scanning spectrum confocal 
system (Leica Microsystems GmbH) linked to a Leica DM IRBE microscope. Images were 
taken using a 63x oil objective (NA 1.40-0.60) at RT and using Leica confocal acquisition 
software. Adjustments of brightness and contrast were applied to the entire images and were 
done using Adobe Photoshop (Adobe Systems Inc.). 
 
 
Chapter 3 – Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons  
                    in vitro 
 
 66 
3. Results 
3.1. PRV and HSV-1 proceed to productive replication in porcine TG neurons 
 Porcine TG neurons grown in two-chamber models were infected with PRV or HSV-1 
by addition of virus to the outer chamber. For PRV, at 24hpi, the vast majority of neurons 
(98%) that had axons growing in the outer chamber were positive for late viral antigens (Fig. 
1C), indicating that PRV proceeds to productive infection in virtually all infected neurons. In 
some infected neurons at 24hpi, late PRV protein expression was limited to the neuronal cell 
body (Fig. 1A) while in others, infection had already spread to non-neuronal cells surrounding 
the cell body (Fig. 1B). Initiation of productive infection was less efficient when TG neurons 
were infected with HSV-1, but still resulted in 12% of the neurons with axonal outgrowth in 
the outer chamber being positive for the late HSV-1 antigen gD at 48hpi (Fig. 1F). As for 
PRV, some neurons showed HSV-1 gD expression limited to the neuronal cell body (Fig. 1D) 
while in others infection had already spread from the cell body to surrounding non-neuronal 
cells at this time point (Fig. 1E). To ensure that the substantial difference in percentage of 
productively infected neurons between HSV-1 and PRV was not due to the difference in 
antibodies used (polyclonal mixture for PRV versus monoclonal gD-specific for HSV-1), 
experiments with PRV were repeated using a PRV gD-specific monoclonal antibody. Again, 
the vast majority (75.3 ± 6.2%) of neurons with axonal outgrowth in the outer chamber were 
positive at 24hpi with PRV. To analyze whether the limited percentage of productively HSV-1 
infected neurons is due to a hampered HSV-1 entry in porcine TG neurons, neurons were 
infected with the SΔUS5-LacZ HSV-1 mutant carrying the reporter gene LacZ under control 
of the human CMV MIEP promoter inserted in the non-essential US5 gene (15). X-gal 
staining of infected cultures showed that over 90% of neurons with axons growing into the 
outer chamber were beta-galactosidase positive at 24hpi (Fig. 1F), indicating that HSV-1 
efficiently enters porcine TG neurons but does not efficiently initiate productive replication. To 
evaluate whether the block in productive HSV-1 replication occurs before or after expression 
of the earliest viral proteins (immediate-early or IE proteins), HSV-1 experiments were 
repeated using an ICP4-specific monoclonal antibody. This resulted in a percentage of 
positive neurons (11.7 ± 1.5%) similar to the percentage observed using gD-specific 
antibodies, indicating that the neurons that do not proceed to productive HSV-1 replication 
are halted before detectable ICP4 protein expression. Overall, these results indicate that 
upon viral entry, PRV efficiently proceeds to productive replication. For HSV-1, ± 12% of 
infected neurons proceed to productive replication whereas the others are halted at a stage 
very early in infection.  
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Figure 1. Productive replication of PRV 
and HSV-1 in porcine TG neurons. 
Confocal images of TG neuronal cultures in 
the inner chamber at 24hpi with PRV (A,B) 
and 48hpi with HSV-1 (D,E) stained for 
neurofilament (red) and late viral antigens 
(green) (bar = 50 µm). Percentage of 
neurons with axons growing out to the 
outer chamber that show viral antigens at 
24hpi with PRV (C) and 48hpi with wt HSV-
1 (F, left bar) and β-galactosidase activity 
at 24hpi with SΔUS5-LacZ HSV-1 (F, right 
bar). Data represent the mean ± s.e.m. of 
three independent experiments. 
 
 
 
3.2. Interferon alpha suppresses PRV and HSV-1 productive replication in TG 
neurons for several days 
 The effect of IFNα on the expression of late viral proteins upon inoculation with both 
viruses was analyzed. Two-chamber systems were pretreated with IFNα for 24h and after 
infection, IFNα remained present in the inner chamber for the entire experiment. A dose 
dependent decrease was observed in the number of PRV infected neurons expressing late 
viral proteins at 24hpi, ranging from 36 ± 1% late viral antigen positive neurons with 0.5 U/ml 
IFNα (data not shown) to 2 ± 1% with 500 U/ml (Fig. 2A). The latter concentration was 
selected for all further experiments. The suppressive effect of IFNα on PRV replication was 
sustained over a longer period of time since at 5dpi, still only 10 ± 4% of infected neurons 
were late viral antigen positive (Fig. 2A). For HSV-1, the suppressive effect of IFNα was even 
more pronounced since not a single HSV-1 gD positive infected neuron was detected, both 
at 2 and 5dpi (Fig. 2B). Both for PRV and HSV-1, in the absence of IFNα, cytopathic effect 
was complete well before 5dpi. These results indicate that IFNα is able to efficiently suppress 
alphaherpesvirus replication in porcine TG neurons for several days. 
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Figure 2. IFNα induces a reactivatable, latent PRV and HSV-1 infection in porcine TG neurons. Percentage 
infected neurons that are late viral antigen positive at 1, 5 and 8dpi with PRV (A) and at 2, 5 and 12dpi with HSV-
1 (B) in the presence or absence of 500 U/ml IFNα. For the neurons fixed at 8dpi with PRV and 12dpi with HSV-1, 
medium containing IFNα was washed out at 5dpi and replaced with new culture medium or new culture medium 
supplemented with forskolin (200 µM). Data represent the mean ± s.e.m. of three independent experiments. 
3.3. Interferon alpha suppresses PRV IE180 and HSV-1 ICP4 protein expression 
in TG neurons  
 To determine whether IFNα not only suppresses late viral protein expression, but may 
also affect IE protein expression, levels of ICP4 of HSV-1 or the corresponding IE180 protein 
of PRV were analyzed in IFNα–treated two-chamber systems. For HSV-1, IFNα treatment 
resulted in fast and efficient suppression of ICP4 protein levels, leading to undetectable ICP4 
levels at both 2dpi and 5dpi. For PRV, IFNα-mediated suppression of IE180 appeared to be 
less efficient and slower, resulting in 91.5 ± 14.8% of IE180-positive neurons with axonal 
outgrowth in the outer chamber at 1dpi, and 46.1 ± 3.2% of IE180-positive neurons at 5dpi. 
These results indicate that IFNα is able to suppress alphaherpesvirus IE protein levels in 
porcine TG neurons, and that this appears to occur more efficiently in HSV-1-infected 
neurons compared to PRV-infected neurons.  
 
Chapter 3 – Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons  
                    in vitro 
 
 69 
3.4. Interferon alpha induces a stably suppressed quiescent PRV and HSV-1 
infection 
 During virus latency, the virus is present in a stably suppressed state. In other words, 
latency persists, even when the suppressive agent is removed. To analyze whether IFNα is 
able to induce such a stably suppressed state of alphaherpesvirus infection, we analyzed 
whether or not withdrawal of IFNα at 5dpi resulted in re-expression of late viral antigens in 
TG neurons. For PRV, infection was stably suppressed in 60% of the neurons, as they did 
not express detectable levels of late viral proteins at 3 days post IFNα withdrawal (Fig. 2A). 
For HSV-1, none of the neurons initiated expression of detectable levels of HSV-1 gD even 
at 7 days after withdrawal of IFNα (12dpi) (Fig. 2B), showing that all HSV-1 infected TG 
neurons were in a stably suppressed quiescent state of infection.  
3.5. Forskolin treatment triggers PRV and HSV-1 reactivation in neurons 
containing quiescent virus 
 Alphaherpesvirus latency is defined as a functional viral genome retained in neurons 
in the absence of virus particles but capable to reactivate resulting in production of new 
infectious virus (Decman et al., 2005). Forskolin is a known stimulus of alphaherpesvirus 
reactivation (Colgin et al., 2001; Danaher et al., 2003; Smith et al., 1992). Therefore, we 
analyzed whether forskolin was able to reactivate PRV and HSV-1 in the neurons containing 
stably suppressed virus. Again, IFNα was withdrawn at 5dpi and medium supplemented with 
forskolin (200 µM) was added. For PRV, 70% of the infected neurons were late viral antigen 
positive at 3 days post IFNα withdrawal (Fig. 2A), often with virus spread to neighboring non-
neuronal cells, indicating that forskolin treatment induced reactivation of PRV in 50% of 
neurons that contained stably suppressed virus at 5dpi. For HSV-1, a similar experiment was 
performed but medium supplemented with forskolin was added twice, at 5dpi (when IFNα 
was withdrawn) and again at 8dpi. Analysis of neurons at 12dpi showed that forskolin had 
induced reactivation of HSV-1 since 11% of infected neurons were positive for HSV-1 gD at 
that time point (compared to 0% without forskolin)(Fig. 2B), often with spread of the virus to 
neighboring non-neuronal cells. Reactivation ultimately led to complete cytopathic effect in 
the inner chamber (data not shown). Forskolin triggers reactivation but was found not to 
prevent the IFNα–mediated suppression of productive viral replication, since addition of IFNα 
and forskolin in parallel did not influence the ability of IFNα to suppress productive viral 
replication (data not shown). Overall, these data show that forskolin can reactivate HSV-1 
and PRV from IFNα–induced quiescence. 
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3.6. PRV and HSV-1 express LATs during in vitro latency-like quiescence 
 During HSV-1 and PRV latency in vivo, expression of LATs is frequently observed 
(Cheung, 1989; Stevens et al., 1987). To determine LAT expression during in vitro latency-
like quiescence by wild type HSV-1 and PRV, RT-PCR was performed on RNA isolated from 
TG neurons derived from these two-chamber models that were i) mock infected, ii) 
productively infected, and iii) uniformly quiescently infected (Fig. 3A,B). For PRV, all three 
quiescently infected cultures (CPE negative at 5dpi) examined were negative for immediate-
early (IE180) and late (gB) viral RNA but one was positive for LAT RNA (Fig. 3A). For HSV-1, 
all three quiescently infected cultures examined were negative for late (gB and gD) viral RNA 
but 2 were positive for LATs (Fig. 3B). RT-PCR assays contained quite prominent aspecific 
amplification signals, which are likely due to the high number of PCR cycles needed to detect 
sufficient signal. Specificity of the bands was confirmed via sequencing and contamination by 
viral genomic DNA was excluded by DNAseI treatment and by performing control reactions in 
the absence of reverse transcriptase. The RT-PCR assays show that both PRV and HSV-1 
express detectable levels of LATs in a subset of infected porcine TG neurons during IFNα 
induced latency-like quiescence. Interestingly, one of the three quiescently HSV-1 infected 
cultures examined, which were all negative for gD RNA, was positive for ICP0 transcripts 
(Fig. 3B).  
 
Figure 3. PRV and HSV-1 express LATs during in vitro latency. (A) Percentage of infected neurons positive 
for LAT promoter-driven β-galactosidase at 2 and 5dpi with HSV-1 LbetaA in the presence or absence of 500 
U/ml IFNα. Data represent the mean ± s.e.m. of three independent experiments. (B) Light microscopic images of 
uniform (1,2) and focal (3) LAT promoter-driven β-galactosidase distribution during the acute stage (2dpi without 
IFNα, 1, 2) or the latent stage (5dpi with IFNα, 3) of infection with HSV-1 LbetaA. Arrows point to infected non-
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neuronal cells (1), dashed line marks contour of neuronal cell body in (3) (bar = 20 µm). (C,D) RT-PCR analysis of 
actin and viral immediate-early (IE180 and ICP0), late (gB and gD) and LAT transcript RNA isolated from 
neuronal cultures that were either mock infected, productively infected with PRV (C, 1dpi) or HSV-1 (D, 2dpi), or 
latently infected with PRV (C, 5dpi with IFNα) or HSV-1 (D, 9dpi, 4 days post IFNα withdrawal). For each condition 
three different samples were analyzed and representative gels are shown. For HSV-1, two samples of 9dpi, 4 
days post IFNα withdrawal are shown, one without and one with detectable ICP0 transcript expression. Specific 
bands are marked with a black arrowhead.  
3.7. The HSV-1 LAT promoter is activated over time during latency-like in vitro 
quiescence 
 For HSV-1, LAT promoter activity was assessed during IFNα induced latency-like 
quiescence in vitro. Two-chamber systems were infected with the LbetaA HSV-1 mutant 
carrying a LacZ reporter gene under control of the LAT promoter (Lachmann & Efstathiou, 
1997) in the presence or absence of IFNα. X-gal staining of cultures not treated with IFNα 
showed that 16% of infected neurons were β-galactosidase positive at 48hpi (Fig. 3A). This 
percentage is similar to the percentage of HSV-1 gD positive neurons after wild type HSV-1 
infection at 48hpi (12%). In the presence of IFNα, we observed an increase of β-
galactosidase positive infected neurons over time to about 50% positive neurons at 5dpi (Fig. 
3A). As a control, no evidence for β-galactosidase activity was found at 5dpi in the presence 
of IFNα in neurons infected with the SΔUS5-LacZ HSV-1 mutant carrying the reporter gene 
LacZ under control of the human CMV MIEP promoter. The activation of the LAT promoter 
over time suggests a gradual de-repression of the LAT promoter. Analysis of β-galactosidase 
distribution in ± 20 neurons in either lytically infected neurons (2dpi in the absence of IFNα) 
or quiescently infected neurons (5dpi in the presence of IFNα) indicated that in lytically 
infected neurons, β-galactosidase distribution was generally uniform throughout the neuronal 
cell body (Fig. 3B 1, 2)  and sometimes associated with spread of infection to surrounding 
non-neuronal cells (Fig. 3B 1), while a more focal β-galactosidase distribution was frequently 
found in quiescently infected neurons (Fig. 3B 3). In summary, in the presence of IFNα, HSV-
1 LAT promotor activity can be observed in up to ± 50% of infected neurons at 5dpi. Since 
this percentage is higher than the percentage of neurons that proceed to a productive 
replication in the absence of interferon (12%, Fig1F), this suggests that at least a fraction of 
the neurons that do not show the capacity to proceed to productive replication in the absence 
of IFNα do show LAT promoter activity during prolonged incubation with IFNα.  
 
 
 
Chapter 3 – Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons  
                    in vitro 
 
 72 
4. Discussion 
 In the current report, we show that addition of IFNα to two-chamber systems of 
porcine TG neurons is sufficient to induce a quiescent PRV and HSV-1 infection that shows 
strong similarities to in vivo latency.  
 Besides the insights in alphaherpevirus latency/reactivation generated by in vivo 
studies in animals, ex vivo explants of latently infected neurons, and from biopsies of 
deceased individuals, over the years, several very valuable in vitro models have been 
developed that have increased our understanding of HSV quiescence and latency. Some of 
the most notable of these in vitro systems are based on the use of antiviral drugs, mainly 
nucleoside analogues that act as viral DNA chain terminators. Such drugs have been shown 
to induce a stably suppressed state of HSV infection that shows similarities to in vivo latency. 
Cells used in these models vary from fibroblasts over neuronal cell lines (e.g. PC12) to 
primary rat dorsal root ganglion neurons (Danaher et al., 1999; Wigdahl et al., 1982; Wigdahl 
et al., 1984a; Wigdahl et al., 1984b; Wilcox et al., 1997). Like noncytotoxic lytic granules and 
type II interferon, antiviral drugs like acyclovir have also been shown to have the capacity to 
prevent HSV reactivation in vitro upon explantation of TG neurons obtained from latently 
infected mice (Halford et al., 2001; Knickelbein et al., 2008; Liu et al., 2001). Some of the 
other in vitro models of HSV latency are based on the use of replication-defective, attenuated 
virus strains (Wilcox et al., 1992). Still other models are based on a reversible, temperature-
dependent suppression of virus replication (Kondo et al., 1990; Wrzos & Rapp, 1987). Some 
previous in vitro latency models contained IFN – however, simultaneous addition of 
nucleoside analogues was required to establish quiescence (Wigdahl et al., 1982; Wigdahl et 
al., 1984a; Wigdahl et al., 1984b). Since addition of nucleoside analogues without IFN also 
prevents viral replication and leads to quiescence (Wilcox et al., 1997), these data were 
inconclusive on a potential involvement of IFN in latency establishment. In our current model, 
addition of IFNα is sufficient to establish latency-like quiescence, without the need for 
nucleoside analogues. This important difference is perhaps due to the use of a two-chamber 
system that allows an in vivo-like route of infection of neurons, via retrograde axonal spread. 
It has been suggested before that the long distance retrograde transport of HSV in neurons 
results in reduced levels of the viral VP16 transactivator reaching the nucleus (Roizman & 
Sears, 1987). Without a two-chamber system, virus can access the neurons via the cell 
body, thereby circumventing retrograde axonal spread.  
 The obtained results indicate a strong similarity between the currently described in 
vitro quiescence and alphaherpesvirus latency in vivo. First of all, our results show that both 
PRV and HSV-1 express detectable levels of LATs in a subset of quiescently infected in vitro 
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systems. It will be interesting to further explore LAT expression in the in vitro latency model, 
e.g. by determining nuclear localization of the LAT transcripts. Our observation that not all 
cultures contain detectable LAT expression appears to be in line with the notion that in vivo a 
varying number of latently HSV-1 infected human TG neurons expresses detectable levels of 
LATs (Wang et al., 2005). We observed that some quiescently infected cultures are positive 
for both LAT and ICP0 transcripts. Although we cannot formally rule out the possibility that 
these LAT/ICP0 mRNA double-positive quiescent cultures may consist of neurons that 
express either LAT or ICP0 mRNA, it is also possible that quiescently infected neurons 
express both transcripts at the same time. Interestingly, there is increasing evidence for the 
presence of ICP0 transcripts in ganglia of humans and mice latently infected with HSV-1 
(Chen et al., 2002; Derfuss et al., 2009; Maillet et al., 2006), and our current data may 
therefore be in line with indications that ICP0 protein expression in latently infected neurons 
may at least partly be blocked at the post-transcriptional level, probably due to microRNA 
activity of LATs and perhaps other, unknown, viral and host factors (Chen et al., 2002; Maillet 
et al., 2006; Thompson et al., 2003; Umbach et al., 2008). Using a previously described 
HSV-1 recombinant expressing β-galactosidase under control of the LAT promoter 
(Lachmann & Efstathiou, 1997), a focal β-galactosidase distribution was observed in latently 
infected neurons. Such a focal β-galactosidase distribution was also observed during in vivo 
latency in ganglia of mice latently infected with the LbetaA mutant and with another HSV 
mutant expressing LacZ under control of the LAT promoter (Lachmann & Efstathiou, 1997; 
Ho & Mocrski, 1989). It has been suggested that the focal β-galactosidase distribution may 
be due to physiological differences between lytically and latently infected neurons.  
 Our results indicate that IFNα leads to efficient establishment of PRV and HSV-1 
latency-like quiescence in TG neurons in vitro. Based on these data, it is tempting to 
speculate that IFNα also represents a key immune component involved in the efficient 
establishment of alphaherpesvirus latency in sensory neurons in vivo. Some in vivo data may 
support this hypothesis: several reports indicate that impaired IFN responses in vivo can 
result in uncontrolled lytic virus replication and, often fatal, afflictions of the central nervous 
system, including herpes simplex encephalitis in humans (Casrouge et al., 2006; Zhang et 
al., 2007), and increased replication efficiency of strongly attenuated HSV-1 mutants in TG 
neurons of mice (Leib et al., 1999). Based on the current in vitro data, it will be interesting to 
further investigate if type I IFNs indeed act as a double-edged sword in vivo: on the one hand 
protecting the host from severe infection by alphaherpesviruses, on the other hand 
contributing to their lifelong persistence in a latent form.  
 In vivo, there is evidence that type II IFN (IFNγ), mainly produced by CD8+ T 
lymphocytes, plays only a minor additional role to type I IFNs in controlling early acute 
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infection (Leib et al., 1999; Cantin et al., 1995) but is important to prevent reactivation of 
alphaherpesviruses from latency (Liu et al., 2001; Khanna et al., 2004). Further in line with 
the similarity between alphaherpesvirus in vivo latency-like quiescence and the currently 
described in vitro model, we found that IFNγ, although unable to suppress PRV replication 
over longer periods of time and therefore unable to induce PRV quiescence in vitro as 
observed for IFNα, is able to maintain PRV quiescence in vitro (data not shown). Although 
speculative at this point, together with the literature data, this may suggest that especially 
type I IFNs, as a crucial factor of the innate antiviral immunity, may be of importance during 
establishment of latency whereas type II IFN produced by the adaptive immunity are of 
crucial importance in maintaining the virus in a latent state and preventing reactivation. It will 
be interesting to determine whether the latency-like quiescent state of infection is the result 
of IFNα directly promoting the establishment of latency/quiescence, or, alternatively, of an 
IFNα-mediated inhibition of lytic replication that indirectly promotes latency/quiescence. 
Dissecting which IFNα-induced effectors are involved in the induction of quiescence will aid 
to clarify this. Both in PRV and HSV, IFNα suppressed protein expression levels of IE genes 
ICP4/IE180, suggesting that IFNα–mediated IE suppression may be a key element in the 
ability of this innate immune effector to establish quiescence. In line with this hypothesis, we 
observed that the percentage of neurons that still show detectable IE180 protein levels at 
5dpi with PRV in the presence of IFNα correlates well with the percentage of neurons that 
are not in a stable quiescent infection at that time point and proceed to productive replication 
upon IFNα withdrawal (46% versus 40%). 
 In summary, this study presents a novel and unique in vitro system to dissect aspects 
of the latency/reactivation cycle of wild type alphaherpesviruses and points to IFNα as a 
potential driving force in efficient alphaherpesvirus latency establishement. In addition, the 
currently described in vitro model may provide a unique tool to screen possible drug 
candidates that interfere with the latency/reactivation cycle. 
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Abstract 
Most alphaherpesviruses are able to establish latency in sensory neurons and reactivate 
upon specific stimuli to cause recurrent symptoms. We have previously shown that interferon 
(IFN) is capable of inducing a quiescent HSV-1 and PRV infection that strongly resembles in 
vivo latency in primary cultures of TG neurons. This IFN-induced latency-like quiescence was 
found to correlate with suppression of the immediate-early protein ICP4 in HSV-1 and its 
ortholog IE180 in PRV. Here, we mechanistically investigated the IFN-mediated suppression 
of ICP4 and IE180 in sensory neuronal cells. Using RT-qPCR, mRNA levels of either HSV 
ICP4 or PRV IE180 at 4hpi were mildly but not significantly different in IFN-treated samples 
versus control samples, whereas a strong reduction was observed at 8hpi and 12hpi. 
However, at 4hpi, HSV ICP4 but not PRV IE180 protein expression was already strongly 
reduced in IFN-treated samples. In line with this difference in IFN-mediated suppression of 
HSV ICP4 versus PRV IE180 protein levels, we found that IFN resulted in an increase in 
phosphorylation of the translation initiation factor eIF2α in HSV-infected but not in PRV-
infected cells. The latter finding indicates that PRV efficiently circumvents IFN-mediated 
translation inhibition by interfering with phosphorylation of eIF2α.  
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1. Introduction 
 The human herpes simplex virus type 1 (HSV-1) and the porcine pseudorabies virus 
(PRV) are closely related and belong to the alphaherpesvirus subfamily of the Herpesviridae.  
 A central characteristic of most alphaherpesviruses is their ability to establish a 
lifelong latent infection in sensory neurons. During HSV-1 and PRV latency, no infectious 
virus or viral proteins are produced (Roizman and Knipe, 2001). Specific stimuli, often 
associated with stress and/or immune suppression, can lead to reactivation of the virus from 
latency, which may be associated with recurrent virus spread and disease symptoms, such 
as cold sores with HSV-1 (Sainz et al., 2001). The establishment and control of latency and 
the induction of reactivation are regulated by an incompletely understood interplay between 
the virus, the neuron and several components of the immune system (Decman et al., 2005).  
 The interferon (IFN)-mediated innate immunity is at the front line of host defence 
against viral infections. IFNs are able to interfere with several steps of virus replication. One 
important example is the IFN-mediated shutdown of mRNA translation through 
phosphorylation and thereby inactivation of the translation initiation factor eIF2α and through 
activation of RNase L (Goodbourn et al., 2000). IFNs have been reported to be very 
important in limiting replication and spread of alphaherpesviruses (Hendricks et al., 1991; 
Mikloska and Cunningham, 2001; Sainz and Halford, 2002). Recently, we have 
demonstrated that IFN is able to drive both HSV-1 and PRV into a latency-like quiescent 
state in in vitro cultures of sensory neurons (De Regge et al., 2010).  
 Importantly, IFN-mediated suppression of the immediate-early (IE)  protein ICP4 of 
HSV-1 or its counterpart IE180 in PRV appeared to be a key step in the establishment of in 
vitro latency and IFN-mediated IE protein suppression was more rapid and efficient in HSV-1 
compared to PRV (De Regge et al., 2010). 
 The aim of the current study was to further mechanistically investigate the 
suppressive effect of IFN on ICP4 and IE180 levels in sensory neuronal cells. We report that, 
at the mRNA level, IFN reduced ICP4 and IE180 mRNA expression to a similar extent, in 
both cases predominantly late in infection. At the protein level, IFNα was found to rapidly and 
efficiently shut down ICP4 protein expression whereas IE180 protein expression was 
diminished slower and less efficient, in line with our earlier observations. Remarkably, in 
HSV-1 infected sensory neuronal cells, IFN caused a rapid and marked phosphorylation and 
therefore inactivation of the translation initiation factor eIF2α, whereas no such 
phosphorylation could be observed in PRV-infected sensory neurons. The latter finding may 
explain the difference in efficiency of IFN-mediated IE suppression in HSV-1 versus PRV, 
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since it suggests that PRV may efficiently circumvent the IFN-mediated phosphorylation of 
eIF2α that normally would inhibit IE180 translation.   
2. Materials and Methods 
2.1. Cells and viruses 
 Sensory neuronal cells originating from rat dorsal root ganglion neurons (50B11) cells 
were a kind gift from Dr. Höke (Department of Neurology, Johns Hopkins University). The 
cells were grown in neurobasal medium supplemented with 1,1% glucose (20%), 0,27% L-
glutamine, 10% fetal calf serum, 2% B-27 and 0,1% blasticidin (Chen et al., 2007).  
Differentiation of the cells was obtained by treatment with forskolin (50µM) (Sigma) for 24h. 
HSV-1 strain VR-733 (Ejercito et al., 1968) was grown and titrated on Vero cells and stored 
at -80°C. PRV strain Becker (Card et al., 1990) was grown and titrated on Swine Testicle 
(ST) cells and stored at -80°C. 
2.2. Interferons and antibodies 
 Cells were pre-treated with a combination of 1000U/ml Universal Type I IFN-α (R&D) 
and 100ng/ml Recombinant Rat IFN-γ (R&D) for 24h before virus inoculation. IFN remained 
present during infection. HSV-1 mouse monoclonal anti-ICP4 (sc56986) was purchased from 
Santa Cruz. The rabbit polyclonal anti-IE180 antibody was a kind gift from E. Tabarés 
(Universidad Autonoma de Madrid, Spain). Rabbit monoclonal anti-actin (A2066) was 
purchased from Sigma-Aldrich. Mouse monoclonal anti-eIF2α (L57A5) and rabbit monoclonal 
anti-phospho-eIF2α (D9G8) were purchased from Cell Signalling. HRP-conjugated 
secondary goat anti-rabbit was purchased from Cell Signaling and goat anti-mouse 
antibodies were purchased from Dako Cytomation. Thapsigarin was purchased from 
Invitrogen. 
2.3. Total RNA isolation and quantitative RT-PCR 
 RNA from cultured cells was isolated using the Trizol Plus RNA purification kit from 
Invitrogen according to the manufacturer’s protocol. Samples were treated with DNase I and 
subsequently RNA was converted into cDNA using the SuperScript III enzyme and oligodT 
primers (Invitrogen) according to the manufacturer’s protocol. Subsequently quantitative PCR 
was performed using the SYBR Green dye from the SYBR Fast Bio-rad Readymix Kit 
(Sopachem). The primers that were used are 5’ CGACACGGATCCACGACCC 3’ and 
5’GATCCCCCTCCCGCGCTTCGTCCG 3’ at 60°C for ICP4 (Kramer and Coen, 1995), 5’ 
ACGCGAGAGGAAGTAGGGAG 3’ and 5’GTACCTGCACCGCAGTGAAG 3’ at 57°C for 
IE180, 5’CTGCCGTCTGGAGAAACCTG 3’ and 5’ CCACCACCCTGTTGCTGTAG 3’ at 53°C 
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for the reference gene GAPDH. GAPDH expression was not affected by IFN treatment or 
infection. RNA samples were prepared as four independent replicates and results of each 
replicate were normalized to GAPDH.    
2.4. Western blotting 
 SDS/PAGE and Western blotting were performed as described previously (Deruelle et 
al., 2007). Blots were blocked in 5% non-fat dry milk in PBS/Tween-20 for 1h at room 
temperature. The blots were incubated for 1h or overnight (according to the manufacturer’s 
instructions) with primary antibodies and washed 3 times in 0.1% TBS/Tween-20 (TBS-T). 
Blots were incubated with HRP-conjugated secondary antibodies for 1h at room temperature 
and after several washing steps they were developed with enhanced chemiluminescence 
(ECL Plus; GE Healthcare).  
2.5. Immunofluorescence staining 
 Cells were washed in PBS and fixed at room temperature with 3% paraformaldehyde 
in PBS for 10min, washed in PBS and permeabilized at room temperature in 0,2% Triton-X-
100 in PBS for 2min. After washing in PBS, cells were incubated for 1h at 37°C with P-eIF2α 
primary antibody (1/100) diluted in PBS, washed twice in PBS and subsequently incubated 
for 1h at 37°C with the goat-anti-rabbit FITC secondary antibody (Invitrogen) (1/200) diluted 
in PBS. Afterwards cells were washed in PBS and incubated at room temperature for 10min 
with Hoechst 33342 (Invitrogen) (1/200) diluted in PBS. Then cells were analyzed using the 
C2 confocal microscope from Nikon.    
2.6        Statistics 
 RNA samples were prepared as four independent replicates and results of each 
replicate were normalized to GAPDH. Means and standard deviations were calculated and 
subsequently the ratio of IFN-treated versus untreated values was determined. Statistical 
analysis was performed by using Graphpad Prism software using a t-test (p < 0.05). 
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3. Results 
3.1. mRNA levels of PRV IE180 and HSV-1 ICP4 are suppressed with similar and    
relatively late kinetics 
 Earlier, we reported that IFN-mediated suppression of ICP4 in HSV-1 and its 
counterpart IE180 in PRV correlates with establishment of in vitro latency in primary sensory 
neurons and that this occurs more rapid and efficient after infection with HSV-1 than with 
PRV (De Regge et al., 2010). To determine whether IFN-mediated IE suppression is 
noticeable at the mRNA level, RT-qPCR assays were performed. 50B11 sensory neuronal 
cells were either or not pre-treated with IFN for 24h and subsequently infected with PRV 
Becker or HSV-1 VR-733 (MOI 1). Total RNA was isolated at 4hpi, 8hpi or 12hpi and 
converted to cDNA followed by quantitative PCR.  The results were normalized to GAPDH 
and the ratio of IE mRNA levels in IFN-treated versus untreated cell samples was calculated. 
Figure 1 shows that both IE180 and ICP4 mRNA levels were mildly and non-significantly 
reduced at 4hpi. At the later time points (8hpi and 12hpi), however, we did see a very strong 
and significant reduction in both IE180 and ICP4 mRNA expression. These data suggest that 
IE transcription is not substantially affected by IFN early in infection, allowing leaky 
transcription of both ICP4 and IE180 early in infection. Later in infection (>4hpi), a substantial 
suppression of IE mRNA, suggestive for a block in transcription, was observed for both HSV-
1 and PRV. No apparent differences could be observed between HSV-1 and PRV.  
 
 
 
 
 
Figure 1: IFN suppresses mRNA levels of PRV IE180 and HSV-1 ICP4 with similar kinetics. 50B11 cells 
were pre-treated or not with IFN for 24h before virus inoculation. Total RNA samples were isolated at 4hpi, 8hpi or 
12hpi with (A) PRV Becker or (B) HSV-1 VR-733 (MOI 1).  RNA was converted to cDNA followed by RT-qPCR for 
GADPH, IE180 (PRV) and ICP4 (HSV-1). Viral mRNAs were normalized to GAPDH and the fold change was 
determined by calculating the ratio between IFN-treated and untreated samples. * p < 0.05 
 
 
 
B A 
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3.2. Protein levels of PRV IE180 are suppressed later compared to HSV-1 ICP4 
 To determine whether the relatively slow IFN-mediated suppression of ICP4 and 
IE180 mRNA levels correlate with the kinetics of IE protein levels in sensory neuronal cells, 
Western blot assays were performed. 50B11 cells were either or not pre-treated with IFN for 
24h and subsequently infected with PRV Becker or HSV-1 VR-733 (MOI 1). Cell lysates were 
collected at 4h, 8h and 12hpi and immunoblotting was performed for IE180 and actin (loading 
control) for PRV samples and ICP4 and actin (loading control) for HSV-1 samples. For HSV-
1, IFN treatment resulted in a rapid and strong reduction of ICP4 protein expression at 4hpi 
(Fig. 2). For PRV, however, IFN-mediated IE180 protein suppression was markedly slower. 
IE180 protein levels were not noticeably suppressed at 4hpi and were only substantially 
reduced later in infection (8hpi and 12hpi) (Fig. 2). These results implicate a rapid 
translational inhibition of HSV-1 ICP4 compared to a markedly slower suppression of PRV 
IE180 protein levels.  
 
Figure 2 :  Protein levels of PRV IE180 are suppressed later compared to HSV-1 ICP4 upon IFN treatment. 
50B11 cells were either or not pre-treated with IFN for 24h before virus inoculation. Cell lysates were collected at 
4hpi, 8hpi or 12hpi with (A) PRV Becker or (B) HSV-1 VR-733 (MOI 1). Western blotting was performed for actin, 
IE180 (PRV) and ICP4 (HSV-1).  
3.3. PRV strongly suppresses IFN-induced phosphorylation of eIF2α 
 Our results suggest that IFN-mediated translational shutdown in 50B11 cells is 
markedly more rapid and efficient for HSV-1 ICP4 compared to PRV IE180. Through 
upregulation of protein kinase R (PKR), IFN induces phosphorylation of the translation 
initiation factor eIF2α, which shuts down translation. To determine whether the observed 
differences in IFN-mediated HSV-1 ICP4 versus PRV IE180 protein suppression in 50B11 
cells correlate with differences in IFN-mediated phosphorylation of the translation initiation 
factor eIF2α, immunoblotting was performed. Thapsigargin, an inhibitor of sarco/ER Ca2+ 
ATPases that induces phosphorylation of eIF2α, was included as a positive control for 
phosphorylation of eIF2α. 50B11 cells were either or not pre-treated with IFN for 24h and 
subsequently infected with PRV-Becker or HSV-1 VR-733 (MOI 1). Lysates were collected at 
4hpi and Western blotting was performed for eIF2α and phosphorylated eIF2α (P-eIF2α), 
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ICP4 (in HSV-1 infected samples) and IE180 (in PRV infected samples). Figure 3.A. shows a 
substantial phosphorylation of eIF2α in IFN-treated samples infected with HSV-1, but not in 
PRV-infected cells, corresponding with the clear reduction of ICP4 protein expression and 
the lack of IE180 protein reduction in IFN-treated samples. To confirm these results, an 
immunofluorescence staining was performed on mock cells either or not pre-treated with 
thapsigargin and pre-treated cells infected with PRV or HSV-1 (MOI 1). At 4hpi cells were 
fixed and stained for phosphorylated eIF2α. Figure 3.B. shows that the thapsigargin 
treatment effectively stimulates the phosphorylation of eIF2α. In PRV-infected cells a clear 
reduction was seen compared to both untreated and thapsigargin-treated mock cells. The 
HSV-1 infected cells however had a reduced level of phosphorylation compared to the 
thapsigargin treated mock cells, but not to the untreated mock cells. Hence, in 50B11 cells, 
PRV efficiently counteracts both the IFN-induced and thapsigargin-induced phosphorylation 
of the translation initiation factor eIF2α.  
 
 
 
Figure 3:  PRV strongly suppresses IFN-induced phosphorylation of eIF2α. (A) 50B11 cells were either or 
not pre-treated with IFN for 24h before virus inoculation. Cell lysates were collected at 4hpi with PRV Becker or 
HSV-1 VR-733 (MOI 1). Western blotting was performed for total eIF2α, P-eIF2α, IE180 (PRV) and ICP4 (HSV-1).  
Thapsigargin treatment (1µM for 2h) was included as a positive control to induce phosphorylation of eIF2α. (B) 
50B11 cells were either or not pre-treated with thapsigargin (1µM for 1h) before virus inoculation with PRV Becker 
or HSV-1 VR-733 (MOI 1). Cells were fixed at 4hpi and immunofluorescence staining was performed for P-eIF2α. 
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4. Discussion 
 The immediate-early (IE) protein ICP4 in HSV-1 and its ortholog IE180 in PRV are the 
first viral proteins produced during infection of a host cell and are of central importance in the 
onset of a lytic alphaherpesvirus replication as they act as transactivators of the viral genome 
(Deluca and Schaffer, 1985). Hence, to enable the establishment of latency in sensory 
neurons, ICP4/IE180 expression needs to be shut down. Recently, we reported that IFN is 
able to suppress ICP4 and IE180 protein levels in sensory neurons to undetectable levels, 
which correlated with the establishment of virus latency in vitro (De Regge et al., 2010). IFN-
mediated suppression was less efficient for IE180 compared to ICP4, which correlated with 
less efficient establishment of in vitro latency for PRV versus HSV-1 (De Regge et al., 2010).  
 Here, we provide mechanistic insights in the IFN-mediated suppression of ICP4 and 
IE180 in sensory neuronal cells. We observed that levels of ICP4/IE180 mRNA were mildly 
but not significantly reduced by IFN at 4hpi, although we did observe a strong ICP4 protein 
shutdown at that time point. This indicates that IE transcription is not immediately 
suppressed by IFN in sensory neuronal cells, allowing some ICP4/IE180 mRNA to be 
produced. At later stages of infection (8hpi and 12hpi), however, we did observe a 
substantial reduction in ICP4/IE180 mRNA levels in IFN-treated samples, suggesting a 
transcriptional block at these time points. A transcriptional block of HSV-1 and PRV 
immediate-early expression has been reported before, although the underlying mechanism 
remains unknown (Gloger and Panet, 1984; Oberman and Panet, 1988; De Stasio and 
Taylor, 1990; Nicholl and Preston, 1996; Yao et al., 2007). Several potential explanations 
could be given to explain such a transcriptional block. On the one hand, IFN may affect 
expression levels of cellular proteins involved in viral DNA transcription. Initial transcription of 
alphaherpesviruses is regulated by a transcription complex that comprises the viral VP16 
protein and the cellular Oct-1 and HCF1 (Hagmann et al., 1995). It has been reported that 
IFNα causes a downregulation of Oct-1 and Oct-2 resulting in a repressed transcription (Dent 
et al., 1991). Other IFN-mediated effects on transcription have mostly focussed on RNA 
viruses and include IFN-induced proteins like APOBEC3G, TRIM5alpha, and ISG20 (Liu et 
al., 2010). Whether these or other IFN-induced effectors may also interfere with transcription 
of DNA viruses will be interesting to further investigate. On the other hand, IFN has been 
reported to induce activity of RNase L, which may lead to IE mRNA degradation (Liu et al., 
2010). Arguing against this possible explanation is our observation that expression of the 
reference gene GADPH was not reduced in IFN-treated samples (data not shown). This 
either suggests that the effects of IFN on ICP4/IE180 mRNA cannot be (solely) attributed to 
IFN-induced RNA degradation or that  such degradation is selective towards viral transcripts. 
For HSV-1, we observed a fast and efficient IFN-induced suppression in ICP4 protein levels 
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in sensory neuronal cells (4hpi), before substantial shutdown of mRNA levels (from 8hpi 
onwards). This may indicate that in HSV-1, ICP4 transcripts that are present at 4hpi are not 
efficiently translated into protein. One of the most potent effects of IFN on translation is 
phosphorylation and thereby inactivation of the translation initiation factor eIF2α through 
protein kinase R (PKR) (Liu et al., 2010). Accordingly, in HSV-1-infected sensory neuronal 
cells, we observed a marked, IFN-induced phosphorylation of eIF2α. For PRV, on the other 
hand, we did not observe eIF2α phosphorylation. Probably as a result of this, PRV IE180 
protein levels were not reduced by IFN at 4hpi. The apparent ability of PRV to counteract 
phosphorylation of eIF2α and the concomitant inability of IFN to efficiently shut down IE180 
protein levels correlate well with our earlier findings that IFN results in less efficient 
suppression of PRV IE180 compared to HSV-1 ICP4 and concomitant less efficient 
establishment of PRV versus HSV-1 latency in in vitro cultures of sensory neurons (De 
Regge et al., 2010). Nevertheless, our finding that HSV-1 is less capable to suppress eIF2α 
phosphorylation than PRV in sensory neuronal cells was somewhat surprising. Indeed, HSV-
1 has been reported to encode a potent factor that interferes with eIF2α phosphorylation, 
ICP34.5, which functions as an antagonist of the PKR response by redirecting the host 
protein phosphatase 1α to dephosphorylate eIF2α (He et al., 1997). To exclude the 
possibility that ICP34.5 was lost by growing virus on cell cultures, ICP34.5 was detected after 
HSV-1 infection in 50B11 cells (data not shown). It appears that ICP34.5 is less efficient in 
dephosphorylating eIF2α than PRV (Fig. 3.A. and 3.B.). In cells pre-treated with thapsigargin 
and subsequently infected with HSV-1 an intermediary level of phosphorylation was 
observed. The phosphorylation of eIF2α was lower in HSV-1 infected cells pre-treated with 
thapsigargin than in pre-treated mock cells, indicating that ICP34.5 is able to 
dephosphorylate eIF2α. The dephosphorylation is PRV infected cells pre-treated with 
thapsigargin was more efficient (Fig. 3.B.). Despite the fact that, under the current 
experimental conditions, PRV prevented IFN-induced eIF2α phosphorylation more efficiently 
than HSV-1, PRV does not encode an ICP34.5 ortholog. Future research will aim at 
identifying the viral factor(s) involved. An important first clue towards the underlying 
mechanism of PRV-mediated interference with eIF2α phosphorylation can already be 
deduced from the current experiments. Both in the absence or presence of IFN, the 
phosphorylation signal of eIF2α in PRV-infected cells was undetectable and therefore even 
lower than the basal level observed in mock-infected cells (Fig. 3.A.). This suggests that PRV 
actively dephosphorylates eIF2α, rather than merely preventing induction of phosphorylation 
of eIF2α upon IFN treatment. Hence, it is likely that a cellular phosphatase, activated by 
PRV, is involved.  
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 In conclusion, IFN is able to suppress HSV-1 ICP4 and PRV IE180 levels in sensory 
neuronal cells by i) reducing the transcription of these viral genes, relatively late in infection 
and ii) for HSV-1, preventing translation of ICP4 early in infection likely through the 
phosphorylation of eIF2α. In addition, PRV is able to efficiently inhibit phosphorylation of 
eIF2α through an unknown mechanism. 
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Abstract 
Interferon (IFN) suppresses mRNA and protein expression levels of immediate-early (IE) 
genes of alphaherpesviruses like herpes simplex virus (HSV) and may contribute to viral 
latency in neurons. Although it is unclear how IFN affects viral IE mRNA expression levels, 
increasing evidence indicates that transcription of alphaherpesviruses is tightly controlled by 
chromatin modifications. Specifically, the repressive CoREST/REST/HDAC/LSD1 complex 
controls transcription of the viral genome and may be involved in latency. Here, using 
different assays (RT-qPCR, Western blot, and immunofluorescence), we show that inhibition 
of histone deacetylase (HDAC) activity by trichostatin A significantly decreases the ability of 
IFN to suppress mRNA and protein expression levels of the IE gene ICP4 of HSV in neuronal 
cells. In addition, IFN substantially upregulated CoREST, a critical component of the 
CoREST/REST/HDAC/LSD1 transcription repressor complex. Together, these data for the 
first time indicate that the suppressive effect of IFN on viral replication may involve gene 
silencing factors, including histone deacetylases.  
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1. Introduction 
 The human herpes simplex virus type 1 is a common human pathogen that causes 
disease symptoms that may range from socially discomforting but relatively benign like cold 
sores and genital lesions, to severe and potentially life-threatening like keratitis, blindness, 
and encephalitis (Jones, 2003). A critically important characteristic of alphaherpesviruses is 
their ability to establish lifelong latent infections, generally in sensory neuronal cells. Stress 
and other triggering factors factors may lead to virus reactivation and recurrent symptoms 
(Sainz et al., 2001). The transition from a lytic infection to latency is thought to be the result 
of an interplay between the virus, the neuron and the immune system. Increasing evidence 
indicates that the switch from lytic to latent and back is regulated by chromatin modifications 
(Kutluay and Triezenberg, 2009). The CoREST/REST/HDAC/LSD1 repressor complex 
appears to play a central role in this process (Knipe and Cliffe, 2008; Kutluay and 
Triezenberg, 2009; Roizman, 2011). This complex may silence the viral genome during some 
stages of infection, like latency, through the activity of its histone deacetylases (HDAC) that 
remove the acetylation marks on the genome-associated histones, thereby leading to a 
transcription suppressing heterochromatin state of the genome (Knipe and Cliffe, 2008; 
Kutluay and Triezenberg, 2009; Roizman, 2011). On the other hand, this HDAC-dependent 
silencing complex may be disrupted to allow lytic infection at other stages of infection, like 
acute infection and reactivation. As an example of the latter, the ICP0 protein of HSV is able 
to dislodge HDACs from the CoREST/REST/HDAC/LSD1 complex to preserve acetylation 
and thus open chromatin structure of the viral genome (Hobbs and Deluca, 1999; Poon et al., 
2002; Poon et al., 2003).  
 Over the past years, it has become evident that interferons play a central role in the 
latency-reactivation cycle of alphaherpesviruses. By suppressing the expression of the 
earliest viral genes, the immediate-early (IE) genes, interferons contribute to both the 
establishment and maintenance of alphaherpesvirus latency in neurons (Gloger and Panet, 
1984; De Stasio and Taylor, 1990; Nicholl and Preston, 1996; De Regge et al., 2010). 
Depsite its potential importance for our understanding of alphaherpesvirus latency, the 
mechanism how IFN suppresses mRNA levels of IE genes like ICP4 of HSV is unclear (De 
Regge et al., 2010; Van Opdenbosch et al., 2011). Here, we report that the histone 
deacetylase inhibitor trichostatin A counteracts the IFN-mediated effect on ICP4 gene 
expression. To our knowledge, this is the first report to suggest IFN may act on the 
transcription of viral IE genes through histone modifications. In support of such an activity, 
IFN potently upregulated protein expression of CoREST, an important component of the 
CoREST/REST/HDAC/LSD1 repressor complex.  
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2. Material and methods 
2.1. Cells and virus 
 Sensory neuronal cells originating from rat dorsal root ganglion neuronal (50B11) 
cells were a kind gift from Dr. Höke (Department of Neurology, Johns Hopkins University). 
The cells were grown in neurobasal medium supplemented with 1.1% glucose (20%), 0.27% 
L-glutamine, 10% fetal calf serum, 2% B-27 and 0.1% blasticidin (Chen et al., 2007).  
Differentiation of the cells was obtained by treatment with forskolin (50µM) (Sigma) for 24h. 
HSV-1 strain F (Ejercito et al., 1968) was grown and titrated on Vero cells and stored at -
80°C.  
2.2. Chemical treatments 
 Trichostatin (TSA; Sigma) is an HDAC inhibitor. Different concentrations were tested 
for cytotoxicity and 100nM was found to be the optimal concentration in line with other 
reports (Pinnoji et al., 2007; Everett et al., 2008). Pre-treatment of 2h prior to infection was 
performed. Cells were pre-treated with a combination of 1000U/ml universal type I IFN-α 
(R&D) and 100ng/ml recombinant rat IFN-γ (R&D) for 24h before virus inoculation. IFN 
remained present during infection. 
2.3. Infection 
 A monolayer of cells was inoculated with HSV-1 strain F at a multiplicity of infection of 
1. Cells were fixed or lysed at 8hpi. Before Western blot assays, protein concentrations of all 
lysates were determined using BCA protein assay reagent according to the manufacturer’s 
instructions (Pierce Biotechnology).  
2.4. Immunofluorescence staining 
 Immunofluorescence staining was performed as described before (Van Opdenbosch 
et al., 2011). Primary antibody mouse monoclonal anti-ICP4 (Santa Cruz; sc56986), 
secondary antibody goat-anti-rabbit FITC (Invitrogen) and Hoechst 33342 (Invitrogen) were 
diluted 1/200 in PBS. Cells were analyzed using an Olympus X81 microscope connected to a 
Cell*M Imaging Module (Olympus). ICP4 positive cells were counted (5 microscope fields 
using a 40X magnification lens) and percent reduction in ICP4-positive cells in TSA-treated 
versus non-treated infected cells upon IFN treatment was calculated. Statistical analysis on 
four independent replicates was performed using GraphPad Prism software using a t-test (p 
< 0.01).  
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2.5. Western blotting 
 SDS/PAGE and Western blotting were performed as described previously (Deruelle et 
al., 2007). The blots were incubated for 1h or overnight (according to the manufacturer’s 
instructions) with primary antibodies ICP4 (Santa Cruz; sc56986), HDAC1 (Santa Cruz; 
sc8410), CoREST (Santa Cruz; sc135873), eIF2α (Cell Signaling; L57A5), phospho-eIF2α 
(Cell Signaling; D9G8), LSD1 (Cell Signaling; C69G12), tubulin (abcam; ab15246) and 
washed 3 times in 0.1% TBS/Tween-20 (TBS-T). Blots were incubated with HRP-conjugated 
secondary antibodies (Cell Signaling or Dako Cytomation) for 1h at room temperature and 
after several washing steps they were developed with enhanced chemiluminescence (ECL 
Plus; GE Healthcare). Protein band intensities were measured using Image J software. 
Statistical analysis on four independent replicates was performed using GraphPad Prism 
software using a t-test (p < 0.001). 
2.6. Quantitative RT-PCR 
 RT-qPCR was performed as described before (Van Opdenbosch et al., 2011). RNA 
samples were prepared as four independent replicates and results of each replicate were 
normalized to GAPDH. Means and standard deviations were calculated from 4 independent 
repeats with 2 replicates within each repeat. Subsequently the ratio of IFN-treated versus 
untreated values was determined. Statistical analysis was performed by using GraphPad 
Prism software using a t-test (p < 0.05).    
3. Results and discussion 
3.1. HDAC inhibitor trichostatin results in reduced IFN-mediated suppression of 
ICP4 mRNA and protein levels  
 We previously showed that treatment of 50B11 cells with IFN resulted in suppressed 
mRNA and protein levels of the immediate-early (IE) gene ICP4 of HSV (Van Opdenbosch et 
al., 2011). Other studies have also shown a suppressive effect of IFN on IE gene mRNA 
expression (Gloger and Panet, 1984; De Stasio and Taylor, 1990; Nicholl and Preston, 1996; 
De Regge et al., 2010), although the underlying mechanism has remained elusive. 
Alphaherpesvirus transcription is controlled by chromatin modifications, especially histone 
deacetylases (HDACs) (Kutluay and Triezenberg, 2009). To investigate whether histone 
deacetylation is involved in the suppressive effect of IFN on ICP4 expression levels, the 
histone deacetylase inhibitor trichostatin (TSA) was used. Differentiated 50B11 cells were 
treated or not with IFN for 22h, and subsequently treated or not with 100nM TSA for 2h 
followed by inoculation with HSV-1. At 8hpi, total RNA was isolated and converted to cDNA 
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followed by quantitative PCR. The results were normalized to GAPDH and the ratio of IE 
mRNA levels in IFN-treated versus untreated cell samples was calculated both for cells with 
or without TSA treatment. Figure 1 shows that mRNA levels of ICP4 were significantly higher 
in IFN-pretreated cells that were treated with TSA as compared to cells that were mock-
treated. In the absence of IFN, TSA had no noticeable effect on ICP4 expression levels (data 
not shown). These data indicate that HDACs are involved in IFN-mediated reduction of 
transcription of ICP4. 
Figure 1: Trichostatin counteracts IFN-
mediated suppression of ICP4 mRNA levels. 
Differentiated 50B11 cells were pre-treated with 
IFN for 22h and subsequently either or not 
treated with 100nM TSA for 2h prior to 
inoculation with HSV. At 8hpi, total RNA was 
isolated and converted into cDNA followed by 
RT-qPCR for GADPH and ICP4. RNA samples 
were prepared as four independent replicates and results of each replicate were normalized to GAPDH. Means 
and standard deviations were calculated and subsequently the ratio of IFN-treated versus untreated values was 
determined. Asterisk indicates significant difference. 
 To test whether the effect of TSA on ICP4 mRNA levels resulted in effects on the 
protein level of ICP4, immunofluorescence and Western blot assays were performed. Earlier 
reports have shown that simultaneous addition of the HDAC inhibitor TSA and IFN results in 
suppressed expression of different IFN-inducable genes (Genin et al., 2003; Nusinzon and 
Horvath, 2003; Chang et al., 2004; Sakamoto et al., 2004; Vlasakova et al., 2007). To avoid 
any effects of TSA on the induction of IFN-stimulated genes, cells were pre-treated for 22h 
with IFN before being subjected to a 2h treatment with TSA and virus infection. Differentiated 
50B11 cells were treated or not with IFN for 22h, and subsequently treated or not with 100nM 
TSA for 2h followed by inoculation with HSV-1. At 8hpi, cells were either fixed for 
immunofluorescence staining or lysed to perform Western blotting for ICP4. 
Immunofluorescently labelled samples were analysed to determine the percentage of ICP4 
positive cells.  As shown in figure 2.A., IFN treatment resulted in 31.24% ± 4.5 of ICP4 
positive cells that were not treated with TSA, while it resulted in 51.04% ± 1.5 of ICP4 
positive cells in cells treated with TSA. Again, in the absence of IFN, TSA had no noticeable 
effect on the percentage of ICP4-positive cells (data not shown). This indicates that addition 
of TSA significantly counteracted the suppressive effect of IFN on ICP4 protein expression. 
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These results were confirmed by Western blotting (Fig.2.B and C). Samples treated with both 
IFN and TSA showed a significantly higher expression level of ICP4 as compared to IFN 
alone. Again, as can be seen in the blot, in the absence of IFN, TSA had no noticeable effect 
on ICP4 protein expression levels. Together, the RT-qPCR data, immunofluorescence and 
Western blot data show that the IFN-mediated effect on IE transcription involves the activity 
of histone deacetylases. 
 
 
 
 
 
 
 
Figure 2: Trichostatin counteracts IFN-mediated suppression of ICP4 protein levels. Differentiated 50B11 
cells were either or not treated with IFN for 22h. Prior to HSV inoculation, TSA was either or not added to the 
medium for 2h (100nM). At 8hpi, cells were either fixed and stained or lysed for Western blotting. A) Percentage 
of ICP4 positive cells after IFN pre-treatment and TSA or mock treatment based on immunofluorescence staining 
for ICP4. Asterisk indicates significant difference. B) Western blotting for ICP4 with or without IFN pre-treatment 
and TSA treatment. C) Relative percentage of ICP4 protein, compared to HSV-infected controls (set to 100%). 
Asterisk indicates significant difference.   
 Obviously, the fact that TSA treatment does not fully restore ICP4 protein levels to 
untreated controls (Fig.2.C) is in line with the multiple effects of IFN on viral transcription and 
translation. For example, IFN-mediated activation of RNaseL, IFN-mediated induction of 
APOBECs and ADAR1 proteins, and IFN-induced phosphorylation of translation initiation 
factor eIF2α all have suppressive consequences for protein translation (Bass, 1997; Baumert 
et al., 2007; Suspene et al., 2011; Van Opdenbosch et al., 2011). 
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3.2. IFN treatment upregulates CoREST  
 The alphaherpesvirus genome can be silenced through the 
CoREST/REST/HDAC/LSD1 repressor complex (Liang et al., 2009; Roizman, 2011). To 
investigate whether IFN may affect expression levels of one or more components of this 
repressor complex, which would be in line with the HDAC-mediated effect of IFN on ICP4 
expression, protein levels of HDAC1/2, CoREST and LSD1 were determined in differentiated 
50B11 cells either mock-treated or treated with IFN for 24h. Figure 3 shows that IFN 
treatment caused a robust upregulation of CoREST protein levels, without affecting HDAC1/2 
and LSD1 protein levels. Although further studies are needed to further explore this, these 
data suggest that IFN treatment primes the cell to silence the incoming viral genomes by 
increasing CoREST protein levels.  
 
 
 
 
 
Figure 3: IFN treatment upregulates CoREST protein levels. Differentiated 50B11 cells were mock-treated or 
treated with IFN for 24h. Cells were lysed subsequently and Western blotting was performed for HDAC1/2, 
CoREST, LSD1 and the loading control tubulin.  
 The CoREST/REST/HDAC/LSD1 repressor complex is known to play a critical role in 
silencing of the HSV-1 genome (Gu et al., 2005; Gu and Roizman, 2009b; Gu and Roizman, 
2009a; Zhou et al., 2011). REST and CoREST are central players in the transcriptional and 
epigenetic regulatory circuitry that is responsible for modulating neural genes and they have 
been implicated in establishing cell identity and function, both within the nervous system and 
beyond (Qureshi et al., 2010). In  a  recent study, Du et al. (2010) generated HSV-1 
recombinant viruses overexpressing either WT-REST or dnREST to investigate whether 
HSV-1 hijacks the repressor complex to silence itself. Interestingly, they found that HSV-1 
overexpressing WT-REST (but not the strain overexpressing dnREST) was unable to 
replicate in trigeminal ganglia (TG) of mice, the major site of latency. This indicates that 
upregulation/overexpression of the REST/CoREST complex may be sufficient to silence 
HSV-1, a critical step in the establishment of latency (Du et al., 2010). This is entirely in line 
with our findings. Indeed, we showed before that IFN suppresses ICP4 expression and 
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drives HSV latency in porcine TG neurons (De Regge et al., 2010). In the current manuscript, 
we show that IFN upregulates REST’s partner CoREST and suppresses HSV ICP4 
expression levels through histone modifications, which may interconnect these findings.  
 Interestingly, we found that IFN upregulates CoREST while protein expression levels 
of two other central components of the CoREST/REST/HDAC/LSD1 repressor complex, 
HDAC and LSD1, were not affected. A REST-specific antibody unfortunately did not yield a 
specific signal. A hypothetical explanation for the difference in modulation of CoREST versus 
HDAC/LSD1 protein levels in IFN-treated cells perhaps may be that HDAC and LSD1 are 
constitutively highly expressed in cells, as they are involved in several different cellular 
complexes, which is the case for CoREST (Bertos et al., 2001; Fischle et al., 2002; 
Karagianni and Wong, 2007; Mcdonel et al., 2009; Ramirez and Hagman, 2009; Qureshi et 
al., 2010; Hayakawa and Nakayama, 2011). Further research will clarify this. In line with the 
findings of Du et al. (2010), we hypothesize that upregulation of CoREST or its partner REST 
contributes to the silencing of the incoming viral genome.        
 In conclusion, we report in this study that the IFN-mediated effect on the IE gene 
transcription is at least partly regulated by HDACs and possibly by the involvement of the 
CoREST/REST/HDAC/LSD1 repressor complex. This report for the first time suggests that 
IFN treatment may prime the cell to a viral genome silencing state.  
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Abstract 
We have previously shown that the porcine alphaherpesvirus pseudorabies virus (PRV) 
efficiently interferes with phosphorylation of the eukaryotic translation initiation factor eIF2α. 
Inhibition of phosphorylation of eIF2α has been reported earlier for the closely related 
alphaherpesvirus herpes simplex virus type 1 through its ICP34.5 and US11 proteins. PRV 
however does not encode an ICP34.5 or US11 ortholog. Assays using cycloheximide, UV-
inactivated PRV or phosphonoacetic acid (PAA) showed that de novo expression of one or 
more (immediate) early viral protein(s) is required for interference with eIF2α 
phosphorylation. In line with this, a time-course assay showed that eIF2α phosphorylation 
was abolished within 2h post PRV inoculation. PRV encodes only one immediate-early 
protein, IE180, the orthologue of HSV-1 ICP4. A combinational treatment of cells with 
cycloheximide and actinomycin D, allowing the sole expression of IE180 in PRV-infected 
cells, led to a substantial reduction in eIF2α phosphorylation levels, indicative for an 
involvement of IE180. In support of this, transfection of IE180 also potently reduced eIF2α 
phosphorylation. IE180-mediated interference with eIF2α phosphorylation was not cell type 
dependent as it occurred both in rat neuronal 50B11 cells and in swine testicle ST cells. 
Inhibition of the cellular phosphatase PP1 impaired PRV-mediated interference with eIF2α 
phosphorylation, indicating that PP1 is involved in this process. In conclusion, the immediate-
early IE180 protein of PRV has the previously uncharacterized ability to suppress 
phosphorylation levels of the eukaryotic translation initiation factor eIF2α.   
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1. Introduction 
 The translation initiation factor eIF2α plays a critical role in the onset of translation of 
mRNA, including viral mRNA. Phosphorylation of eIF2α prevents recycling of GDP-bound 
eIF2α into its active GTP-bound form, thereby globally inhibiting protein synthesis (Schneider 
and Mohr, 2003). Phosphorylation of eIF2α represents one of the potent antiviral 
consequences of the interferon (IFN)-mediated immune response (Goodbourn et al., 2000). 
IFN leads to the production of protein kinase PKR, but viral dsRNA is necessary to mediate 
PKR dimerization and activation. Activated PKR then phosphorylates eIF2α, shutting down 
translation and viral protein production.  
Because of its central importance in ensuring translation of mRNA, different viruses 
have evolved mechanisms to counteract phosphorylation of eIF2α. We have recently shown 
that the porcine alphaherpesvirus pseudorabies virus (PRV) very efficiently counteracts 
phosphorylation of eIF2α  (Van Opdenbosch et al., 2011). PRV is closely related to the 
human herpes simplex virus type 1 (HSV-1). Inhibition of eIF2α phosphorylation has been 
reported earlier for HSV-1 through its US11 and ICP34.5 proteins (Chou et al., 1995; He et 
al., 1997; Cassady et al., 1998; Mulvey et al., 1999). US11 binds dsRNA, thereby abrogating 
its ability to bind PKR, resulting in PKR inactivity and preservation of protein synthesis 
(Poppers et al., 2000; Cassady and Gross, 2002). The ICP34.5 protein directly causes 
dephosphorylation of eIF2α through association with the protein phosphatase 1 (PP1) (He et 
al., 1997). PRV however does not encode an ICP34.5 or US11 ortholog. The aim of the 
current study was therefore to investigate the mechanism of PRV-mediated 
dephosphorylation of eIF2α. 
 In this study, we report that both in rat 50B11 neuronal cells and swine ST cells, de 
novo synthesis of the immediate-early protein IE180 of PRV is able to interfere with eIF2α 
phosphorylation in 50B11 rat neuronal cells and ST swine testicle cells. We also show that 
the cellular protein phosphatase 1 is involved in this process although IE180 does not 
upregulate protein expression levels of the PP1/GADD34 complex.  
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2. Materials and Methods 
2.1. Cells and virus 
 Sensory neuronal cells originating from rat dorsal root ganglion neurons (50B11) cells 
were a kind gift from Dr. Höke (Department of Neurology, Johns Hopkins University). The 
cells were grown in neurobasal medium supplemented with 1.1% glucose (20%), 0.27% L-
glutamine, 10% fetal calf serum (FCS), 2% B-27 and 0.1% blasticidin (Chen et al., 2007). 
Before use in experiments, cells were differentiated as described before (Chen et al., 2007; 
Van Opdenbosch et al., 2011), by treatment with forskolin (50µM) (Sigma) for 24h. Swine 
Testicle (ST) cells were cultivated in Eagle’s minimal essential medium (MEM) supplemented 
with 10% FCS, glutamine (0.3 mg/ml) and antibiotics (100 U/ml penicillin, 0.1 mg/ml 
streptomycin). The PRV strain Becker (Card et al., 1990) was grown and titrated on ST cells 
and stored at -80°C. 
2.2. Antibodies and chemicals  
 The rabbit polyclonal anti-IE180 antibody has been described before (Gomez-
Sebastian and Tabares, 2004). Mouse monoclonal anti-US3 antibody was kindly provided by 
L.A. Olsen and L. Enquist (Princeton University, USA). Mouse anti-eIF2α (L57A5), rabbit 
anti-phospho-eIF2α (D9G8), rabbit anti-phospho-PERK (16F8) and rabbit anti-PP2A (52F8) 
were purchased from Cell Signaling. Mouse anti-PP1 (sc-7482) and rabbit anti-GADD34 (sc-
8327) were purchased from Santa Cruz. Rabbit anti-GFP (G10362) was purchased from 
Invitrogen and rabbit anti-alpha tubulin (ab15246) was purchased from Abcam. HRP-
conjugated secondary goat anti-rabbit was purchased from Cell Signaling and goat anti-
mouse antibodies were purchased from Dako Cytomation.    
 To induce phosphorylation of eIF2α, cells were treated with 1µM thapsigargin 
(Invitrogen) for 1h. Thapsigargin induces eIF2α phosphorylation by activating the pancreatic 
endoplasmic reticulum PERK protein kinase (Wong et al., 1993). Cycloheximide (CHX, 
Sigma-Aldrich) treatment (10µg/µl) for 30min prior to inoculation was used to inhibit protein 
translation and phosphonoacetic acid (PAA, Sigma-Aldrich) treatment (250µg/ml) was used 
to inhibit viral replication. When ultraviolet (UV) inactivated PRV was used, inactivation was 
performed by UV irradiating the inoculum in a petri dish on ice with 1000mJ/cm2 using the 
CL-1000 UV Crosslinker (UVP, Inc.), all as described before (Deruelle et al., 2009). 
Sequential treatment with cycloheximide and actinomycin D (ActD, Invitrogen) was used to 
allow expression of the immediate-early protein IE180, as described before (Ambagala et al., 
2000). Briefly, cells were treated with CHX (10µg/µl) for 30min prior to inoculation. At 2hpi 
(hours post inoculation), CHX was washed away and medium with ActD (5µg/ml) was added. 
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PP1- and PP2 inhibitors inhibitor 2 (I2) and okadaic acid (OA) were obtained from Millipore 
and Sigma-Aldrich respectively, and used at concentrations recommended by the 
manufacturer (I2) or found in literature (Wang et al., 2009). Cells were treated for 1h prior to 
inoculation with 0.2µM I2 or 20nM OA to inhibit cellular phosphatases PP1 or PP2 
respectively. 
2.3. Infection and transfection 
 For infection assays, monolayers of cells, pre-treated with thapsigargin (1µM for 1h) 
were inoculated with the PRV strain Becker at a multiplicity of infection (MOI) of 1. Cells were 
lysed for immunoblotting at 4hpi. For transfection assays, subconfluent 50B11 cells were 
transfected with an IE180 expressing plasmid (Munoz et al., 2010) or an eGFP expressing 
plasmid (pTrip, obtained from B. Verhasselt, Ghent University) using the jetPRIMETM reagent 
(Polyplus) according to the manufacturer’s protocol. Medium was renewed 4h post 
transfection. Cells were treated with thapsigargin (1µM for 1h) prior to lysis 24h post 
transfection. 
2.4. Western blotting 
 SDS/PAGE and Western blotting were performed as described previously (Deruelle et 
al., 2007). Protein concentrations of 30-40µg were used for all experiments. Protein 
concentration was determined using the BCA protein assay reagent and spectrophotometry 
according to the manufacturer’s instructions (Pierce Biotechnology). Blots were blocked in 
5% non-fat dry milk in PBS/Tween-20 for 1h at room temperature. The blots were incubated 
for 1h or overnight (according to the manufacturer’s instructions) with primary antibodies and 
washed 3 times in 0.1% TBS/Tween-20 (TBS-T). Blots were incubated with HRP-conjugated 
secondary antibodies for 1h at room temperature and, after several washing steps, 
developed using enhanced chemiluminescence (ECL Plus; GE Healthcare). Protein band 
intensities were measured using Image J software. Statistical analysis on three independent 
replicates was performed using GraphPad Prism software using a t-test. 
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3. Results 
3.1. PRV interferes with eIF2α phosphorylation 
 We previously described that PRV is able to counteract IFN-mediated 
phosphorylation of eIF2α in 50B11 neuronal cells (Van Opdenbosch et al., 2011). Here, we 
used thapsigargin to induce phosphorylation of eIF2α. Thapsigargin induces eIF2α 
phosphorylation by activating the pancreatic endoplasmic reticulum PERK protein kinase 
(Wong et al., 1993). Differentiated 50B11 cells were pre-treated or not with thapsigargin 
(1µM) for 1h prior to inoculation with PRV. Lysates were collected at 4hpi and Western 
blotting was performed for total and phosphorylated eIF2α. Thapsigargin treatment effectively 
induced phosphorylation of eIF2α (Fig. 1A, lanes 1-2, Fig. 1B). PRV efficiently counteracted 
phosphorylation of eIF2α in thapsigargin-stimulated cells and also reduced basal levels of 
eIF2α phosphorylation in non-stimulated cells (Fig. 1A, lanes 3-4, Fig. 1B). This indicates that 
PRV is able to interfere with phosphorylation of eIF2α induced by different stimuli. Since PRV 
is able to counteract both pre-induced (by thapsigargin) and basal levels of phosphorylation 
of eIF2α, this suggests that PRV leads to dephosphorylation of eIF2α rather than preventing 
phosphorylation of eIF2α. In support of the latter, PRV did not influence thapsigargin-induced 
phosphorylation of PERK, the kinase that phosphorylates eIF2α upon thapsigargin treatment 
(Fig. 1A).  
 
Figure 1. PRV suppresses phosphorylation of eIF2α. (A) Differentiated 50B11 cells were pre-treated or not 
with thapsigargin (1µM) for 1h prior to mock inoculation or inoculation with PRV (MOI 1). Lysates were collected 
at 4hpi and Western blot detection was performed for total and phosphorylated eIF2α and phosphorylated PERK. 
US3 detection was included as a control for infection. (B) shows ratios of PeIF2α/total eIF2α of three independent 
replicates. Different letters indicate statistically significant differences (p < 0.05).  
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3.2. An (immediate) early protein is involved in PRV-mediated interference with 
eIF2α phosphorylation  
 For HSV-1, it has been described that the infected-cell protein 34.5 (ICP34.5) triggers 
dephosphorylation of eIF2α by recruiting the cellular protein phosphatase 1 (PP1) to a 
multiprotein complex (He et al., 1997). PRV, however, does not encode an ortholog of 
ICP34.5. To elucidate which viral protein(s) is responsible for interference with eIF2α 
phosphorylation in PRV-infected cells, we first determined at which stage of infection 
interference with eIF2α phosphorylation occurs. To investigate whether de novo viral protein 
synthesis is required, thapsigargin-stimulated cells were either treated with cycloheximide 
(CHX), a translation inhibitor, before and during virus inoculation or were inoculated with UV-
inactivated PRV. Cell lysates were collected at 4hpi and Western blot detection was 
performed for total and phosphorylated eIF2α. Both in PRV-infected cells treated with CHX or 
cells inoculated with UV-inactivated PRV, the level of phosphorylation of eIF2α was 
comparable to mock-infected cells, indicating that viral protein synthesis is required for 
interference with eIF2α phosphorylation (Fig. 2A&B). Phosphonoacetic acid (PAA) inhibits 
viral replication and thus late viral protein expression. PAA did not affect PRV-mediated 
interference with eIF2α phosphorylation (Fig. 2C), implicating that one or more (immediate) 
early viral protein(s) are involved.   
 In order to confirm these findings, a time-course experiment of PRV infection was 
performed to determine the time-point of suppression of eIF2α phosphorylation. Levels of 
phosphorylated eIF2α were determined at 30min, 1h, 2h, 3h and 4hpi. Figure 2D shows that 
a reduction in phosphorylation of eIF2α is already evident at 1hpi. From 2hpi onwards, 
phosphorylation levels were very strongly reduced. Expression of the PRV immediate-early 
protein IE180 was first detected at 1hpi, while substantial expression of the early viral protein 
US3 was detected from 2hpi onwards. These data indicate that PRV interference with eIF2α 
phosphorylation occurs very early in infection and involves the expression of one or more 
immediate-early or early viral proteins. 
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Figure 2.  An (immediate) early protein is involved in PRV-mediated suppression of eIF2α 
phosphorylation. (A, B, C) Differentiated 50B11 cells were pre-treated with thapsigargin (1µM for 1h). 
Subsequently, cells were mock-inoculated or inoculated with UV-inactivated PRV (theoretical MOI 1)(A) or treated 
with cycloheximide (10µg/µl)(B) or PAA (250µg/ml) (C) prior to inoculation with PRV (MOI 1). Lysates were 
collected at 4hpi and Western blot detection was performed for total and phosphorylated eIF2α. US3 detection 
was included as a control for treatment and infection. (D) Differentiated 50B11 cells were pre-treated with 
thapsigargin (1µM for 1h). Subsequently, cells were inoculated with PRV (MOI 1). Lysates were collected at 
different time points post inoculation and Western blot detection was performed for total and phosphorylated 
eIF2α, the immediate early protein IE180, and the early protein US3. 
3.3. Expression of IE180 interferes with eIF2α phosphorylation  
 PRV encodes only one protein with immediate-early kinetics, immediate-early protein 
180 (IE180), an ortholog of HSV-1 ICP4. To investigate the possible involvement of IE180, 
first, a sequential treatment of CHX and actinomycin D (ActD) was used. This treatment 
results in protein expression of viral genes with immediate-early characteristics (transcribed 
without de novo viral protein synthesis) (Hayes and Rock, 1990; Debrus et al., 1995; 
Ambagala et al., 2000). In the case of PRV, this results in expression of IE180, the only viral 
gene product with immediate-early characteristics (Ambagala et al., 2000). At 4hpi, lysates 
were collected and Western blot detection was performed for total and phosphorylated 
eIF2α. Detection of IE180 and the absence of detectable early protein US3 were used as 
controls for the treatment. As shown in Figure 3A&B, phosphorylation of eIF2α is significantly 
reduced under these circumstances, indicating that the expression of IE180 interferes with 
eIF2α phosphorylation. 
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Figure 3. Expression of IE180 causes suppression of eIF2α phosphorylation. (A, B) Differentiated 50B11 
cells were pre-treated with thapsigargin (1µM for 1h). Subsequently, cells were treated with cycloheximide 
(10µg/µl) prior to mock inoculation or inoculation with PRV (MOI 1). At 2hpi, CHX was washed away and 
actinomycin D (5µg/ml) was added to the cells for the remainder of the experiment. At 4hpi, lysates were collected 
and Western blot detection was performed for total and phosphorylated eIF2α. IE180 and US3 detection were 
included as control for treatment and tubulin detection was included as a loading control. (B) shows ratios of P-
eIF2α/total eIF2α of three independent replicates. (C, D) Differentiated 50B11 cells were transfected with a 
eukaryotic expression vector encoding IE180 (pIE180) or eGFP (pTrip) for 24h. Upon stimulation with 
thapsigargin (1µM for 1h), lysates were collected and Western blot detection was performed for total and 
phosphorylated eIF2α. GFP and IE180 detection were included as transfection control and tubulin detection as 
loading control. (D) shows ratios of P-eIF2α/total eIF2α of three independent replicates. Asterisks indicate 
statistically significant differences (p < 0.05).  
 To confirm a potential involvement of IE180, phosphorylation of eIF2α was assessed 
in 50B11 cells transfected with a eukaryotic expression vector encoding either IE180 or (as a 
control) eGFP. At 24h post transfection, lysates were collected and Western blot detection 
was performed for total and phosphorylated eIF2α. Figure 3C&D show that, in samples 
containing IE180-transfected cells, phosphorylation of eIF2α was significantly diminished. 
The degree of reduction corresponded well with the transfection efficiency of ± 40%. In 
conclusion, expression of IE180 protein is sufficient to interfere with phosphorylation of 
eIF2α.  
  
Chapter 6 – The IE180 protein of pseudorabies virus suppresses phosphorylation of the translation   
                    initiation factor eIF2α 
 112 
3.4. PRV IE180-mediated suppression of eIF2α phosphorylation also occurs in 
swine ST cells  
 To determine whether our observations hold true in other cells, particularly swine 
cells, key experiments were repeated in ST swine testicle cells. A time course infection 
experiment showed rapid suppression of eIF2α phosphorylation in ST cells, within 2hpi, 
similar compared to 50B11 cells (data not shown). Also, like in 50B11 cells (Fig. 3A), 
subjection of ST cells to a sequential treatment with CHX and ActD that leads to IE180 
protein expression during PRV infection again resulted in a substantial reduction in eIF2α 
phosphorylation (Fig. 4A). In addition, like in 50B11 cells (Fig. 3B), transfection of IE180 in 
ST cells resulted in substantial interference with eIF2α phosphorylation that corresponded 
well with the ± 30% transfection efficiency (Fig. 4B).  
 
 
 
 
 
 
Figure 4. PRV IE180-mediated suppression of eIF2α phosphorylation in ST cells. (A) ST cells were pre-
treated with thapsigargin (1µM for 1h). Subsequently, cells were treated with cycloheximide (10µg/µl) prior to 
mock inoculation or inoculation with PRV (MOI 1). At 2hpi, CHX was washed away and actinomycin D (5µg/ml) 
was added to the cells for the remainder of the experiment. At 4hpi, lysates were collected and Western blot 
detection was performed for total and phosphorylated eIF2α. IE180 and US3 detection were included as control 
for treatment and tubulin detection was included as a loading control. (B) ST cells were transfected with a 
eukaryotic expression vector encoding IE180 (pIE180) or eGFP (pTrip) for 24h. Upon stimulation with 
thapsigargin (1µM for 1h), lysates were collected and Western blot detection was performed for total and 
phosphorylated eIF2α. GFP and IE180 detection were included as transfection control and tubulin detection as 
loading control.  
3.5. Protein phosphatase 1 but not protein phosphatase 2 is involved in PRV-
mediated interference with eIF2α phosphorylation  
 As described higher, the observations that PRV suppresses both basal and 
thapsigargin pre-induced levels of eIF2α phosphorylation and does not affect thapsigargin-
induced phosphorylation of PERK (Fig. 1) suggest that PRV leads to dephosphorylation of 
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eIF2α rather than preventing phosphorylation of eIF2α. This would imply the involvement of a 
phosphatase. PRV does not encode a viral phosphatase, suggesting that a cellular 
phosphatase may be recruited or induced by PRV to induce dephosphorylation of eIF2α. 
Both protein phosphatase 1 (PP1) and protein phosphatase 2 (PP2A) have been reported to 
dephosphorylate eIF2α (Ernst et al., 1982). To investigate whether PP1 and/or PP2A are 
involved in PRV-mediated interference with eIF2α phosphorylation, assays were done in the 
presence of 0.2µM I2 to inhibit PP1 activity or 20nM OA to inhibit PP2 activity. At 4hpi, 
lysates were collected and immunoblotting was performed for total and phosphorylated 
eIF2α. Treatment with I2 significantly counteracted PRV-mediated interference with eIF2α 
phosphorylation while treatment with OA had no effect (Fig. 5A&B). These results indicate 
that PP1 is involved in PRV-mediated dephosphorylation of eIF2α. 
 
Figure 5. Protein phosphatase 1 but not 2 is involved in PRV-mediated suppression of eIF2α 
phosphorylation. (A) 50B11 cells were pre-treated with thapsigargin (1µM for 1h). Prior to and during inoculation 
with PRV (MOI 1), cells were treated with  PP1 specific inihibitor I2 (200nM), PP2-inhibiting okadaic acid (OA 
20nM) or a DMSO control. At 4hpi, lysates were collected and Western blotting was performed for total and 
phosphorylated eIF2α. US3 detection was included as control for infection. (B) shows ratios of P-eIF2α/total eIF2α 
of three independent replicates. Asterisk indicates statistically significant difference (p < 0.05).  
3.6. PRV infection or IE180 transfection does not affect PP1 or GADD34 protein 
expression levels 
 Since IE180 is a transactivator, one possibility could be that IE180 induces protein 
expression of PP1 or its regulatory complex partner GADD34, thereby promoting 
dephosphorylation of eIF2α. To investigate this, thapsigargin-stimulated 50B11 cells were 
either mock-infected or infected with PRV or transfected with a eukaryotic expression vector 
either encoding IE180 or, as a control, eGFP. Western blot detection at 4hpi or 24h post 
transfection was performed for PP1, PP2A and GADD34 and IE180/US3/tubulin detection 
was included as control. As shown in Figure 6, neither PRV infection nor IE180 transfection 
affected PP1, PP2A or GADD34 protein levels. These findings indicate that IE180 does not 
alter protein expression levels of PP1 or GADD34, to initiate dephosphorylation of eIF2α. 
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Figure 6. PRV infection or IE180 transfection does not affect protein expression levels of PP1, PP2, or 
GADD34. (A) Differentiated 50B11 cells were transfected with pIE180 or the control plasmid pTrip for 24h and 
subsequently pre-treated with thapsigargin (1µM for 1h). Lysates were collected and subjected to Western blot 
detection of PP1, PP2 and GADD34. IE180 and tubulin detection were included as controls. (B) Differentiated 
50B11 cells were pre-treated with thapsigargin (1µM for 1h) and subsequently mock inoculated or inoculation with 
PRV (MOI 1). Lysates were collected at 4hpi and Western blot detection was performed for PP1, PP2 and 
GADD34. US3 and tubulin detection were included as controls.  
4. Discussion 
 Phosphorylation of the translation initiation factor eIF2α results in shutdown of 
translation, and represents one of the key antiviral effector mechanisms of interferon 
(Randall and Goodbourn, 2008). Here, we show that the PRV immediate-early protein IE180 
interferes with phosphorylation of eIF2α. We also show that the cellular phosphatase PP1 is 
involved in PRV-mediated interference with eIF2α phosphorylation.  
 PRV IE180 is the ortholog of HSV-1 ICP4 and VZV IE62. Before the current report, 
three alphaherpesvirus proteins had been reported to interfere with phosphorylation of eIF2α: 
ICP34.5 and US11 of HSV-1 (neither of which have orthologs in PRV) and IE63 of VZV (the 
putative homolog/ortholog of HSV-1 ICP22 and PRV RSp40/ICP22). ICP34.5 and US11 of 
HSV-1 counteract phosphorylation of eIF2α via different mechanisms. US11 binds to PKR, 
preventing its activation and thus phosphorylation, while ICP34.5 recruits PP1 to eIF2α to 
mediate its dephosphorylation (He et al., 1997; Cassady and Gross, 2002; Li et al., 2011). 
The mechanism underlying VZV immediate-early protein IE63-mediated dephosphorylation 
of eIF2α is unknown (Ambagala and Cohen, 2007). However, since activation of PKR does 
not appear to be significantly affected in VZV infected cells (Desloges et al., 2005), PKR 
probably is not involved in IE63-mediated dephosphorylation of eIF2α. Since we found that 
PRV suppresses basal and thapsigargin pre-induced phosphorylation of eIF2α, this suggests 
that IE180 dephosphorylates eIF2α, rather than preventing its phosphorylation, suggestive 
for the involvement of a phosphatase. In this way, the mode of action of IE180 appears to 
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resemble ICP34.5 more than US11. In support of this, like for ICP34.5, we showed an 
involvement of PP1.  
 Since phosphorylation of eIF2α and subsequent shutdown of protein synthesis brings 
the entire viral replication in jeopardy, it would appear to make sense if a virus tries to 
interfere with this system soon upon infection of a host cell. Our finding that the only 
immediate-early protein encoded by PRV, IE180, interferes with phosphorylation of eIF2α fits 
with this assumption. VZV also interferes with phosphorylation through a protein with 
immediate-early kinetics, IE63 (the putative homolog/ortholog of HSV-1 ICP22 and PRV 
RSp40/ICP22)(Ambagala and Cohen, 2007). Perhaps surprisingly, both HSV-1 proteins that 
interfere with eIF2α phosphorylation, ICP34.5 and US11, are reported to be late proteins (He 
et al., 1997; Cassady and Gross, 2002; Bryant et al., 2008). However, at least for ICP34.5, 
this late expression appears to be leaky, and low amounts of ICP34.5 protein can already be 
detected 3h post inoculation (Pasieka et al., 2006). These low amounts of ICP34.5 early in 
infection are sufficient to generate an effect on eIF2α phosphorylation (Pasieka et al., 2006).  
 It will be interesting to determine in future research whether the ability of PRV IE180 
to interfere with phosphorylation of eIF2α is conserved in other alphaherpesviruses.  The 
overall amino acid homology between IE180 orthologs is relatively low, ranging from 32% to 
40% in HSV ICP4, VZV IE62, bovine and equine ICP4. However, ClustalW analysis showed 
that amino acid homology is condensed in 4 highly conserved regions over the different 
alphaherpesviruses. Hence, it will be interesting to investigate whether other IE180 orthologs 
affect eIF2α phosphorylation and, if so, to analyze the involvement of these four conserved 
domains.  
 How does IE180 affect phosphorylation levels of eIF2α? IE180 is predominantly 
located in the nucleus, acting as a transactivator to control expression of different genes. 
From this viewpoint, one potential explanation for the ability of IE180 to interfere with the 
phosphorylation status of eIF2α could be that IE180 affects gene expression of cellular 
factors that influence the phosphorylation status of eIF2α. Although we provide evidence that 
the cellular phosphatase PP1 is involved in IE180-mediated dephosphorylation of eIF2α, 
IE180 did not affect protein expression levels of either PP1 (or PP2) or its regulatory complex 
partner GADD34. Future research will show whether IE180 may affect expression of other 
components that direct eIF2α dephosphorylation. For example, overexpression of the cellular 
protein CReP has been reported to promote dephosphorylation of eIF2α through recruitment 
of PP1 (Jousse et al., 2003). Alternatively, it is possible that IE180, upon its production in the 
cytoplasm, physically interacts with one or more cellular components affecting 
phosphorylation of eIF2α, thereby modulating their function. Cytoplasmic IE180 has been 
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detected in PRV-infected cells (Huang et al., 1997). Such putative interaction of IE180 with 
cellular components affecting eIF2α phosphorylation would be in line with mechanisms 
employed by different other viruses. For example, ICP34.5 of HSV-1 displays sequence 
homology to both PP1 and eIF2α. This allows ICP34.5 to serve as a molecular bridge, 
thereby mediating eIF2α dephosphorylation (He et al., 1997; He et al., 1998; Li et al., 2011). 
Although we did not find any obvious sequence homology between IE180, eIF2α or PP1, we 
cannot exclude a similar function for IE180 at this stage and will further address this in future 
experiments.  
 In conclusion, we report that the PRV immediate-early protein IE180 has the 
previously uncharacterized ability to suppress phosphorylation of eIF2α, which may have 
important consequences for the virus during early stages of virus replication, in the face of an 
active innate immune response.  
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 Herpesviruses are among the most successful pathogens as they are able to 
establish lifelong latent infections from which they may reactivate to spread to new hosts. 
Their delicate balance with the host immune system is key to their success. Interferon (IFN) 
is one of the major components of the host defense against viruses in general and 
herpesviruses in particular. Indeed, defects in the IFN system may lead to aggravated and 
sometimes fatal herpesvirus disease (Al-Khatib et al., 2002; Al-Khatib et al., 2003; Vollstedt 
et al., 2004; Casrouge et al., 2006; Zhang et al., 2007; Zhang et al., 2008; Perez De Diego et 
al., 2010). 
 The closely interacting dance, or battle, between IFN and alphaherpesviruses has 
already been extensively studied, identifying several IFN-mediated effects that control viral 
replication and viral escape mechanisms. Type I IFNs are among the first immune effectors 
produced upon alphaherpesvirus infection, playing a key role in limiting replication at the 
initial stage of infection (Hendricks et al., 1991; Mikloska et al., 1998; Mikloska and 
Cunningham, 2001; Sainz and Halford, 2002; Jones, 2003). These innate interferons are 
present both at the periphery and in the trigeminal ganglion (TG) at the time when latency is 
established (Hendricks et al., 1991; Carr et al., 1998). However, the role of type I IFNs in the 
switch between lytic and latent infection had not yet been described. To investigate this, we 
made use of a two-chamber in vitro model. This in vitro model allows infection of trigeminal 
ganglion (TG) neurons via the nerve endings in the outer chamber, whereafter the virion is 
transported retrograde to the nucleus in the inner chamber where replication can occur, 
much like the infection route in vivo (De Regge et al., 2006). Our data indicate that addition 
of IFNα is sufficient to instigate the switch from lytic to latent infection at least in primary TG 
neurons in an in vitro system. 
 In the absence of exogenous added IFN, the vast majority of the accessible neurons 
with axons growing in the outer chamber proceeded to productive infection upon PRV 
inoculation, correlating with previous results that were obtained without the two-chamber 
system (Geenen et al., 2005). However, this seems at odds with earlier reports, which 
suggested that latency establishment may be a default pathway of alphaherpesvirus infection 
in neurons. An important reason for this belief was the assumption that tegument protein 
VP16, which is a transactivator required for the onset of lytic replication, might be lost during 
virion transport along the axon (Roizman and Sears, 1987; Kristie and Roizman, 1988). 
However, using an inducible VP16-mutant HSV-1, this hypothesis was contradicted, showing 
that latency was established even in the presence of a functional VP16 (Sears et al., 1991). 
Another theory posed that sensory neurons lack Oct1 transcription factors, leading to default 
establishment of latency in neurons (He et al., 1989). However, Hagmann et al. (1995) 
showed that all components necessary for onset of transcription are present in sensory 
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neurons, although at lower levels (Hagmann et al., 1995). Later on, it was shown that in 
neurons, HCF1 is sequestered to the cytoplasm as opposed to the general nuclear 
distribution in other cell types (Kristie et al., 1995; Kristie et al., 1999; La Boissiere et al., 
1999). As HCF-1 is required to recruit VP16 to the nucleus, it might be that this does not 
occur (efficiently) in sensory neurons (La Boissiere et al., 1999). Although our data show 
that, at least for PRV, latency does not appear to be the default pathway of infection in TG 
neurons, some side-remarks have to be made. A potentially important difference between 
the in vivo TG neurons and our in vitro system is the length of axons and thus transport 
distance for the virion. In the in vitro model, the virus only has to overcome 1 - 2cm while in 
vivo the virus has to travel at least 10cm, which may for example affect the VP16 protein 
amounts reaching the nucleus. Also, in vitro culture of TG neurons may affect expression 
levels and/or subcellular localization of transcription factors such as HCF1 and Oct-1. It might 
be interesting to look at the presence and localization of HCF1, Oct-1, and VP16 in the in 
vitro model to further explore this. Another big difference between the in vivo situation and 
the in vitro model is the presence of cytokines and other immune factors. To give just one 
example, dendritic cells are not present in the in vitro cultures whereas these cells have been 
shown to produce IFNα in response to HSV-1 (Ghanekar et al., 1996) and IFNα has been 
implicated in restricting viral HSV-1 replication in the cornea (Hendricks et al., 1991). We 
have shown that addition of IFNα is sufficient to switch alphaherpesvirus infection from lytic 
to latent in the in vitro model, but different other cytokines have been detected in mouse TG 
carrying latent HSV-1, including IL2, IL6, IL10 and IFNγ (Halford et al., 1996). A very recent 
study strongly suggests that TGFβ signaling, which generally functions to dampen immune 
responses, results in increased HSV-1 latency (Allen et al., 2011). Thus it is possible, and 
even likely, that some of these cytokines affect the process of latency establishment and/or 
maintenance. Hence, the loss of immune factors in the in vitro model has to be taken into 
account when interpreting results. 
 While we found 98% of accessible neurons positive for productive PRV infection in 
the absence of IFN, this percentage was much lower for HSV-1 (12%). Possible explanations 
are that HSV-1 has difficulties in infecting porcine cells or specifically porcine TG neurons. 
Previous studies showed that HSV-1 is able to infect porcine cells although the infection 
efficiency was 1000fold lower in porcine kidney PK15 cells than in monkey Vero cells (Kim et 
al., 2010). We found that in ST cells (swine testicle cells), only 5-10% of cells were positive 
for gD at 15hpi with HSV-1 compared to 100% in PRV infected cells, using equivalent 
infectious doses (data not shown), suggesting a general lower ability of HSV-1 to 
productively infect porcine cells. To investigate whether the roadblock towards productive 
HSV-1 infection is situated at the entry level or later in infection, a mutant HSV-1 carrying the 
Chapter 7 – General discussion 
 122 
LacZ gene under control of the human CMV MIEP promoter was used in the in vitro model. 
This virus generated detectable β-galactosidase activity in 90% of accessible neurons, 
indicating that HSV-1 efficiently enters and delivers its DNA in the nucleus of porcine TG 
neurons. Another possibility is that HSV-1 productive infection is hampered early in infection. 
In support of this, we found the percentage of neurons positive for the immediate-early 
protein ICP4 to be similar to the percentage of neurons positive for the late protein gD later in 
infection, indicating that HSV-1 is able to trigger immediate early viral protein expression and 
subsequent productive infection in only a small part of the TG neurons whereas the others 
are halted very early in infection. A recent report from Bertke et al. (2011) showed that in 
mice, a subpopulation of primary TG neurons, A5-positive neurons, appear to be non-
permissive for HSV-1 productive infection. In these A5+ cells, latency was induced 
immediately upon entry of the cell. Although A5+ neurons make up only 11% of an adult TG, 
it limits HSV-1 replication as their results showed a maximum of 22% neurons positive for 
HSV-1 infection at a high MOI (Bertke et al., 2011). The same study showed that the block 
occurred at or before the IE level as only 2.1% of A5+ neurons were positive for ICP0 and 
also early and late proteins were present in very low amounts. However there is currently no 
clear explanation on why this seems to happen (Bertke et al., 2011). Hence, it may be that 
HSV-1, but not PRV, is only able to initiate productive infection in a subpopulation of TG 
neurons. Numerous alternative hypothetical explanations may be put forward to explain the 
substantially lower ability of HSV-1 to initiate productive infection in porcine TG neurons 
compared to PRV. For example, it might be that, because of the species difference, the 
VP16/HCF1 interaction may be less efficient or strong in HSV-1 infected porcine TG neurons 
compared to PRV, resulting in a lower transcription efficiency. It might also be that the 
CoREST/REST/HDAC/LSD1 repressor complex may be recruited faster and/or more efficient 
to HSV-1 genomes than to PRV genomes, thereby silencing the genome in a more efficient 
manner. Yet another possibility may be that VP16 is more tightly associated with the capsid 
in PRV versus HSV-1, which may lead to higher levels of VP16 reaching the nucleus, 
allowing more efficient onset of productive infection.  
 One important question is: what happens with the (majority of) HSV-1 genomes that 
do not lead to lytic infection? Are they in a latent state ? Although not all latently infected 
neurons express (detectable) latency-associated transcripts (LATs), it would be interesting to 
determine whether these non-lytically infected neurons express LATs, as this would clearly 
point in the direction of latency (Wagner and Bloom, 1997). In case LAT expression would be 
observed, localization of the LAT transcripts may point to latent versus lytic infection. Indeed, 
it has been  described that the stable LAT 2kb intron can be exported to the cytoplasm during 
lytic infection as part of the 60S ribosomal subunit (Atanasiu and Fraser, 2007). Hence, 
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nuclear LAT would point to latent neurons. Another possibility to address whether non-
lytically infected neurons may contain latent HSV-1, is the use of an HSV-1 LAT-specific in 
situ hybridisation assay (Theil et al., 2001; Gussow et al., 2006).  Alternatively, earlier studies 
using an HSV-1 mutant that expresses β-galactosidase from the LAT promoter (LβA HSV-1) 
and our own studies (Chapter 3) comparing IFN-treated versus non-treated HSV-1-infected 
TG cultures, showed a distinct localization of LacZ in lytic and latent infected neurons. Lytic 
infected neurons showed a cytoplasmic distribution of the LacZ staining, while latently 
infected neurons had a focal staining (Ho and Mocarski, 1989; Lachmann and Efstathiou, 
1997).  
 Interestingly, triggering reactivation in IFN-treated HSV-1-infected porcine TG 
neurons resulted in 11% of the accessible neurons that initiated expression of glycoprotein 
gD, a marker for productive infection. This percentage is very similar to the percentage of 
neurons that is able to proceed to productive infection during acute infection in the absence 
of IFN. This suggests that the cells that do not proceed to lytic infection during acute infection 
in the absence of IFN also do not respond to the reactivation stimulus (in our case forskolin). 
As described above, A5+ neurons are non-permissive for lytic infection of HSV-1, but are also 
non-permissive for reactivation upon addition of the HDAC inhibitor trichostatin A (TSA) 
(Bertke et al., 2011). The A5+ neurons that are non-permissive for lytic replication are mostly 
positive for TrkA, while other neurons that do support lytic replication are GDNF positive 
(Bertke et al., 2011). Interestingly, signalling through Trk receptor appears to be required to 
maintain latency of HSV-1, while this is not the case for signalling through GDNF (Camarena 
et al., 2010). Hence it might be interesting to study the presence of TrkA and/or GDNF in the 
in vitro system: in the subpopulation of neurons that shows expression of lytic viral genes 
during acute infection and reactivation, versus the (large) subpopulation that does not show 
such expression. 
 How does IFNα cause alphaherpesvirus latency-like quiescence in the TG cultures ? 
IFNα–induced latency in the two-chamber model correlated with the IFNα–induced 
suppression of expression of the immediate early viral protein ICP4 in HSV-1 and its 
counterpart in PRV, IE180. This ICP4/IE180 suppression was much more efficient in HSV-1 
versus PRV, which correlated with the more efficient IFNα–mediated establishment of 
latency in HSV-1-infected versus PRV-infected TG neurons. As working with the primary TG 
neurons in the in vitro two-chamber posed too many technical difficulties, the question how 
IFN is causing latency-like quiescence was further addressed using a continuous cell line 
originating from rat dorsal root ganglion neurons (50B11s) (Chen et al., 2007). First, it was 
determined whether IFN caused similar effects on HSV-1/PRV replication in 50B11 cells 
compared to TG neurons. One difference was that the addition of IFNα alone was insufficient 
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to generate a very substantial reduction in HSV-1/PRV replication (data not shown). We 
found that the combination of IFNα and IFNγ resulted in the best suppression of viral 
replication, which is in line with other reports (Sainz and Halford, 2002).  This combinatorial 
treatment was used in all following experiments.  
 Our data in general indicated that the 50B11 cells and the primary TG neurons share 
important similarities with regard to the effect of IFN on PRV/HSV-1 infection. However, one 
needs to keep in mind that important differences were also obvious between the 50B11 
continuous cell line and the primary TG neurons. The first difference was the amount of IFN 
needed to suppress the infection. In TG neurons, infection was efficiently reduced using 
500U/ml IFNα, while in 50B11 a combination of 1000U/ml IFNα and 100ng/ml IFNγ was 
needed to substantially suppress replication. Despite these higher amounts (and 
combination) of IFN, stable latency-like quiescence was never obtained in 50B11s, as in long 
term infections, CPE would eventually show up. Several hypotheses to explain these 
differences between TG neurons and 50B11 cells may be put forward. First, the 50B11 cell 
line was not cultured in a two-chamber system. Therefore, virus did not need to engage in 
retrograde transport to reach the cell nucleus, which likely will result in much higher levels of 
the viral transactivator VP16 reaching the nucleus. As the 50B11s do not establish a stable 
axon network, it is not possible to set up a two chamber system using 50B11 cells instead of 
TG neurons. In addition, it is likely that in 50B11 cells, which have the ability to replicate 
indefinitely, expression levels of cellular transcription factors such as HCF and Oct-1 and 
other cellular factors (e.g. cell cycle proteins) that affect HSV-1 replication may be 
substantially higher than in primary TG neurons. It is also possible that the fact that 50B11, 
which originate from rat, instigate more difficulties for the human IFNα to suppress the viral 
replication. Although this would not solve the issues related to cellular 
transcription/replication factors inherent to continuous cell lines compared to primary cells, it 
might be interesting to create a continuous cell line originating from porcine TGs to solve at 
least some of the issues mentioned above. 
 Notwithstanding the issues mentioned above comparing 50B11 and TG neurons, 
interesting similarities were observed that allowed to lift a tip of the veil regarding how IFN 
may aid in establishing alphaherpesvirus latency and why there is a difference in efficiency in 
IFN-mediated suppression of immediate early gene expression in HSV versus PRV. Like in 
the TG neurons, IFN treatment caused suppression of ICP4 and IE180 protein levels. Again, 
this IFN-mediated suppression was more efficient for HSV-1 ICP4 (from 4hpi onwards) 
compared to PRV IE180 (from 8hpi onwards). This was not due to differences in IFN-
mediated suppression of mRNA levels of ICP4/IE180, as both were only suppressed 
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relatively late in infection (8hpi) and to comparable levels. Our data suggest that IFN 
efficiently and rapidly inhibits translation of HSV-1 mRNAs, while for PRV this is not the case. 
 Addition of IFN resulted in a suppression of mRNA levels of both HSV-1 ICP4 and 
PRV IE180, relatively late in infection (8hpi) of 50B11 cells. A transcriptional block of HSV-1 
and PRV IE genes had been reported before, although the underlying mechanism remains 
unknown. Both in vivo and in vitro studies showed that IFN is able to block transcription at 
the immediate-early level (Gloger and Panet, 1984; Oberman and Panet, 1988; De Stasio 
and Taylor, 1990; Nicholl and Preston, 1996; Yao et al., 2007). To investigate the underlying 
mechanism for the transcriptional block, several paths need to be explored. First, there are 
several RNA degrading/modulating proteins that are upregulated by IFN that might be 
involved, e.g. APOBEC3, TRIMα, ADAR1 and RNaseL (Liu et al., 2010). RNA degradation is 
not likely to be the main cause of suppressed ICP4/IE180 mRNA levels, as cellular GAPDH 
mRNA levels were not affected by IFN or infection. RNA editing, e.g. through APOBEC3 or 
ADAR1 may affect successful translation of mRNA but likely would not interfere with RT-
qPCR-based detection of these mRNAs, arguing against the possibility that RNA editing 
causes ICP4/IE180 mRNA suppression. Also, these RNA editing proteins have mainly been 
reported to affect replication of RNA viruses, including IFN-mediated suppression of HIV-1 
replication (Argyris et al., 2007). Recently it was described that APOBEC3C is able to 
suppress viral replication of HSV-1, but through an IFN-independent pathway as APOBEC3C 
is not affected by IFN (Jarmuz et al., 2002; Suspene et al., 2011).  
 Alternatively or in addition to the above-mentioned effects of IFN on mRNA levels, it 
may be that IFN affects chromatin modifications that promote a closed chromatin structure. 
Histone deacetylases (HDACs) have been reported to promote such chromatin 
modifications, and, consequently, the inhibitor of HDACs trichostatin A (TSA) may activate 
the alphaherpesvirus genome (Poon et al., 2003). Our data show that HDAC is at least 
involved in the IFN-mediated suppression of transcription of HSV-1 ICP4, since TSA partially 
reverses the effect of IFN on ICP4 mRNA and protein levels. It might be possible that IFN 
primes the cell to immediately silence the incoming viral genome through the 
CoREST/REST/HDAC/LSD1 respressor complex, as we observed that CoREST is 
upregulated by IFN treatment. However, there is no universal agreement over the presence 
of REST (Repressor Element-1 Silencing Transcription) and CoREST (Corepressor of REST) 
in neurons as the main function of these proteins is the repression of neuronal genes in non-
neuronal cells (Qureshi et al., 2010). However, an abundant amount of REST was detected 
in TGs of uninfected mice (Du et al., 2010) and CoREST staining on 50B11 cells showed a 
clear nuclear signal indicating that REST and CoREST might be present in neurons. It was 
shown before that the CoREST/REST/HDAC/LSD1 repressor complex plays a central role in 
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silencing the HSV-1 genome (Gu et al., 2005; Gu and Roizman, 2009b; Gu and Roizman, 
2009a; Zhou et al., 2011). Recently, it was described that in mice, HSV-1 hijacks the 
CoREST/REST/HDAC/LSD1 repressor complex to silence itself as a mutant HSV-1 
expressing dnREST is more virulent then WT virus (Du et al., 2010). It is possible that in the 
presence of IFN, the repressor complex is stimulated to silence the viral genome more 
efficiently than the virus would do itself. It might be interesting to investigate, e.g. through 
chromatin immunoprecipitation assays (ChIP), the chromatin structure on the viral genome in 
cells infected with or without IFN pre-treatment. Detection of acetyl groups on histones 
(especially H3) might give a clue towards the state of the chromatin as acetylation results in 
open chromatin structure while deacetylation causes a repressed chromatin structure. In 
addition, the genome may be assessed for increased repressive methylation markers 
(H3K9me2) and decreased activating methylation markers (H3K4me3) upon IFN treatment.  
 Although the effect of IFN on ICP4 and IE180 mRNA levels was similar, the effect on 
the protein level of these genes was quite different. The fact that, both in TG neurons and 
50B11 cells, ICP4 was very quickly translationally repressed upon IFN treatment while IE180 
was not, came as a surprise as HSV-1 encodes two viral proteins, ICP34.5 and US11, that 
counteract the IFN-mediated phosphorylation of the eukaryotic translation initiation factor 
eIF2α resulting in repression of translation. PRV does not encode orthologs for either of 
these proteins. Nevertheless, our data show that PRV is able to efficiently counteract the 
IFN-mediated phosphorylation of eIF2α in 50B11 cells, much more efficiently than HSV-1. It 
appears that the IFN-mediated suppression of HSV-1 replication in 50B11 cells is so efficient 
and rapid that ICP34.5 and US11, both expressed as (leaky-)late proteins, may not get the 
chance to function. As the dephosphorylation of eIF2α mediated by PRV occurs very early 
after infection (from 2hpi onwards), this points to the involvement of a tegument protein or an 
(immediate) early protein. Our data show that the PRV immediate-early protein IE180 is 
responsible and sufficient for the dephosphorylation of eIF2α. By encoding an immediate-
early protein with the ability to counteract eIF2α phosphorylation, PRV resembles VZV, which 
encodes the immediate-early protein IE63 that causes dephosphorylation of eIF2α through a 
still unknown mechanism (Ambagala and Cohen, 2007). Although IE180 and IE63 are not 
orthologs, both closely related viruses use a similar manner of counteracting IFN-mediated 
repression of translation. All this suggests that these viruses may have gained their ability to 
counteract IFN-mediated phosphorylation of eIF2α relatively late in evolution, after the 
Simplexvirus genus has split from the Varicellovirus genus. Further research is required to 
determine whether IE180/ICP4 orthologs of HSV-1, BHV-1 and EHV-1 are also able to play a 
role in this process. The in vivo relevance of the immediate-early protein IE180 as a factor 
important for the dephosphorylation of eIF2α is not yet clear. ICP34.5-/- HSV-1 strains lost 
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their neurovirulence as the absence of ICP34.5 renders them extremely sensitive to IFNs 
(Leib et al., 1999). Similar experiments with PRV to assess the in vivo importance of IE180-
mediated dephosphorylation of eIF2α will be less straightforward as IE180 mutants are 
unable to replicate, since IE180 is required for onset of transcription of the other viral genes. 
Hence, in order to be able to assess the in vivo relevance of our findings, it may be important 
to determine which domains in IE180 are involved in eIF2α dephosphorylation. If these 
domains are separatable from the parts of the protein involved in its transactivating function, 
mutants may be generated that still replicate but not longer dephosphorylate eIF2α.   
 Our data show the involvement of protein phosphatase 1 in dephosphorylation of 
eIF2α, which resembles the activity of ICP34.5 in HSV-1. Hence, although the viral protein 
may be completely different, the underlying mechanism of eIF2α dephosphorylation may be 
similar. Although future research is required to study whether IE180, like ICP34.5, is also 
able to interact directly with PP1, no sequence homologies were found to point in that 
direction. At first glance, it would appear more likely that IE180 induces the expression of a 
protein involved in PP1-mediated dephosphorylation of eIF2α (but not PP1 itself), which may 
then recruit PP1 to dephosphorylate eIF2α, such as GADD34 or CReP. Further research, 
using Western blot assays to determine expression levels of PP1-affecting proteins and 
immuno- precipitation assays to determine binding partners of IE180, will be needed to 
explore these different possibilities. 
 
Conclusions and general hypotheses (Figure 1)    
Based on the findings in the current thesis, we hypothesize that interferon promotes the 
establishment of alphaherpesvirus latency in sensory neurons, likely through inhibition of 
immediate-early gene expression both at the mRNA and protein level.  
We hypothesize that the inhibitory effect of IFN on IE mRNA expression occurs partly 
through histone modifications, including histone deacetylases and the induction of 
components involved in repressor complexes like CoREST/REST/HDAC/LSD1. 
As a countermeasure towards the suppressive effects of IFN on viral replication, we have 
found that the IE180 protein of PRV causes dephosphorylation of eIF2α, at least partly 
through the cellular phosphatase PP1. We hypothesize that IE180 causes these effects 
either through upregulation of components involved in PP1-mediated effects (apart from PP1 
itself) or through establishing interactions with and thereby affecting the activity of PP1 or 
PP1-regulating factors.  
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Figure 1: Hypothetical model to explain the interactions of alphaherpesviruses, interferon, and sensory 
neurons observed in the current thesis. We observed that IFN is able to induce HSV-1 and PRV latency in 
porcine TG neurons in vitro. We also found that IFN acts on alphaherpesvirus immediate early gene expression 
through the activity of HDACs (histone deacetylases) and that IFN upregulates protein levels of CoREST, an 
important component of the transcription suppressing CoREST/REST/HDAC/LSD1 complex. These effects 
potentially may all contribute to the ability of IFN to induce latency in vitro. In addition, we found that PRV 
efficiently counteracts phosphorylation of eIF2α, a translation-inhibiting consequence of IFN. We identified the 
immediate early IE180 protein of PRV as being able to suppress phosphorylation of eIF2α and demonstratedthe 
involvement of the cellular phosphatase PP1. Observations made in this thesis are indicated in red. 
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 Herpesviruses share the common characteristic of being able to establish a latent 
infection in sensory neurons. It has become increasingly clear that the host immune system, 
the neuron and the virus act as a triple entente to establish and maintain viral latency. The 
major aim of this thesis was to gain a better insight in the interaction between the immune 
system, the neuron and the virus. 
 The first chapter consists of a brief introduction on alphaherpesviruses in general, on 
the sensory neurons where alphaherpesvirus latency is commonly established, and on 
alphaherpesvirus latency. Since interferon, a potent antiviral component of the immune 
respons, is of major importance in the current thesis, an overview of the antiviral effect of 
interferon and of alphaherpesvirus countermeasures is also given in this introductory 
chapter.  
 Chapter 2 describes the aims of this thesis.     
 In Chapter 3, using an in vitro model that enables a natural route of alphaherpesvirus 
infection, we showed that interferon alpha (IFNα) has the capacity to induce a quiescent 
HSV-1 and PRV infection in porcine TG neurons which shows strong similarity to in vivo 
latency.  Latency of HSV-1 and PRV is characterized by the absence of viral proteins but the 
presence of viral DNA that can be reactivated upon specific stress stimuli. Addition of IFNα to 
the in vitro cultured primary TG neurons induced a stably suppressed HSV-1 and PRV 
infection in 100% and 45% respectively of the neurons growing axons into the outer 
chamber. HSV-1 and PRV latency in vivo is often accompanied by the expression of latency 
associated transcripts (LATs). RT-PCR was used to detect the latent transcript LAT or lytic 
transcripts IE180 and gB (PRV) or ICP4 and gD (HSV-1). Both for PRV and HSV-1,  
productively infected neurons were positive for both lytic and latent transcripts. Quiescent TG 
cultures were either only positive for LAT, or positive for both LAT and ICP0 (the latter 
suggestive for neurons on the verge of reactivation). Infection of TG neurons with an HSV-1 
mutant expressing LacZ under control of the LAT promoter confirmed activation of the LAT 
promoter in quiescent TG cultures. For both viruses, treatment of quiescently infected 
neurons with forskolin resulted in reactivation. Together, these data represent a unique in 
vitro model of alphaherpesvirus latency and indicate that IFNα may be a driving force in 
promoting efficient latency establishment.  
In addition, establishment of latency in vitro by the addition of IFNα correlated with 
suppressed expression of immediate-early (IE) genes ICP4 (HSV-1) and IE180 (PRV). For 
HSV-1, expression of ICP4 protein was suppressed fast en efficiently, correlating with 
efficient latency establishment in vitro. For PRV however, IE180 protein expression was less 
efficient and correlated well with the percentage of latency establishment in vitro. This 
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suggest IFNα-mediated suppression of IE expression like ICP4 and IE180 may be important 
in promoting alphaherpesvirus latency.  
 Since IFN-induced latency-like quiescence correlated with suppression of the 
immediate-early protein ICP4 in HSV-1 and its orthologue IE180 in PRV, in Chapter 4, we 
investigated the IFN-mediated suppression of ICP4 and IE180 in sensory neuronal cells. As 
working with primary TG neurons posed too many technical difficulties to address this, we 
opted to use a continuous cell line originating from rat dorsal root ganglion neurons, 50B11 
cells. RT-qPCR assays showed that mRNA levels of either HSV-1 ICP4 or PRV IE180 at 
were only mildly but not significantly suppressed in IFN-treated samples at 4hpi, whereas a 
strong reduction was observed at 8hpi and 12hpi. However, when looking at protein levels 
using Western blot, at 4hpi, HSV ICP4 but not PRV IE180 protein expression was strongly 
reduced in IFN-treated samples. Hence, this indicates that for HSV-1, IFN results in rapid 
suppression of ICP4 protein levels, possibly through inhibition of translation, and a slower 
suppression of ICP4 mRNA levels, possibly through inhibition of transcription. PRV, on the 
other hand, appears to escape to some extent from IFN-mediated fast suppression of IE180 
protein levels. To explain this difference in ability of IFN to suppress either HSV-1 ICP4 or 
PRV IE180 protein levels, the phosphorylation level of the translation initiation factor eIF2α 
was assessed. Indeed, one of the antiviral effector mechanisms of interferon consists of 
PKR-mediated phosphorylation of translation initiation factor eIF2α, resulting in shutdown of 
translation. In line with the difference in IFN-mediated suppression of HSV ICP4 versus PRV 
IE180 protein levels, we found that IFN resulted in an increase in phosphorylation of the 
translation initiation factor eIF2α in HSV-infected but not in PRV-infected cells. The latter 
finding indicates that PRV efficiently circumvents IFN-mediated translation inhibition by 
interfering with phosphorylation of eIF2α.  
 As Chapter 4 showed that IFN pre-treatment resulted in a decrease of HSV-1 ICP4 
(and PRV IE180) mRNA levels later in infection, we set out to study this apparent block in 
transcription in Chapter 5. Over the past decade, it has already been suggested extensively 
that transcription of alphaherpesviruses is controlled by chromatin modifications. Specifically, 
the repressive CoREST/REST/HDAC/LSD1 complex controls transcription of the viral 
genome and has been suggested to be involved in control of alphaherpesvirus latency. 
Hence, we investigated whether histone modifications may be involved in IFN-mediated 
suppression of ICP4 in HSV-1 infected cells. First, the involvement of histone deacetylases 
(HDACs) was evaluated using the histone deacetylase inhibitor trichostatin A (TSA). RT-
qPCR analysis showed that treatment with TSA partially counteracted the suppressive effect 
of IFN on ICP4 mRNA levels. Subsequently immunofluorescent staining and Western blotting 
for ICP4 confirmed these findings. These data suggest that the IFN-mediated suppressive 
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effect on ICP4 mRNA and protein expression includes the involvement of histone 
deacetylases. In a next step, protein levels of several components of the 
CoREST/REST/HDAC/LSD1 repressor complex were compared in mock versus IFN-treated 
samples. IFN was found to induce CoREST expression, while LSD1 and HDAC expression 
levels remain unchanged. Based on these data, we have indications that the suppressive 
effects of IFN on ICP4 levels may involve gene silencing factors, including histone 
deacetylases.  
 
 Since Chapter 4 showed that PRV appears to efficiently circumvent IFN-mediated 
translation inhibition by interfering with phosphorylation of eIF2α in 50B11 cells, we 
investigated the mechanism of PRV-mediated suppression of eIF2α phosphorylation in 
Chapter 6. Inhibition of phosphorylation of eIF2α has been reported earlier for HSV-1 through 
its ICP34.5 protein. PRV however does not encode an orthologue of ICP34.5. We report that 
PRV actively dephosphorylates eIF2α, rather than preventing its phosphorylation as PRV is 
not only able to remove basal levels of eIF2α phosphorylation, but also thapsigargin-pre-
induced levels. Assays using cycloheximide (inhibitor of protein synthesis) or 
phosphonoacetic acid (inhibitor of replication and therefore alphaherpesvirus late protein 
expression) showed that de novo expression of one or more (immediate) early viral protein(s) 
was required for eIF2α dephosphorylation. Infection with UV-inactivated PRV confirmed 
these results. PRV encodes only one immediate-early protein, IE180, the orthologue of HSV-
1 ICP4. A combinational treatment of 50B11 cells with cycloheximide and actinomycin D 
allowed the sole expression of IE180 in PRV infected cells which still resulted in a substantial 
reduction in eIF2α phosphorylation, indicative for an involvement of IE180 in this process. In 
support of this, transfection of IE180 also reduced phosphorylation of eIF2α. Taken together, 
we show that IE180 causes dephosphorylation of eIF2α. These data were confirmed in 
porcine ST cells. Active dephosphorylation of eIF2α implies the involvement of a cellular 
phosphatase as the virus does not encode a viral phosphatase. By using a PP1-specific 
inhibitor we showed that inhibition of the cellular phosphatase PP1 interfered to some extent 
with PRV-mediated dephosphorylation of eIF2α, indicating that PP1 may be involved in the 
IE180-mediated dephosphorylation of eIF2α, although IE180 did not upregulate PP1 protein 
expression. In conclusion, the immediate-early IE180 protein of PRV has the previously 
uncharacterized ability to cause dephosphorylation of the eukaryotic translation initiation 
factor eIF2α. 
 In conclusion, based on the findings in the current thesis, we hypothesize that 
interferon promotes the establishment of alphaherpesvirus latency in sensory neurons, likely 
through inhibition of immediate-early gene expression both at the mRNA and protein level. 
Chapter 8 – Summary – Samenvatting 
 
 
137 
We hypothesize that the inhibitory effect of IFN on IE mRNA expression occurs partly 
through histone modifications, including histone deacetylases and the induction of 
components involved in repressor complexes like CoREST/REST/HDAC/LSD1. As a 
countermeasure towards the suppressive effects of IFN on viral replication, we have found 
that the IE180 protein of PRV causes dephosphorylation of eIF2α, at least partly through the 
cellular phosphatase PP1. We hypothesize that IE180 causes these effects either through 
upregulation of components involved in PP1-mediated effects (apart from PP1 itself) or 
through establishing interactions with and thereby affecting the activity of PP1 or PP1-
regulating factors.  
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Samenvatting 
 Herpesvirussen hebben de unieke eigenschap dat ze een latente, slapende infectie 
kunnen veroorzaken. Alfaherpesvirussen veroorzaken dergelijke latente infectie veelal in 
sensorische neuronen. Het wordt steeds duidelijker dat het gastheer immuunsysteem, het 
neuron en het virus zich gedragen als een “triple entente” om een latente infectie in te stellen 
en te onderhouden. De belangrijkste doelstelling van deze thesis was om een beter inzicht te 
verwerven in de interactie tussen het immuunsysteem, het neuron en het virus. 
 Het eerste hoofdstuk omvat een korte inleiding over alfaherpesvirussen in het 
algemeen, over de neuronen waarin latentie optreedt door alfaherpesvirussen en over 
alfaherpesvirus latentie zelf. Aangezien interferon, een sterke antivirale component van het 
immuunsysteem, een belangrijk element vormt in deze thesis, wordt in dit inleidende 
hoofdstuk ook een overzicht gegeven van de antivirale effecten van interferon en de 
mechanismen die alfaherpesvirussen hebben ontwikkeld om deze antivirale effecten te 
omzeilen. 
 Hoofdstuk 2 beschrijft de doelstellingen van deze thesis.  
 In hoofdstuk 3, hebben we, gebruik makend van een in vitro model dat het mogelijk 
maakt om de natuurlijke infectie route van een alfaherpesvirus infectie in sensorische 
neuronen na te bootsen, aangetoond dat interferon alfa (IFNα) in staat is om een slapende 
HSV-1 en PRV infectie te veroorzaken die sterke gelijkenissen vertoont met in vivo latentie. 
Latentie bij HSV-1 en PRV wordt gekarakteriseerd door de afwezigheid van virale eiwitten, 
maar de aanwezigheid van viraal DNA dat kan reactiveren onder invloed van bepaalde 
stress factoren. Toediening van IFNα aan de in vitro gecultiveerde primaire TG neuronen 
resulteerde in een stabiel onderdrukte HSV-1 en PRV infectie in respectievelijke 100% en 
45% van de voor het virus toegankelijke. HSV-1 en PRV latentie in vivo wordt vaak 
vergezeld door de expressie van latentie-geassocieerde transcripten (LATs). RT-PCR werd 
gebruikt voor de detectie van LAT of de lytische transcripten IE180 en gB (PRV) of ICP0 en 
gD (HSV-1). Zowel voor PRV als HSV-1 waren productief geïnfecteerde neuronen positief 
voor zowel lytische als latente transcripten. De TG culturen die enkel door IFNα onderdrukt 
virus bevatten waren ofwel enkel positief voor LAT, ofwel positief voor zowel LAT als ICP0 
(dit suggereert dat deze neuronen op de overgang van latentie naar reactivatie staan). 
Infectie van TG neuronen met een HSV-1 mutant die LacZ tot expressie brengt onder 
controle van de LAT promoter bevestigde de activatie van de LAT promoter in TG culturen 
met onderdrukte virusinfectie. Voor beide virussen resulteerde behandeling van deze 
culturen met forskoline in reactivatie. Op basis van deze gecombineerde data kan gesteld 
worden dat een uniek in vitro model voor alfaherpesvirus latentie werd opgesteld. De data 
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impliceren daarenboven dat IFNα een drijvende kracht kan vormen bij het instellen van 
alfaherpesvirus latentie in sensorische neuronen. Interessant hierbij was dat het instellen van 
latentie in vitro door toediening van IFNα correleerde met de onderdrukking van de expressie 
van immediate early (IE) genen ICP4 (HSV-1) en IE180 (PRV). Bij HSV-1 werd de expressie 
van ICP4 snel en efficiënt onderdrukt door IFNα, wat correleerde met de efficiënte instelling 
van latentie van dit virus  in vitro. Voor PRV, daarentegen, werd het IE180 eiwit minder 
efficiënt onderdrukt en in een lager percentage cellen wat ook correleerde met het 
percentage van latentie in vitro. Dit suggereert dat de IFN-gemedieerde onderdrukking van 
IE expressie zoals ICP4 en IE180 belangrijk kan zijn bij de overgang naar een latente 
alfaherpesvirus infectie.    
 Aangezien IFN-geïnduceerde latentie in vitro bleek te correleren met de IFN-
gemedieerde onderdrukking van de IE eiwitten ICP4 van HSV-1 en zijn ortholoog IE180 van 
PRV, werd in hoofdstuk 4 onderzocht op welk niveau (mRNA en/of eiwit) de IFN-
gemedieerde onderdrukking van ICP4 en IE180 in sensorische neuronen plaatsvindt. 
Aangezien het werken met primaire TG neuronen teveel technische problemen met zich 
meebracht om dit te ontrafelen, werd geopteerd voor het gebruik van een continue cellijn 
afkomstig van rat DRG neuronen, 50B11 cellen. Door gebruik te maken van RT-qPCR 
werden de mRNA expressieniveaus vergeleken van ICP4 (HSV-1) en IE180 (PRV) in stalen 
zonder en met IFN voorbehandeling. Voor beide virussen waren de resultaten gelijkaardig. 
Het bleek dat expressie van zowel ICP4 als IE180 op 4hpi niet significant verschillend was 
met of zonder IFN behandeling terwijl een sterke reductie werd waargenomen in de IFN-
behandelde stalen op 8hpi en 12hpi. Echter, bij het bestuderen van de eiwitniveaus bleek dat 
op 4hpi de ICP4, maar niet de IE180 expressie, sterk gereduceerd was in IFN behandelde 
stalen. Dit impliceert dat voor HSV-1, IFN behandeling resulteert in een snelle onderdrukking 
van ICP4 eiwitniveaus mogelijk door reductie van translatie. Voor beide virussen is er een 
(tragere) onderdrukking van ICP4/IE180 mRNA gehaltes, mogelijk door inhibitie van 
transcriptie. PRV lijkt echter te ontsnappen aan de snelle IFN-gemedieerde onderdrukking 
van IE180 eiwitgehaltes. Om het verschil te verklaren in capaciteit van IFN om enerzijds 
HSV-1 ICP4 en anderzijds PRV IE180 eiwitgehaltes te onderdrukken, werd het niveau van 
fosforylatie van de eukaryote translatie initiatie factor eIF2α bepaald. Eén van de sterkste 
antivirale effector mechanismen van IFN bestaat immers uit PKR-gemedieerde fosforylatie 
van de translatie initiatie factor eIF2α wat resulteert in het inhiberen van translatie. In 
overeenstemming met het waargenomen verschil in IFN-gemedieerde onderdrukking van 
ICP4 versus IE180 proteïneniveaus, bleek dat IFN behandeling zorgde voor een verhoogde 
fosforylatie van eIF2α in HSV-1-, maar niet in PRV-geïnfecteerde cellen. Dit wijst erop dat 
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PRV in staat is om op een efficiënte manier de IFN-gemedieerde inhibitie van translatie 
tegen te werken door te interfereren met de fosforylatie van eIF2α.     
 Aangezien hoofdstuk 4 toonde dat IFN voorbehandeling resulteerde in een 
onderdrukking van HSV-1 ICP4 (en PRV IE180) mRNA niveaus tijdens latere stadia van 
infectie, werd deze ogenschijnlijke blokkade van transcriptie verder bestudeerd in hoofdstuk 
5. Steeds meer data suggereren dat transcriptie van alfaherpesvirussen gecontroleerd wordt 
door chromatine veranderingen. Vooral het repressieve CoREST/REST/HDAC/LSD1 
complex blijkt transcriptie van het virale genoom te controleren en werd gesuggereerd 
betrokken te zijn bij alfaherpesvirus latentie. Daarom werd de rol van histon-modificaties  
bestudeerd in de IFN-gemedieerde onderdrukking van ICP4 in HSV-1 geïnfecteerde cellen. 
Eerst werd de betrokkenheid van histon deacetylasen (HDACs) geëvalueerd door gebruik te 
maken van de inhibitor trichostatin A (TSA). RT-qPCR analyse toonde dat behandeling van 
TSA het onderdrukkend effect van IFN op ICP4 mRNA niveaus gedeeltelijk kon 
tegenwerken. Vervolgens werd dit bevestigd op eiwitniveau door zowel immunofluorescente 
kleuringen als Western blotting. Deze data suggereren dat het IFN-gemedieerde 
onderdrukkende effect op ICP4 expressie deels veroorzaakt wordt door betrokkenheid van 
histon deacetylases. In een volgende stap werden de eiwitniveaus van verschillende 
componenten van het CoREST/REST/HDAC/LSD1 repressorcomplex vergeleken in mock 
versus IFN-behandelde stalen. IFN bleek in staat om CoREST expressie te verhogen, terwijl 
LSD1 en HDAC expressie onveranderd bleef. Deze data suggereren dat het onderdrukkende 
effect van IFN op ICP4 mede het gevolg kan zijn van genoom silencing waarbij histon 
deacetylasen betrokken zijn.      
 Aangezien in hoofdstuk 4 aangetoond werd dat PRV in staat is om op een efficiënte 
manier de IFN-gemedieerde inhibitie van translatie tegen te werken door te interfereren met 
de fosforylatie van eIF2α in 50B11 cellen, werd in hoofdstuk 6 het mechanisme hiervan 
verder onderzocht. Inhibitie van fosforylatie van eIF2α werd eerder beschreven voor HSV-1 
via het ICP34.5 eiwit van dit virus. PRV echter heeft geen ortholoog voor ICP34.5. Verlaagde 
fosforylatieniveaus van eIF2α kunnen te wijten zijn aan verhinderde fosforylatie van dit eiwit 
of actieve defosforylatie van het eiwit. PRV bleek te zorgen voor actieve defosforylatie eerder 
dan voorkomen van fosforylatie aangezien zowel basale als thapsigargine-geïnduceerde 
niveaus van fosforylatie van eIF2α teniet gedaan werden door PRV infectie. Om na te gaan 
welk viraal eiwit verantwoordelijk is voor deze defosforylatie van eIF2α, werd eerst het 
stadium van infectie bepaald waar defosforylatie optreedt. Experimenten met cylcoheximide 
(inhibitor van proteine synthese) en phosphonoacetic acid (inhibitor van replicatie en 
daardoor expressie van late eiwitten van alfaherpesvirussen) toonden aan dat de novo 
expressie van één of meer (I)E virale eiwitten nodig zijn om eIF2α te defosforyleren. Infectie 
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experimenten met UV geïnactiveerd PRV bevestigde deze resultaten. PRV codeert slecht 
voor één IE eiwit, namelijk IE180, het ortholoog van ICP4. Een combinatie behandeling van 
cycloheximide en actinomycine D laat toe om enkel IE180 tot expressie te laten komen in 
PRV geïnfecteerde cellen. Deze behandeling resulteerde nog steeds in een substantiële 
reductie van gefosforyleerd eIF2α wat impliceert dat IE180 betrokken is bij dit proces. Om dit 
te bevestigen werden IE180 transfectie experimenten uitgevoerd, waarbij opnieuw een 
significante reductie van gefosforyleerd eIF2α werd bekomen. Deze data tonen dus aan dat 
IE180 verantwoordelijk is voor de defosforylatie van eIF2α. Deze data werden verder 
bevestigd in porciene ST cellen. Actieve defosforylatie van eIF2α impliceert de betrokkenheid 
van een cellulair fosfatase aangezien het virus zelf niet codeert voor een fosfatase. Door 
gebruik te maken van een inhibitor van het cellulaire fosfatase PP1 werd aangetoond dat 
PP1 betrokken lijkt te zijn bij de IE180-gemedieerde defosforylatie van eIF2α. IE180 zorgde 
echter niet voor een opregulatie van PP1 eiwitexpressie. Samenvattend werd aangetoond 
dat het IE eiwit IE180 van PRV de voorheen onbeschreven eigenschap heeft om 
defosforylatie van eIF2α te veroorzaken. 
 Gebaseerd op de bevindingen van deze thesis, stellen we de hypothese op dat 
interferon het instellen van een alfaherpesvirus latente infectie promoot in sensorische 
neuronen, vermoedelijk via inhibitie van IE gen expressie zowel op mRNA als eiwitniveau. 
We suggereren dat het inhibitorisch effect van IFN op IE mRNA expressie deels voorkomt uit 
IFN-geïnduceerde histon-modificaties, waarbij histon deacetylasen betrokken zijn, mogelijk 
via het repressorcomplex CoREST/REST/HDAC/LSD1. Om het onderdrukkende effect van 
IFN op virale vermeerdering te omzeilen blijkt IE180 van PRV aanleiding te geven tot 
defosforylatie van eIF2α, waarbij het cellulaire fosfatase PP1 deels betrokken lijkt te zijn. We 
suggereren dat IE180 dit effect veroorzaakt ofwel door opregulatie van componenten die 
betrokken zijn bij PP1-gemedieerde effecten (maar niet PP1 zelf) ofwel door een interactie 
aan te gaan met PP1 of PP1-regulerende factoren. 
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beetje teveel voor de gezondheid . Ik wens je heel veel succes in de toekomst en hopelijk 
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dingen . Jammer dat je nu in Amerika zit, maar heel leuk voor jou natuurlijk. Geniet ervan 
en vooral profiteer ervan en dan terug aan het werk . Karen, ik hoop dat je de moed vindt 
om te blijven doorgaan ondanks de tegenslagen van de laatste tijd. Ik vond het super dat ik 
altijd bij je terecht kon voor een leuke babbel doelgericht of gewoon om de tijd te doden . Ik 
wens je dan ook alle succes van de wereld om verder te doen. De volledige targeting-groep 
wil ik een duwtje in de rug geven om de moed erin te houden. Iedereen van de FIP-groep, 
heel veel succes met jullie onderzoek. Sjouke, heel succes nog met je doctoraat. Aan 
iedereen, ik wens jullie heel veel karakter om vol te houden. Doorzettingsvermogen is een 
must voor PhDs en Yes, we can! 
 
Eva, de wereld is heel klein. Eerst mijn zus en dan ikzelf, wie had dat gedacht . Ik vond het 
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en ik zie je ongetwijfeld nog wel! Tine, jou kende ik al van vroeger op de feestjes van Marjan 
en Maartje en het was dan ook een leuke verrassing toen jij bij ons kwam werken. Aangezien 
je nu beslist hebt om weg te gaan, ik wens je heel veel succes op je nieuwe job en ook wij 
zien elkaar nog wel in de toekomst . Philippe, jij gaat dan weer terug naar mijn Bio-
ingenieursjaren en het was leuk om met je samen te werken. Veel succes nog met het 
afronden van de doctoraat en nu zeker ook met Arthurke. Edith, jij bent al weg en dus wil ik 
je geluk wensen in je job. Delfien, veel succes met de laatste fase van je doctoraat en met 
Aurélie. Kim, Johanna and Anastasia, I wish you all the best of luck for the IWT. Ut and Bakr, 
good luck with the future experiments. Gosia, heel veel succes met het assistentschap en 
het doctoraat. Bert en Simon, de twee fluiters die je van ver hoor aankomen, merci voor het 
goede humeur en de vele grapjes. Vesna, Michaela en Annelies, bedankt voor de interesse 
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brengen, ook al wordt dat meestal niet in dank afgenomen. Pieter, welkom aan boord van de 
Immuno. Rudy en Denise, bedankt om jullie bezig te houden met algemene dingen zodat wij 
daar geen tijd mee verliezen. Ik wil jullie allemaal bedanken voor de heerlijke taartmomenten. 
 
Naast het leven in het labo, ja dat bestond ook nog, waren er nog mijn fantastische 
vriendinnen! Onze Ladies Nights waren super en werkten steeds opbeurend voor mijn 
humeur. Maartje, Marjan, Miet, Naomi en Tanja, jullie hebben mij steeds bijgestaan en 
gesteund , opgepept indien nodig en wij hebben een super leuke tijd achter de rug. Maartje, 
jij bent zeker goed bezig met je doctoraat en dus kan ik alleen maar zeggen: doe zo verder! 
Ik kijk al uit naar de moment dat ik naar Antwerpen mag komen om jouw verdediging te 
bekijken. Je bent een schat en je staat altijd klaar voor iedereen. Marjantje, merci voor je 
hulp met Pixie  en voor alle keren dat je opgewektheid mijn dag heeft goedgemaakt. Jij 
hebt met je eeuwige optimisme meerder conversaties een positieve draai kunnen geven. Ik 
hoop dat, als je naar zee verhuist, we elkaar nog voldoende gaan zien maar in elk geval veel 
succes aan ’t Zeetje . Naomi, jij woont misschien iets verder, maar dat maakt onze 
vriendschap er niet minder op. Merci voor de behandelingen van mijn nek/rug. Ik wil je alle 
succes wensen met je praktijk en neem op tijd een beetje tijd voor jezelf. Je bent een 
fantastische meid en verdient het beste van de wereld. En nog een dikke merci aan je papa 
voor het maken van de cover! Miet, we hebben 3 jaar lang samen geleefd wat misschien als 
nadeel had dat we het werk ook mee naar huis namen, maar we hebben er ook voldoende 
voordeel uitgehaald om te compenseren . Je fantastische danspasjes zijn super om te zien 
en werken aanstekelijk voor iedereen rondom jou. Je bent een echt kameraadje en ik weet 
dat ik op je kan rekenen. Je hebt nu genoeg tegenslagen te verwerken gekregen, maar ik 
ben zeker dat je er sterker zal uitkomen. Ik kan alleen maar zeggen, blijf volhouden, bijt op je 
tanden en ga ervoor. Je moet alleen maar in  jezelf geloven! En dan is er nog Tanja, lieve 
Tanja, jij hebt zo vaak naar mijn gezaag en geklaag moeten luisteren, maar door het 
volhouden om te gaan tennissen, slaagden we er toch in om een beetje ontspanning te 
creëren in ons veel te drukke leven . Merci om het blijven vol te houden met mij, je bent 
een vriendin uit de duizend. Ik hoop dat ook jij een nieuwe uitdaging vindt in je werk en ik 
wens je in elk geval heel veel plezier in je nieuwe huis. We gaan dat zeker komen inwijden 
. Ladies, dat we nog vele leuke tijden mogen meemaken. En guys, merci om onze 
vrouwenavonden zo goed te verdragen . Ook alle bio-ingenieursvriendjes wil ik bedanken 
voor de leuke tijd die we altijd samen hebben. En aan iedereen die ook in het 
doctoraatsschuitje zit: heel veel succes! 
 
En dan zijn er nog mijn zusje en schoonbroertje. Sara en Siegfried, merci om me altijd te 
steunen en in me te geloven. De vele familiemomenten zijn altijd fantastisch en ik weet dat ik 
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altijd op jullie kan rekenen. Saartje, je staat aan het begin van een nieuwe uitdaging en ik 
wens je heel veel succes als mama. Zelf bij jou zal het mama-gevoel de bovenhand krijgen 
. Je kan er van op aan dat de meter en de peter er zullen zijn om een oogje in het zeil te 
houden. Siegfried, blijf goed zorgen voor mijn zusje en ons ‘Irène’ . Mams en paps, 
bedankt voor alle kansen die jullie mij hebben gegeven, voor het blijvende vertrouwen en alle 
steun die ik gekregen heb. Jullie hulp is maar één telefoontje weg en jullie staan altijd klaar 
voor alles wat we nodig hebben. You’re the best! Merci voor alles! Pépé Ninove, bedankt 
voor je steun. Mijn liefste mémé en pépé Outer, ook al hebben jullie dit niet meer kunnen 
meemaken, jullie zouden trots geweest zijn op jullie kleindochter!  
 
Last but not least wil ik mijn vriend, Guillaume, bedanken voor het geduld en steun. Lieveke, 
je hebt ervoor gezorgd dat ik tijdig mijn gedachten kon verzetten met je super 
verrassingsuitstapjes tijdens dit laatste zware jaar en ik moet zeggen, ik had het niet zonder 
gekund. Je eindeloze geduld en steunende woorden hebben me geholpen om de lastigste 
periode door te komen. Blot na blot na blot en toch deed je me geloven dat het de laatste 
waren . Merci voor dit zware jaar toch fantastisch te maken! Je speelt samen met Pixietje 
een enorm grote rol in mijn leven! En nu gaan we genieten van een welverdiende vakantie in 
de zon!  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
